Table of Contents

f

UNITED STATES

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K


FORM 10-K

(Mark One)

xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2017, 2023

OR

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244


VEECO INSTRUMENTS INC.INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

11-2989601

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

Terminal Drive

Plainview, New York

11803

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code:

(516) (516677-0200

Securities registered pursuant to Section 12(b) of the Act:

(Title of each class)class

Trading Symbol(s)

(Name of each exchange on which registered)registered

Common Stock, par value $0.01 per share

VECO

The NASDAQ Stock Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes oNo x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by references in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x

Accelerated filer

Accelerated filer o

Emerging growth company

Non-accelerated filer o (Do not check if a smaller reporting company)

Smaller reporting company o

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). o Yes x No

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).

The aggregate market value of the common stock held by non-affiliates of the registrant at June 30, 20172023 (the last business day of the registrant’s most recently completed second quarter) was $1,328,017,475$1,411,275,157 based on the closing price of $27.85$25.68 on the NASDAQ StockGlobal Select Market on that date.

The numberAs of February 13, 2024, there were 56,366,998 shares of each of the registrant’s classes of common stock outstanding on February 14, 2018 was 48,156,865 shares of common stock, par value $0.01 per share.share, outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the definitive Proxy Statement to be used in connection with the Registrant’s 20182024 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.10-K.



2

This Annual Report on Form 10-K (“Form 10-K”) contains certain forward-looking informationstatements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, relating to Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “Registrant,” “we,” “our,” or “us,” unless the context indicates otherwise) that isare based on the beliefs of,management’s expectations, estimates, projections, and assumptions made by, our management as well as information currently available to management.assumptions. When used in this Form 10-K, the words “believes,such as “expects,” “anticipates,” “expects,“plans,” “believes,” “scheduled,” “estimates,” “targets,” “plans,” “intends,” “will,”and variations of these words and similar expressions relating to the future are intended to identify forward-looking information.statements. Discussions containing such forward-looking statements may be found in Part I, Items 1 and 3, Part II, Items 7 and 7A hereof, as well as within this Form 10-K generally. This forward-looking information reflectsForward-looking statements in this discussion include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for the current views with respect toand future eventsperiods, our ongoing transformation initiative and isthe effects thereof on our operations and financial results, and other statements that are not historical facts. These statements and their underlying assumptions are subject to certain risks and uncertainties and assumptions, someare not guarantees of which are described under the caption “Risk Factors” in Part I, Item 1A, and elsewhere in this Form 10-K. Should one or more of these risks or uncertainties occur, or should our assumptions prove incorrect,future performance. Factors that could cause actual results may varyto differ materially from those expressed or implied by such statements include, without limitation:

Risks Related to Our Business and Industry

Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results;

We face significant competition;

We operate in industries characterized by rapid technological change;

Certain of our sales are dependent on the demand for consumer electronic products and automobiles, which can experience significant volatility;

We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries;

The cyclicality of the industries we serve directly affects our business;

Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand;

We rely on a limited number of suppliers, some of whom are our sole source for particular components;

Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations;

The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

Our sales cycle is long and unpredictable;

Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed;

We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures;

Risks Associated with Operating a Global Business

We are exposed to risks of operating businesses outside the United States;

3

Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition;

We may be unable to obtain required export licenses for the sale of our products;

We are exposed to various risks associated with global regulatory requirements;

Risks Related to Intellectual Property and Cybersecurity

Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us;

We may be unable to effectively enforce and protect our intellectual property rights;

We may be subject to claims of intellectual property infringement by others;

Financial, Accounting and Capital Market Risks

Our operating results may be adversely affected by tightening credit markets;

We are subject to foreign currency exchange risks;

We may be required to take impairment charges on assets;

Changes in accounting pronouncements or taxation rules, practices, or rates may adversely affect our financial results;

Our current debt facilities may contain certain restrictions, covenants and repurchase provisions that may limit our ability to raise the funds necessary to meet our working capital needs, which may include the cash conversion of the Notes or repurchase of the Notes for cash upon a fundamental change;

Issuance of our common stock, if any, upon conversion of the Notes, as well as the capped call transactions and the hedging activities of the option counterparties, may impair or reduce our ability to utilize our research and development credits carryforwards in the future;

The capped call transactions may affect the value of the 2027 Notes and our common stock;

General Risk Factors

The price of our common shares is volatile and could decrease;

Our inability to attract, retain, and motivate employees could have a material adverse effect on our business;

We are subject to risks of non-compliance with environmental, health, and safety regulations;

We are exposed to risks associated with the increased attention by our stakeholders to environmental, social and governance (“ESG”) matters; and

We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult.

4

All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the forward-looking information describeddate of this filing or, in this Form 10-K as believed, anticipated, expected, estimated, targeted, planned,the case of any document referenced herein or similarly identified. We doincorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect future events, circumstances or circumstanceschanges in expectations after the date of such statements.this filing.

PART I

Item 1. Business

Recent Developments

On May 26, 2017, we completed the acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports atomic layer deposition (“ALD”) equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. With the addition of Ultratech, we establish ourselves as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications, as well as greatly increasing our critical mass in the front-end semiconductor market. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Business Description and Overview

Headquartered in Plainview, New York, we were organized as a Delaware corporation in 1989. We develop, manufacture, sell, and supportare a manufacturer of advanced semiconductor process equipment to meet the demandsthat solves an array of key global trends such as enhancing mobility, increasing connectivity, and improving energy efficiency.challenging materials engineering problems for our customers. Our primary technologies includecomprehensive collection of ion beam, laser annealing, metal organic chemical vapor deposition (“MOCVD”), chemical vapor deposition (“CVD”), advanced packaging lithography, single wafer wet etch and clean, laser annealing, ion beam,processing, molecular beam epitaxy wafer inspection,(“MBE”), and atomic layer deposition systems. These(“ALD”) technologies play an integral role in producing Light Emitting Diodesthe fabrication of key devices that are enabling the 4th industrial revolution of all things connected. Such devices include leading advanced node application processors for AI chips, mobile devices, high-speed data communications, and radio frequency (“LEDs”RF”) filters and power amplifiers for solid-state lightingfifth generation (“5G”) networks and mobile electronics, photonics devices for 3D sensing, advanced displays, and thin film magnetic heads for hard disk drives in the fabricationdata storage. In close partnership with our customers, we combine decades of applications and packagingmaterials know-how with leading-edge systems engineering to deliver high-volume manufacturing solutions with competitive cost of advanced semiconductor devices. Weownership. Serving a global and highly interconnected customer base, we have comprehensive sales and service operations across the Asia-Pacific, region, Europe, and North America regions to address our customers’ needs.ensure real-time close collaboration and responsiveness.

We are focused on:Markets

·                              Providing differentiated semiconductor process equipment to address customers’ current production requirements and next generation product development roadmaps;

·                              Investing to win through focused research and development in markets that we believe provide significant growth opportunities or are at an inflection point in semiconductor process equipment requirements, including LED, power electronics, photonics, front-end semiconductor, and advanced packaging technologies;

·                              Leveraging our sales channel and local process applications support teams to build strong strategic relationships with technology leaders;

·                              Expanding our services portfolio to improve the performance of our systems, including spare parts, upgrades, and consumables to drive growth, reduce our customers’ cost of ownership, and improve customer satisfaction;

·                              Cross-selling our product portfolio across our broad customer base and end markets to both maximize sales opportunities and diversify our business;

·                              Utilizing a combination of outsourced and internal manufacturing strategies to flex manufacturing capacity through industry investment cycles without compromising quality or performance; and

·                              Pursuing partnerships and acquisitions to expand our product portfolio into new and adjacent markets to drive sales growth.

Our products are sold to semiconductor and advanced packaging device manufacturerspurchased by customers in the following four markets: Advanced Packaging, MEMS & RF Filters; LED Lighting, Display &end-markets: 1) Semiconductor; 2) Compound Semiconductor; Front-End Semiconductor;3) Data Storage; and 4) Scientific & Industrial.Other.

Markets

Our array of process equipment systems are used in the creationproduction of a broad range of microelectronic components, including LEDs, micro-electro mechanical systemslogic, dynamic random-access memory (“MEMS”DRAM”), radio frequency (“RF”) filters,photonics devices (including laser diodes and micro-LEDs), power electronics, thin filmRF filters and amplifiers, magnetic heads (“TFMHs”), laser diodes, 3D NAND logic,for hard disk drives, and other semiconductor devices. In additionMany of our systems are used to deposit advanced materials critical to the creationoperation of microelectronic components,the device and some of our systems are used in cleaning and surface preparation as well as the precise removal of critical materials. We are also a leader in systems used in the advanced packaging process flow of suchmicroelectronic components in applications such as flip chip, Fan out Wafer Level Packagingfan-out wafer level packaging (“FOWLP”), and other wafer level packaging approaches. Ourapproaches used in the modern integration of diverse semiconductor products, especially in consumer electronics. In general, our customers who manufacture these devices invest inpurchase our systems to both produce current-generation devices in volume and to develop next generationnext-generation products andwhich deliver more efficient, cost effective,cost-effective, and advanced technological solutions. We operate in aseveral highly cyclical business environment,environments, and our customers’ buying patterns are dependent upon industry trends. Ourtrends and buying patterns for consumer electronics. As our products are sold into multiple markets, the following table describes these markets and the following discussion focuses on the trends that most influence our business within eachapplicable Veeco technologies.

Markets

Description

Applicable Veeco Technologies

Semiconductor

The Semiconductor market refers to process steps in logic and memory applications where silicon wafers are processed. There are many different wafer level process steps in forming patterned wafers, such as deposition, etching, masking, and doping. As device architectures continue to shrink with advanced nodes, more precise process control is paramount to achieving high yields and competitive cost. One such process step is called Laser Annealing,

Laser Annealing

Ion Beam Deposition (“IBD”)

Ion Beam Etch (“IBE”)

Wet Processing

Advanced Packaging Lithography

5

which uses a very precise method to activate dopants, reduce contact resistance and modify material grain structure. The Veeco laser annealing technology enables our customers to have a lower thermal budget by annealing at higher temperatures over a shorter period of time.

This market also includes mask blank production for extreme ultraviolet (“EUV”) lithography, where Veeco’s Ion Beam Deposition technology is used for deposition of the multi-layer EUV reflective coating. Veeco’s Ion Beam technology is also under evaluation for deposition of low resistivity metals for 300mm front end applications.

Veeco’s Advanced Packaging technologies include a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors. Demand for higher performance, smaller form factors, and lower power consumption in applications such as artificial intelligence, mobile devices, consumer electronics, and high-performance computing is driving the adoption of advanced packaging technologies.Veeco serves the advanced packaging market with lithography as well as wet processing equipment.

6

Compound Semiconductor

The Compound Semiconductor market includes Power Electronics, Photonics, RF Filters and Amplifiers, and Solar power applications.

Power Electronics refers to semiconductor devices used in the control and conversion of electric power in growing applications such as wireless charging of consumer electronics and automotive applications. The power electronics market has historically been dominated by silicon devices. However, demand has been rapidly growing for applications in automotive driven by adoption of electric vehicles (“EV”), energy and industrial end-markets which require compound semiconductor devices such as those made from gallium nitride and silicon carbide to address higher voltages and higher power requirements.

Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”).

Micro-LEDs may be used for next generation advanced displays. A micro-LED display is a self-emissive display that offers improved resolution, contrast, and brightness versus conventional technologies. Micro-LEDs will be used in a number of applications from televisions, smartwatches, to augmented reality headsets.

RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications.

Solar power or photovoltaic technology refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Gallium Nitride (“GaN”) MOCVD

Arsenides/ Phosphides (“As/P”) MOCVD

Wet Processing

MBE

ALD

IBE

SiC Chemical Vapor Deposition (“CVD”)

Data Storage

Data Storage refers to the Hard Disk Drives (“HDD”) market which provides significant value for mass storage and is an important part of large capacity storage applications such as Data Centers. Our systems enable customers to manufacture the magnetic heads for hard disk drives.

IBD

IBE

Physical Vapor Deposition

Mechanical (Lapping and Dicing)

Diamond Like Carbon Deposition

Wet Processing

7

Scientific & Other

Scientific & Other refers to advanced materials and device research such as quantum computing, and a range of manufacturing applications including optical devices (lasers, mirrors, optical filters, and anti-reflective coatings).

Ion Beam Sputtering for optical coatings

MBE for specialized laser and sensor devices

Wet Processing for sensors

ALD for a variety of applications

System Products

Advanced Packaging, MEMS & RF Filters

Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable the miniaturization and performance improvement of electronic products, such as smartphones, smartwatches, and other mobile applications.

Demand for higher performance, increased functionality, smaller form factors, and lower power consumption in mobile devices, consumer electronics, and high performance computing is driving the adoption of advanced packaging technologies. Semiconductor Foundries (“Foundries”), Independent Device Manufacturers (“IDMs”) and Outsourced Semiconductor Assembly and Test (“OSAT”) companies are implementing multiple advanced packaging approaches including FOWLP, recently deployed in high-volume manufacturing, and Through Silicon Via (“TSV”) to enable stacked memory, 2.5D, and 3D packaging devices. This increasing demand trend in Advanced Packaging is encouraging as our Lithography and Precision Surface Processing (“PSP”) products enable the process steps for Advanced Packaging.

MEMS devices are used for an increasing number of applications, including accelerometers for automobile airbags, pressure sensors for medical uses, and gyroscopes for a variety of consumer products, such as gaming consoles and mobile devices.

One of the fastest growing MEMS applications has been RF filters for mobile devices, driven by increasingly complex wireless standards, the exponential growth of mobile data, and carrier aggregation. In order to address these growing demands, the number of discrete RF filters in an average smartphone is expected to double from 50 to 100 by 2020. These trends are positive for us, particularly for our PSP products, where our technology is enabling some of the most challenging process steps, as well as our Ion Beam Etch (“IBE”) and Molecular Beam Epitaxy (“MBE”) products, which are used to create Bulk Acoustic Wave (“BAW”) and Surface Acoustic Wave (“SAW”) RF filters.

LED Lighting, Display & Compound Semiconductor

LED Lighting technology has existed for more than 50 years; however, commercial adoption of LEDs was limited to niche applications until the most recent decade. In the early 1990’s, researchers developed a process utilizing Gallium Nitride (“GaN”) that created a low cost blue LED to produce white light. With that breakthrough, the LED industry started, and the number of applications for LEDs began to expand.

Since that time, the LED industry has experienced multiple growth cycles brought on by the adoption of LED technology for consumer and commercial applications. The first wave of LED growth was driven by mobile phones, which implemented the use of LED technology for display backlighting. The LED industry experienced its second period of rapid growth as LEDs were adopted for TV display backlighting. The adoption of LEDs for solid state, general lighting gave rise to a third wave of demand. There is a broader fourth wave of compound semiconductor growth including LEDs, driven by ROY LED applications, optical communication and industrial applications requiring laser diodes, 3D sensing vertical-cavity surface emitting lasers (“VCSELs”), micro-LED displays, 5G RF infrastructure adoption, and power electronics.

Our metal organic chemical vapor deposition (“MOCVD”) technology is at the core of the manufacturing process for GaN-based LEDs. We have benefited with each growth cycle, as LED producers invest in MOCVD process equipment to capture share in these markets. Demand for our equipment has historically been cyclical in nature, influenced by multiple factors, including: macroeconomic conditions; prices for LED chips; supply and demand dynamics; and our customers’ manufacturing plans. However, we expect the ongoing adoption of LED lighting to be a major driver in the need for additional MOCVD capacity over the next several years.

MOCVD technology is equally important in the manufacturing of red, orange, and yellow (“ROY”) LEDs, which are used increasingly for fine-pitch digital signage and automotive lighting applications. For these applications, our MOCVD technology is used to deposit highly uniform Arsenic Phosphide (“AsP”) films which create amber and red hues. AsP MOCVD technology is also used to produce multiple other devices in the photonics market such as infrared LEDs and VCSELs used for optical data communication and 3D sensing. In addition to film deposition, photonics manufacturers also employ cleaning and etching process steps. Our PSP wet etch and clean technologies provide such cleaning and processing capabilities to photonics customers.

The Display market refers to LEDs or micro LEDs used directly for displays. Additionally, organic light emitting diode (“OLED”) displays are part of the Display market and are used in applications such as digital signage, smartphones,

wearable and tablet displays, and TVs. Our MOCVD systems and MBE source technology is ideally suited for the display market.

The Compound Semiconductor market refers to GaN-on-Silicon based power electronic devices and radio frequency devices. Our MOCVD and PSP technologies are crucial in the manufacturing of GaN-on-Silicon based power electronic devices. Global demand is increasing for advanced power electronics with greater energy efficiency, smaller footprints, higher operating temperatures, faster switching capabilities, and greater reliability. These devices support many needs, including more efficient IT servers, electrical motors, electric vehicles, wind turbines, and photovoltaic power inverters. While silicon-based transistors are widely used in power electronic devices today, GaN-on-Silicon based power electronics developed on MOCVD tools can potentially deliver higher performance (e.g., smaller power supply form factors, higher efficiency, and faster switching speeds). In addition to depositing the critical GaN layer with our MOCVD products, our PSP products address multiple etch and clean steps required to manufacture these advanced power electronics devices. In recent years, global industry leaders in power electronics have focused on research and development programs to commercialize this new technology. Device manufacturers will likely begin to transition from development to production of these devices over the next couple of years; we can benefit from this transition as our customers invest in process equipment to support this production ramp-up.

The Radio Frequency device portion of the Compound Semiconductor market is driven by demand for RF power amplifiers in mobile devices. Our PSP products are used for process steps such as metal lift off and photo resist strip for RF devices such as heterojunction bipolar transistors (“HBTs”) used in smartphones.

Front-End Semiconductor

Front-End Semiconductor refers to early process steps where transistors are formed directly on silicon. There are many different process steps in forming integrated circuits, such as Deposition, Etching, Masking, and Doping, where the microchips are created but still remain on the silicon wafer. Our Laser Spike Anneal products are well suited to assist our customers in the doping process. Our IBE for front-end semiconductor applications has been demonstrated in Spin Torque Transfer Magnetic Random Access Memory (“STT-MRAM”) applications. MRAM has many benefits over traditional random access memory such as its non-volatility, speed, endurance, and power consumption. Our Ion Beam Deposition (“IBD”) products are well suited for the manufacture of Extreme Ultraviolet (“EUV”) mask blanks. Our ability to precisely deposit high quality films with extremely low particulate levels make our IBD technology ideal for manufacturing defect-free EUV photomask blanks. The front-end semiconductor industry is expected to adopt EUV lithography to meet future device requirements. Future growth will depend on overall adoption of EUV technology. And lastly, our 3D inspection products are used for shape inspection of 3D topographies in memory and logic applications, which helps our customers improve their lithography and deposition processes.

Scientific & Industrial

The Scientific and Industrial markets include advanced materials research and a broad range of manufacturing applications including high-power fiber lasers, infrared detectors, thin film magnetic heads on HDDs, and optical coatings.

Our MBE systems are used by scientific research organizations and universities to drive new discoveries in the areas of materials science. MBE enables precise epitaxial crystal growth for a wide variety of materials, which supports the development of new performance materials used for emerging technologies. MBE technology is also used in the

manufacturing of products such as high-power lasers and infrared sensors. Our tools create highly uniform Gallium-Arsenide (“GaAs”) or Indium-Phosphide (“InP”) film layers, which are critical to the performance of these devices. Our PSP products are also used in the manufacture of infrared sensors.

Our Ion Beam Deposition, Ion Beam Etch, Physical Vapor Deposition (“PVD”), and lapping and dicing tools are used in data storage applications, including HDDs that will continue to provide significant value for mass storage and will remain an important part of large capacity storage applications. This is especially true for data center applications where large volumes of data storage are required to serve an increasingly mobile population. In addition, our IBD tools are used to produce high quality optical films for multiple applications including laser mirrors, optical filters, and anti-reflective coatings. Our tools deposit thin layers of advanced materials on various substrates to alter how light is reflected and transmitted.

Our ALD tools are sold into a variety of Scientific & Industrial market applications such as optical, semi/nano-electronics, MEMS, nanostructures, and biomedical.

System products

Metal Organic Chemical Vapor Deposition Systems

We are the world’s leading supplier of MOCVD systems. MOCVD production systems are used to make GaN-based devices (such as blue and green LEDs) and AsP-based devices (such as ROY LEDs), which are used in television and computer display backlighting, general illumination, large area signage, specialty illumination, power electronics, and many other applications. Our TurboDisc® EPIK® line of MOCVD systems enables cost per wafer savings for our customers with a combined advantage of best operating uptime, low maintenance costs, and best-in-class wafer uniformity and yield. In 2016, we introduced the TurboDisc K475i™ AsP MOCVD system, which offers best-in-class productivity and yields for ROY LEDs, infra-red LEDs, and high-efficiency triple junction photovoltaic solar cell applications. Our Propel™ PowerGaN™ MOCVD System (“Propel”) enables the development of highly-efficient GaN-based power electronic devices that have the potential to accelerate the industry’s transition from research and development to high volume production. The Propel system offers 200mm technology and incorporates single-wafer reactor technology for outstanding film uniformity, yield, and device performance.

Advanced Packaging Lithography

We have a leading position in the Advanced Packaging lithography equipment market. The Advanced Packaging market is driven by the need for improved performance, reduced power consumption, and smaller geometries for mobile and automotive applications. In turn, these applications continue to demand increasingly complex packaging techniques from IDMs, Foundries, and OSATs. Our Advanced Packaging tools are designed to optimize productivity for leading-edge 200mm and 300mm Advanced Packaging applications by enabling extremely reliable, cost-effective, high-volume manufacturing solutions. Our best-in-class yield coupled with outstanding resolution and depth of focus addresses all leading edge requirements for Advanced Packaging applications such as redistribution layers (“RDLs”), Copper Pillar, Micro-Bump, FOWLP, interposers, and TSVs to provide the lowest cost of ownership in the industry.

Precision Surface Processing Systems (Wet Etch and Clean)

Our PSP systems offer single wafer wet etch, clean, and surface preparation solutions which target high growth segments in advanced packaging, MEMS, LEDs, and compound semiconductor markets. The WaferStorm platform is based on PSP’s unique ImmJET™ technology, which provides improved performance at a lower cost of ownership than conventional wet bench-only or spray-only approaches. This highly flexible platform targets solvent based cleaning applications that require a significant level of process control and flexibility. The WaferEtch® platform provides highly uniform, selective etching with onboard end point detection for improved process control and yield in bumping applications. In addition, PSP has developed a state-of-the-art solution with the WaferEtch platform to address the

requirements of TSV reveal, in which the backside of a wafer is thinned to reveal the copper interconnects. PSP’s TSV technology offers a significant cost of ownership reduction compared with dry etch processing by replacing up to four separate process steps.

Laser Annealing Systems

The progression of Moore’s law has led semiconductor manufacturers to implement a variety of material and process changes to overcome the technical hurdles related to shrinking of feature sizes in integrated circuits. Along with new materials and smaller dimensions have come new process challenges. One such challenge has been new constraints on thermalOur laser annealing processes. One example is the thermal annealing of dopants for activation, in order to form the transistor junction, critical to the function and performance of a complementary metal-oxide semiconductor (“CMOS”) logic integrated circuit. In this and other thermal process steps, traditional lamp-based annealing techniques have challenges meeting the thermal budget (time/temperature regime) required by new materials and designs. Our Laser Spike Anneal (“LSA”) systems meet the industry demand for millisecondultra-short time-scale “millisecond” annealing, heating the wafer up to temperatures just below the Siliconsilicon melting point, over a range of ultra-short timeframes (microseconds to milliseconds), enabling thermal annealing solutions at the 65nm technology node and below.most advanced semiconductor process nodes. This advancedunique annealing technology provides solutionsa solution to the difficult challenge of fabricating ultra-shallow junctions and highly activated source/drain contacts at these advanced logic nodes. In addition, our proprietary hardware design enables outstanding temperature uniformity across the wafer and die, by minimizing the pattern-density effect, thus reducing absorption variations.

We have also developed aOur next generation melt annealnanosecond annealing technology targeted fortargets annealing advanced logic devices and memory devices at 7nm and below.advanced nodes. As FinFET devices scale, below the 10nm node, achieving the performance targets has become a challenge. To continue the roadmap, the industry is looking at new materials and the use of thermal processes that require nanosecond time-scale thermal annealing with temperatures exceeding the melting point. To help address this concern we have developed a unique (and patented) approach to nanosecond-scale thermal annealing. Our design utilizes two lasers; a millisecond laser as a low thermal budget localized preheat and a nanosecond laser “on top” of the millisecond laser to

raise the peak temperature to the melt temperature of the material being processed beyond silicon melt. Similar to LSA, the melt system architecture is targeted to reduce pattern effects and increase the process window. It is believedWe believe that our nanosecond annealing will be required to meet the device targets at 7nm and below; the initial application being explored by customers is contact annealing aimed to improve reduce source/drain contact resistance, which has become a performance bottleneck at the most advanced FinFETfuture nodes and as devices continue to scale, we see the application space forcomplements our melt product expanding.millisecond annealing solutions.

Ion Beam Deposition and Etch and Deposition Systems

Our NEXUS® IBD Ion Beam systems utilize ion beam technologyand IBD300 systems are used to deposit precise layers of thin films. IBD systems deposit high purityand etch thin film layers for multiple end applications in the Semiconductor, Data Storage, RF and provide excellent uniformity and repeatability.other various emerging markets. Our NEXUS® IBD system has a leading position in multiple markets including EUV mask blank manufacturing in which it enables our customers to deposit multilayers with high precision and ultra-low defects which is essential for EUV lithography. Our IBD300 system is being evaluated for 300mm front end semiconductor applications where low resistivity metals like tungsten, ruthenium and molybdenum are critical. The IBD systems are also critical in the manufacture of hard disk drive magnetic heads where they are used to deposit various magnetic and oxide layers and deliver best-in-class film properties. Our NEXUS® IBE systems utilize a charged particle beam consistingare used to precisely etch complex features on materials which are challenging to pattern by traditional reactive ion etching techniques. These systems are widely used in the data storage industry for patterning of ions to etchmagnetic and oxide materials and are essential for forming the precise complex features.shape of the magnetic head. The NEXUS® systems may be included on our cluster system platform to allow either parallel or sequential deposition/etch processes. These systems are used primarily by data storage, semiconductor, and telecommunications device manufacturers in the fabrication of discrete and integrated microelectronic devices.

Our SPECTOR® Ion Beam Sputtering system was developed for high precision optical coatings and offers manufacturers state of the art optical thickness monitoring, improved productivity, and target material utilization, for cutting-edge optical interference coating applications. We also provide a broad array of ion beam sources. These technologies are applicable

8

Advanced Packaging Lithography

Our lithography equipment is used in the HDD industryAdvanced Packaging market for applications such as FOWLP, Flip Chip (including Copper Pillar), Fan In Wafer Lever Packaging, 3D stacking, interposers and embedded die. The Advanced Packaging market is driven by the need for improved performance, reduced power consumption, and the ability to image smaller geometries for mobile and automotive applications. These applications continue to demand increasingly complex packaging techniques and heterogeneous device integration from integrated device manufacturers (“IDMs,”), Foundries, and outsourced semiconductor assembly and test (“OSAT”) companies. Our Advanced Packaging tools are designed to optimize productivity for leading-edge 200mm and 300mm Advanced Packaging applications by delivering proven reliability and low cost of ownership in high-volume manufacturing environments. Our products are known for best-in-class yield coupled with outstanding resolution and depth of focus.

Single Wafer Wet Processing

We offer single wafer wet processing, and surface preparation systems which target growth opportunities in advanced packaging applications in the Semiconductor market as well as RF filters and amplifiers in the Compound Semiconductor market. The WaferStorm® platform is based on our unique ImmJET™ technology, which provides improved performance at a lower cost of ownership than conventional wet bench-only or spray-only approaches. This highly flexible platform targets solvent-based cleaning applications that require a significant level of process control and flexibility. The WaferEtch® platform provides highly uniform, selective etching with onboard end-point detection for optical coatingsimproved process control and other end markets.yield in bumping applications. In addition, we have developed a state-of-the-art solution with the WaferEtch® platform to address the requirements of wafer thinning.

Metal Organic Chemical Vapor Deposition Systems and Chemical Vapor Deposition Systems

MOCVD production systems are used to make GaN and As/P-based devices for applications including power electronics, RF devices, specialty LED, display, and many other photonics applications. Our proven TurboDisc® technology is at the heart of our MOCVD systems and is the key to enabling best-in-class deposition uniformity, yield performance and cost per wafer savings for our customers with a combined advantage of high operating uptime and low maintenance costs. Our Lumina® platform is used for As/P deposition, and features long campaigns and low defectivity for exceptional yield and flexibility. Our Propel® series enables the development of highly-efficient GaN-based power electronics, RF devices and advanced GaN-on-silicon micro-LEDs. The Propel® system offers 200mm and fully-automated 300mm technology and incorporates single-wafer reactor technology for outstanding film uniformity, yield, and device performance. Our SiC CVD system has a base single wafer reactor concept based on a time-tested industry validated architecture and is used for SiC power electronics applications primarily driven by adoption of electric vehicles.

Molecular Beam Epitaxy Systems

Molecular beam epitaxyMBE is the process of precisely depositing epitaxially-aligned atomically-thin epitaxial crystalline layers, or epilayers, of elemental materials onto a substrate in an ultra-high vacuum environment. We are thea leading supplier of MBE systems worldwide.

Our MBE systems, sources, and components are used to develop and manufacture compound semiconductor devices in a wide variety of applications such as quantum computing, high-power fiber lasers, infrared detectors, mobile phones, radar systems, high efficiency solar cells, and basicadvanced materials science research. For many compound semiconductors, MBE is the critical step of the fabrication process, ultimately determining device functionalityresearch in academic, governmental, and overall performance. We offer a full complement of MBE systems customized for the specific end application depositing on single 3” substrates up to fully automated production systems that can deposit on seven 6” substrates simultaneously.industrial organizations. The GENxplor® MBE system creates high quality epitaxial layers and is ideal for cutting-edge research on a wide variety of materials including gallium arsenide, antimonides, nitrides,III-V GaAs, nitride, and oxides. The GENxcel® MBE system extends the same performanceoxide, materials on substrates up to 3” diameter.

9

3D Wafer Inspection Systems

As the semiconductor industry continues its pursuit of increased productivity and performance by shrinking device dimensions along Moore’s law, manufacturers are running into bottlenecks limited by fundamental materials properties and lithographic resolution. The industry has opted for 3D integration schemes to circumvent these limitations (e.g. Vertical NAND, HAR DRAM, Logic FinFET). The high volume manufacturing ramp of these 3D schemes requires low cost, high performance 3D wafer inspection systems. The Superfast 3D Wafer Inspection System is a Coherent Gradient Sensing (“CGS”) based 3D wafer inspection system that enables the wafer fab to inspect the patterned wafer at key processing steps, enabling statistical process control as well as advanced process control (“APC”) for topography, displacement, and stress.

Atomic Layer Deposition and Other Deposition Systems

ALD is a thin-film deposition method in which a film is deposited on a substrate uniformly with precise control down to the atomic scale. Veeco offers a full suite of ALD systems for non-semiconductor front-end production applications across a wide range of markets and applications such as energy,Quantum Computing, optical, electronics, MEMS,micro-electro mechanical systems (“MEMS”), nanostructures, and biomedical.

Other Systems

We have other deposition systems including Physical Vapor Deposition, Diamond-Like Carbon Deposition, and Chemical Vapor Deposition Systems.Systems primarily sold to the data storage market. In addition, our Optium® products generally are used in “back-end” applications inwe have mechanical systems such as saws and lappers for the data storage fabrication facilities where TFMHs or “sliders” are fabricated. This equipment includes lapping tools, which enable precise material removal within three nanometers, which is necessary for advanced TFMHs.industry as well as the power semiconductor market. Finally, we have Gas-mixing systems primarily sold to the semiconductor market. We also manufacture dicing tools that cut wafers into row barscontinue to focus on penetrating adjacent markets with organically developed and TFMHs.acquired technology.

Sales and Service

We sell our products and services worldwide primarily through various strategically located facilities in the United States, Europe, and the Asia-Pacific region. We believe that our customer service organization is a significant factor in our success. We provide service and support on a warranty, service contract, and an individual service-call basis. We believe that offering timely support creates stronger relationships with customers and provides us with a significant competitive advantage.customers. Revenue from the sales of parts, upgrades, service, and support represented approximately 27%22%, 28%24%, and 22%28% of our net sales for the years ended December 31, 2017, 2016,2023, 2022, and 2015,2021, respectively. Parts and upgrade sales represented approximately 22%17%, 22%18%, and 18%21% of our net sales for those years, respectively, and service and support sales were 5%, 6%, and 4%7% respectively.

Customers

We sell our products to many of the world’s LED, MEMS,semiconductor IDMs and Foundries, OSAT, HDD, and semiconductorphotonics manufacturers, as well as research centers and universities. We rely on certain principal customers for a significant portion of our sales. Sales to OSRAM Opto Semiconductors accounted for more than 10% of our total net sales for both 2017 and 2016; sales to San’an Optoelectronics Co. and KAISTAR Lighting (Xiamen) Co. each accounted for more than 10% of our total net sales in 2015. If anythese principal customer discontinues its relationshipcustomers discontinue their relationships with us or sufferssuffer economic difficulties, our business prospects, financial condition, and operating results could be materially and adversely affected.

Research and Development

Our research and development functions are focused on the timely creation of new products and enhancements to existing products, both of which are necessary to maintain our competitive position. We collaborate with our customers to align our technology and product roadmaps to customer requirements. Our research and development activities take place at our facilities in San Jose, California; Waltham, Massachusetts; St. Paul, Minnesota; Somerset, New Jersey; Plainview, New York; Horsham, Pennsylvania; Somerset, New Jersey; St. Paul, Minnesota; Waltham, Massachusetts; and Singapore.Solvegatan, Sweden.

Our research and development expenses were approximately $82.0 million, $81.0 million, and $78.5 million, or approximately 17%, 24%, and 16% of net sales for the years ended December 31, 2017, 2016, and 2015, respectively. These expenses consisted primarily of salaries, project materials, and other product development and enhancement costs.

Suppliers

We outsource certain functions to third parties, including the manufacturingmanufacture of someseveral of our MOCVD and Ultratech systems. While we primarily rely on one supplier for the manufacturing of these systems,our outsourcing partners to perform their contracted functions, we maintain a minimumsome level of internal manufacturing capability for these systems. Refer to Item 1A, “Risk Factors,” for a description of risks associated with our reliance on suppliers and outsourcing partners.

Backlog

Our backlog consists of orders for which we received a firm purchase order, a customer-confirmed shipment date generally within twelve months, and a deposit, when required. Our backlog increased to $334.3was $490.7 million and $499.9 million at December 31, 2017 from $209.2 million at December 31, 2016. During the year ended December 31, 2017, we increased backlog by approximately $41.6 million relating to backlog acquired from Ultratech, while adjusting for a decrease in backlog2023 and 2022, respectively.

10

Competition

In each of the markets that we serve, we face substantial competition from established competitors, some of which have greater financial, engineering, and marketing resources than we do, as well as from smaller competitors. In addition, many of our products face competition from alternative technologies, some of which are more established than those used in our products. Significant factors for customer selection of our tools include system performance, accuracy, repeatability, ease of use, reliability, cost of ownership, and technical service and support. None of our competitors compete with us across all of our product lines.

Our principal competitors include: Advanced Micro-Fabrication Equipment (AMEC); Aixtron; Canon Anelva;Applied Materials; Canon; Grand Plastics Technology Corporation; Leybold Optics; Mattson Technology; Riber; Rudolph Technologies; Scientech;Mattson; Screen Semiconductor Solutions; and Shanghai Micro Electronics Equipment.Equipment; and Suss MicroTec.

Intellectual Property

Our success depends, in part, on our proprietary technology, and we have over 800350 patents in the United States and other countries and have additional applications pending for new inventions.countries.

We have patents and exclusive and non-exclusive licenses to patents owned by others covering certain of our products, which we believe provide us with a competitive advantage. We have a policy of seeking patents on inventions concerning new products and improvements as part of our ongoing research, development, and manufacturing activities. We believe that there is no single patent or exclusive or non-exclusive license to patents owned by others that is critical to our operations, as the success of our business depends primarily on the technical expertise, innovation, customer satisfaction, and experience of our employees.

Refer to Item 1A, “Risk Factors,” for a description of risks associated with intellectual property.

EmployeesHuman Capital Resources

Veeco’s global workforce spans twelve countries around the world. At December 31, 2017the end of 2023, we had 1,0141,215 employees with 267 located in the Asia-Pacific region, 58 in the EMEA region, and 890 in the United States. Approximately 25% of which there were 280our employees are involved in research and development; 56% in operations, manufacturing, service, and testing, 99quality assurance; and 19% in sales, andorder administration, marketing, 214 in service and product support, 260 in engineering and research and development, and 161 infinance, information technology, general administration,management, and finance. Theother administrative functions. Our success of our future operations depends on our ability to recruitattract, retain, and retain engineers, technicians,motivate employees. We compete for talent with other companies and organizations. We consider our relations with the Veeco United Team to be favorable. We are subject to various federal, state, and local regulations, and regularly monitor all key employment activities, such as hiring, termination, pay and working practices to ensure compliance with such regulations. In addition, we may supplement the Veeco United Team with contractors and other highly skilled professionals whotemporary workers.

Our Core Values

All Veeco employees are expected to honor our Core Values, which define the way we conduct our business in considerable demand.everyday actions and choices and form the foundation of our culture:

We will always put our CUSTOMERS first
We will never compromise on SAFETY
We will always demonstrate RESPECT
We will never stop IMPROVING
We will always be ACCOUNTABLE
We will never forget that DIVERSITY and INCLUSION makes us stronger

11

Employment, Recruitment and Development

Our recruitment programs are regionally focused. Hiring is done at a local level to ensure compliance with applicable regulations. We feeladvertise job openings and source candidates broadly to attract a diverse candidate pool. As a leader in our industry, we can attract a strong candidate pool and have successfully filled vacancies. In fiscal 2023, we hired 106 employees, 74 within the United States, 13 in the Asia-Pacific region, and 19 in the EMEA region.

We track and report key talent metrics, including workforce demographics, talent pipeline and diversity. We invest in professional development programs to provide opportunities for individuals to advance their careers in either technical/individual contributor or leadership tracks. We offer many of our training and development programs virtually to benefit employees worldwide. We emphasize the development of future leaders and utilize a talent review process to assess high-potential and high-performing employees for future leadership roles as part of our succession management process. We monitor turnover statistics carefully since turnover is an essential indicator of employee satisfaction. Our 12-month rolling average for voluntary turnover on December 31, 2023 was approximately 7.2%. Our employee average tenure is more than 8 years.

Employee Engagement

The engagement and satisfaction of the Veeco United Team are critical to our culture and our success. In 2019, we conducted a formal employee survey designed to assess global employee engagement, leadership, work environment and culture. Over 90% of our employees participated in the survey, itself an indicator of high employee engagement. Participants provided over 2,000 responses to open-ended questions. The findings from this survey established an agenda for various initiatives designed to strengthen our Company. In 2021, we conducted a second formal employee survey using the same survey instrument. Approximately 90% of employees again participated in the survey and, again, nearly 2,000 responses were provided to open-ended questions. We saw significant improvements across all survey areas. In 2023, we conducted our third formal employee survey using the same survey instrument. Even with a much larger employee population, we maintained a high participation rate of 90% and over 2,000 responses to open-ended questions. Overall survey results were similar to 2021 results. We remain committed to working with employees to strengthen the Company’s culture. Our executives conduct regular meetings with our global workforce, providing employees with opportunities to engage with senior leaders and ask questions in open Q&A sessions. Finally, we maintain and regularly remind our employees about our confidential third-party hotline service that can be utilized to share their concerns.

Compensation Philosophy

Our compensation philosophy is targeted to support our employees’ financial, physical, and mental health and well-being. We utilize independent surveys to ensure that our total compensation packages are competitive. We help employees share in the Company’s success through various programs, including profit sharing and bonus plans, equity awards, and an Employee Stock Purchase Plan (“ESPP”). In addition to providing our employees with competitive compensation packages, we offer benefits designed to meet the needs of employees and their families, including paid time off, medical, dental and vision coverage, disability income protection, life insurance, retirement savings contributions, and more.Veeco pays the majority or all of the costs for many of these benefits.

Diversity and Inclusion

We are committed to building and sustaining a culture of diversity and inclusion where our people can be their authentic selves and are encouraged to reach their full potential. Our Veeco team, like the technologies we enable, is a rich combination of diverse individuals coming together as Veeco United to make a material difference for our people, our customers, and the world. As a global technology company, we recognize that a diverse employee population makes Veeco stronger, more innovative, and a more engaging place to work. We are always striving to attract talented individuals from a global candidate pool.

12

In the second quarter of 2021, Veeco established a Diversity and Inclusion Council. The Council, composed of Veeco colleagues from many different parts of the Company, represents Veeco’s ongoing commitment to inclusion of all genders, sexual orientations, races, ethnic origins, religions, and diversity of thought. The team recently established Veeco’s Diversity and Inclusion Mission Statement and Charter. The charter affirms our commitment to building awareness, enhancing community partnerships, addressing diversity in our recruiting and hiring practices, empowering employees to promote D&I initiatives, and identifying opportunities to have meaningful engagements with peers and the leadership team. We are excited to continue developing initiatives to promote and celebrate diversity at Veeco.

Employee Health and Safety, Pandemic Response

We are committed to providing a safe and healthy workplace for all employees. We accomplish this through strict compliance with applicable laws and regulations regarding workplace safety, including recognition and control of workplace hazards, tracking injury and illness rates, utilizing a global travel health program, and maintaining detailed emergency and disaster recovery plans.

Our highest priorities throughout the pandemic were, and continue to be, the health and well-being of our employees, customers, suppliers, and stakeholders. From the beginning of the pandemic, through the recent challenges posed by the acceleration of coronavirus variants, we have adequate programstaken precautions to protect employees, visitors, and customers while minimizing disruption to our business. Our facilities remained operational as an “essential business” throughout the pandemic. To keep our teams safe and the Company strong, we implemented rigorous health and safety protocols at our manufacturing facilities, including extensively and frequently disinfecting our facilities, limiting access to our facilities, checking temperatures of individuals entering our facilities, staggering shifts to minimize employee overlap in placegowning areas, and providing protective equipment to attract, motivate, and retainminimize the risks to our employees. In addition, we required many of our employees to work from home wherever possible. We protected employees, customers, and stakeholders by providing remote meetings, demos, and service, whenever possible. While the COVID-19 public health emergency has ended, our Veeco United Team remains flexible and responsive to potential health risks and has developed robust response capability through this experience. We continue to carefully monitor industry practicesand respond to make sure thatlocal, state, and federal public health guidance. We continue to use our compensationCOVID-19 Pledge to describe all the measures we implemented in our facilities to keep employees working on-site safe throughout the pandemic and employee benefits remain competitive. We believe that our employee relations are good. Refer to Item 1A, “Risk Factors,” for a description of risks associated with employee retention and recruitment.beyond.

FinancialAvailable Information about Segments and Geographic Areas

We operate as a single reportable segment and report our financial results in four geographic regions: the United States; China; Europe, Middle East, and Africa (“EMEA”); and Rest of World (“ROW”). Refer to Note 18, “Segment Reporting and Geographic Information,” in the Notes to the Consolidated Financial Statements for financial data pertaining to our geographic operations. Refer to Item 1A, “Risk Factors,” for a description of risks relating to our geographic operations.

Available Information

Our corporate website address is www.veeco.com. All filings we make with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K, our proxy statements and any amendments thereto filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are available for free in the Investor Relations section of our website as soon as reasonably practicable after they are filed with or furnished to the SEC. Our SEC filings are available to be read or copied at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information about the operation of the Public Reference Room can be obtained by calling the SEC at 1-800-SEC-0330. Our filings can also be obtained for free on the SEC’s website at www.sec.gov. The reference to our website address does not constitute inclusion or incorporation by reference of the information contained on our website in this Form 10-K or other filings with the SEC, and the information contained on our website is not part of this document.

Item 1A. Risk Factors

Key Risk Factors That May Impact Future Results

Stockholders should carefully consider the risk factors described below.below when evaluating the Company. Any of these factors, many of which are beyond our control, could materially and adversely affect our business, financial condition, operating results, cash flow, and stock price.

Risks Related to Our Business and Industry

Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results.

Conditions of the markets in which we operate are volatile and have inmay experience significant deterioration. Changing market conditions require that we continuously monitor and reassess our strategic resource allocation decisions. If we

13

fail to properly adapt to changing business environments, we may lack the past,infrastructure and resources necessary to scale up our businesses to successfully compete during periods of growth, or we may in the future, deteriorate significantly. We have experienced and may continue to experience customer rescheduling and, to a lesser extent, cancellationsincur excess fixed costs during periods of orders for our products.decreasing demand. Adverse market conditions relative to our products couldmay result in:

reduced demand for our products, or the rescheduling or cancellation of orders for our products which may result in negative backlog adjustments;
asset impairments, including the impairment of goodwill and other intangible assets;
unfavorable changes in customer mix and product mix;
increased price competition for our products, or increased competition from sellers of used equipment or lower-priced alternatives to our products, which could lead to lower profit margins for our products;
increased inventory obsolescence;
disruptions in our supply chain;
higher operating costs, caused by matters such as rising inflation and interest rates in various regions, which the Company experienced in 2023 and may continue to do so in the future; and
an increase in uncollectable amounts due from our customers resulting in increased reserves for doubtful accounts and write-offs of accounts receivable.

·                  reduced demand for our products;

·                  rescheduling and cancellations of orders for our products, resulting in negative backlog adjustments;

·                  increased price competition leading to lower margin for our products;

·                  increased competition from sellers of used equipment or lower-priced alternatives to our products;

·                  increased inventory obsolescence;

·                  an increase in uncollectable amounts due from our customers resulting in increased reserves for doubtful accounts and write-offs of accounts receivable;

·                  disruptions in our supply chain as we reduce our purchasing volumes and limit our contract manufacturing operations; and

·                  higher operating costs as a percentage of revenues.

If the markets in which we participate experience deteriorations or downturns, this could negatively impact our sales and revenue generation, margins, operating expenses, and profitability.

We are exposed to the risks of operating a global business.

Most of our sales are to customers located outside of the United States, and we expect sales from non-U.S. markets to continue to represent a significant portion of our sales in the future. Our non-U.S. sales and operations are subject to risks inherent in conducting business outside the United States, many of which are outside our control including:

·                  political and social attitudes, laws, rules, regulations, and policies within countries that favor local companies over U.S. companies, including government-supported efforts to promote the development and growth of local competitors;

·                  differing legal systems and standards of trade which may not honor our intellectual property rights and which may place us at a competitive disadvantage;

·                  pressures from foreign customers and foreign governments for us to increase our operations and sourcing in the foreign country;

·                  multiple conflicting and changing governmental laws and regulations, including varying labor laws, tax regulations, import/export controls, changes to trade treaties, possible trade wars, and other trade barriers and uncertainties;

·                  reliance on various information systems and information technology to conduct our business, which may be vulnerable to cyberattacks by third parties or breached due to employee error, misuse, or other causes that could result in business disruptions, loss of or damage to intellectual property, transaction errors, processing inefficiencies, or other adverse consequences should our security practices and procedures prove ineffective;

·                  regional economic downturns, varying foreign government support, and unstable political environments;

·                  difficulties in managing a global enterprise, including staffing, managing distributors and representatives, and repatriating cash;

·                  longer sales cycles and difficulties in collecting accounts receivable; and

·                  different customs and ways of doing business.

These challenges, many of which are associated with sales into the Asia-Pacific region, have had and may continue to have a material adverse effect on our business.

We may be unable to effectively enforce and protect our intellectual property rights.

Our success depends in part upon the protection of our intellectual property rights. We rely primarily on patent, copyright, trademark, and trade secret laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary information, technologies, processes, and brand identity. We own various U.S. and international patents and have additional pending patent applications relating to certain of our products and technologies. The process of seeking patent protection is lengthy and expensive, and we cannot be certain that pending or future applications will actually result in issued patents or that issued patents will be of sufficient scope or strength to provide meaningful protection or commercial advantage. In addition, our intellectual property rights may be circumvented, invalidated, or rendered obsolete by the rapid pace of technological change, or through efforts by others to reverse engineer our products or design around patents that we own. Policing unauthorized use of our products and technologies is difficult and time consuming and the laws of other countries may not protect our proprietary rights as fully or as readily as U.S. laws. Given these limitations, our success will depend in part upon our ability to innovate ahead of our competitors.

In addition, our outsourcing strategy requires that we share certain portions of our technology with our outsourcing partners, which poses additional risks of infringement and trade secret misappropriation. Infringement of our rights by a third party, possibly for purposes of developing and selling competing products, could result in uncompensated lost market and revenue opportunities. Similar exposure could result in the event that former employees seek to compete with us through their unauthorized use of our intellectual property and proprietary information. We cannot be certain that the protective steps and measures we have taken will prevent the misappropriation or unauthorized use of our proprietary information and technologies, nor can we be certain that applicable intellectual property laws, regulations, and policies will not be changed in a manner detrimental to the sale or use of our products.

Litigation may be required to enforce our intellectual property rights, protect our trade secrets, and to determine the validity and scope of proprietary rights of others. As a result of any such litigation, we could lose our ability to enforce one or more patents, incur substantial costs, and jeopardize relationships with current or prospective customers or suppliers. Any action we take to enforce or defend our intellectual property rights could absorb significant management time and attention, and could otherwise negatively impact our operating results.

We may be subject to claims of intellectual property infringement by others.

We receive communications from time to time from other parties asserting the existence of patent or other rights which they believe cover certain of our products. We also periodically receive notice from customers who believe that we are required to indemnify them for damages they may incur related to infringement claims made against these customers by third parties. Our customary practice is to evaluate such assertions and to consider the available alternatives, including whether to seek a license, if appropriate. However, we cannot ensure that licenses can be obtained or, if obtained, will be on acceptable terms or that costly litigation or other administrative proceedings will not occur. If we are not able to resolve a claim, negotiate a settlement of the matter, obtain necessary licenses on commercially reasonable terms, or successfully prosecute and defend our position, our business, financial condition and results of operations could be materially and adversely affected.

We may be unable to successfully integrate the Ultratech business and may not realize the anticipated benefits of the acquisition.

On May 26, 2017, we completed the acquisition of Ultratech, Inc., merging two companies that formerly operated as independent public companies. Significant management attention and resources have been devoted, and will need to be devoted, to integrating our respective business operations and practices. The success of our acquisition of Ultratech will depend in part on our ability to realize the anticipated benefits and revenue and cost synergies associated with this business combination, which is subject to the following risks, among others:

·                  whether the combined businesses will perform as expected;

·                  the possibility that we paid more for the acquisition of Ultratech than the value we will derive from the acquisition;

·                  complexities associated with managing the combined businesses, including difficulties addressing possible differences in corporate cultures and management philosophies and the challenge of integrating complex systems, technology, networks, and other assets of each of the companies in a seamless manner that minimizes any adverse impact on customers, suppliers, employees, and other business partners;

·                  the potential loss of customers and strategic partners who may not wish to continue their relationships with the combined company; and

·                  potential unknown liabilities and unforeseen or unanticipated costs.

In connection with the accounting for the Ultratech acquisition, we recorded goodwill and other intangible assets of approximately $539 million. Under U.S. generally accepted accounting principles, we must assess, at least annually and potentially more frequently, whether the value of the goodwill and other indefinite-lived intangible assets have been impaired. Finite-lived intangible assets will be assessed for impairment in the event of an impairment indicator. Any reduction or impairment in the value of goodwill and other intangible assets will result in a charge against earnings, which could materially and adversely affect our results of operations and financial performance.

The price of our common shares is volatile and could further decline.

The stock market in general and the market for technology stocks in particular has experienced significant volatility. The trading price of our common shares has declined, and could continue to decline, independent of the overall market, and shareholders could lose all or a substantial part of their investment. The market price of our common shares could fluctuate significantly in response to several factors, including among others:

·                  difficult macroeconomic conditions, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crisis and a failure of large financial institutions;

·                  the emergence of competitors and competing technologies;

·                  receipt of large orders or cancellations of orders for our products;

·                  issues associated with the performance and reliability of our products;

·                  actual or anticipated variations in our results of operations;

·                  announcements of financial developments or technological innovations;

·                  our failure to meet the performance estimates of investment research analysts;

·                  changes in recommendations and financial estimates by investment research analysts;

·                  strategic transactions, such as acquisitions, divestitures, and spin-offs;

·                  the commencement of, and rulings on, litigation and legal proceedings;

·                  the dilutive impact of our Convertible Senior Notes; and

·                  the occurrence of major catastrophic events.

As with many technology companies, the price of our common shares has fluctuated significantly in the past and is likely to be volatile in the future. Securities class action litigation is often brought against a company following periods of volatility in the market price of its securities. If similar litigation were to be pursued against us, it could result in substantial costs and a diversion of management’s attention and resources, which could materially and adversely affect our financial condition, results of operations, and liquidity.

We face significant competition.

We face significant competition throughout the world, which may increase as certain markets in which we operate continue to evolve. Some of our competitors have greater financial, engineering, manufacturing, and marketing resources than us. Other competitors are located in regions with lower labor costs and other reduced costs of operation. In addition, our ability to compete in foreign countries against local manufacturers may be hampered by nationalism, social attitudes, laws, regulations, and policies within such countries that favor local companies over U.S. companies or that are otherwise designed to promote the development and growth of local competitors. Furthermore, we face competition from smaller emerging equipment companies whose strategy is to provide a portion of the products and services we offer, with a focused approach on innovative technology for specialized markets. New product introductions or enhancements by us or our competitors could cause a decline in sales or loss of market acceptance of our existing or prior generation products. Increased competitive pressure could also lead to intensified price competition resulting in lower profit margins.

To remain competitive, we may enter into strategic alliances with customers, suppliers, and other third parties to explore new market opportunities and possible technological advancements. These alliances may require significant investments of capital and other resources and often involve the exchange of sensitive confidential information. The success of these alliances may depend on factors over which we have limited control and will likely require ongoing cooperation and good faith efforts from our strategic partners. Strategic alliances are inherently subject to significant risks, and the inability to effectively manage these risks could materially and adversely affect our business and operating results.

We operate in industries characterized by rapid technological change.

Each of the industries in which we operate is subject to rapid technological change. Our ability to remain competitive depends on our ability to enhance existing products and develop and manufacture new products in a timely and cost effective manner and to accurately predict technology transitions. New product development commitments must be made well in advance of sales, and we must anticipate the future demand for products when selecting which development programs to fund and pursue. Our financial results depend on the successful introduction of new products, many of which require the achievement of increasingly stringent technical specifications. We may not be successful in selecting, developing, manufacturing, and marketing new products and new technologies or in enhancing our existing products. Our performance may be adversely affected if we are unable to accurately predict evolving market trends and related customer needs and to effectively allocate our resources among new and existing products and technologies.

The semiconductor industry, characterized by a high frequency and complexity of technology transitions and inflections, poses unique risks and challenges. Our ability to successfully compete in this market will depend on our ability to address and manage a number of industry-specific risks, including without limitation the following:

the heightened cost of research and development, associated with matters such as shrinking geometries, complex device structures, multiple applications and process steps, and the use of new materials;
customer demands for shorter cycle times between order placements and product shipments, which will necessitate accurate forecasting of customer investment;
customer demands for continuous reductions in the total cost of manufacturing system ownership, together with challenging equipment service demands and the resulting need for us to properly allocate our service resources;
the number of types and varieties of semiconductors and number of applications across multiple substrate sizes;

14

the need to reduce product development time, despite increasingly difficult technical challenges;
our customers’ ability to reconfigure and re-use our equipment, resulting in reduced demand for new equipment or services from us; and
the importance of establishing market positions in segments with growing demand.

If we fail to properly allocate appropriate resources, successfully develop and commercialize products to meet customer demand, and effectively anticipate industry trends, our business and results of operations may be adversely impacted.

In addition, the semiconductor industry has experienced, and may continue to experience, significant consolidation, among both semiconductor manufacturers and manufacturing equipment suppliers. Larger competitors resulting from consolidations may have certain advantages over us, including but not limited to more efficient cost structures, substantially greater financial and other resources, greater presence in key markets, and greater name recognition. Consolidation among our competitors and integration among our customers could erode our market share, negatively impact our ability to compete, and have a material adverse effect on our business.

WeWhether in connection with the semiconductor industry or otherwise, we are also exposed to potential risks associated with unexpected product performance issues. Our product designs and manufacturing processes are complex and could contain unexpected product defects, especially when products are first introduced. Unexpected product performance issues could result in significant costs and damages, including increased service and warranty expenses, the need to provide product replacements or modifications, reimbursement for damages caused by our products, product recalls, related litigation, product write-offs, and disposal costs. Product defects could also result in personal injury or property damage, claims for which may exceed our existing insurance coverages (as may other claims, notwithstanding our efforts to maintain a program of insurance coverage for a variety of property, casualty and other risks). These and other costs could be substantial and our reputation could be harmed, resulting in a reduced demand for our products and a negative effect on our business.

In addition, our success is also subject to the risk of future disruptive technologies, including machine learning and artificial intelligence (“AI”). While such technologies offer significant opportunities, they also pose complex and novel risks, including operational risks (such as factual errors or inaccuracies in work product developed using AI), the unintended release of proprietary information, costs of compliance associated with evolving AI laws, regulations and standards, privacy concerns with respect to data dissemination, risks related to intellectual property rights (with respect to both the inputs to the program and ownership rights to AI work product), and risks related to AI’s impact on the workforce. While it is not possible at this point to accurately identify or predict all of the risks related to the use of AI technologies, our failure to properly anticipate and timely respond to AI-related developments could adversely affect our business, financial condition, and results of operations.

OurCertain of our sales to manufacturers are highly dependent on sales ofthe demand for consumer electronics applications,electronic products and automobiles, which can experience significant volatility due to seasonal and other factors.volatility.

The demand for LEDs,semiconductors, HDDs semiconductors, and other devices is highly dependent on sales of consumer electronics,electronic products, such as televisions, computers,smartphones, laptops, tablets digital video recorders, smartphones, cell phones, and other mobilewearable devices. ManufacturersIn addition, as a result of LEDs are among our largest customers and accountthe growing automotive semiconductor market, semiconductor demand is also heavily influenced by the demand for a substantial portion of our revenue.automobiles. Factors that could influenceaffect the levels of spending on consumer electronic products and automobiles include consumer confidence, access to credit, volatility in fuel and other energy costs, conditions in the residential real estate and mortgage markets, labor and healthcare costs, and other macroeconomic factors affecting consumer spending behavior. The emergence of new or competing technologies may also affect demand for consumer electronic products. These and other economic factors have had and could continue to have a materialan adverse effect on the demand for our customers’ products and, in turn, on our customers’ demand for our products and services. Furthermore, manufacturers of LEDs have in the past, some of our customers have overestimated their potential for market share growth. If this growth is overestimated, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, obsolete inventory, and liabilities to our suppliers for products no longer needed.

In addition, the demand for our customers’ products can be even more volatile and unpredictable due to the possibility of competing technologies, such as flash memory as an alternative to HDDs. Unpredictable fluctuations Alternatively, changes that result in sudden increases in demand for consumer electronic products and automobiles may result in a shortage of parts and materials needed to manufacture our customers’ products, and attendant shipping delays (both to us and to our customers) and/or rapid shifts in demand fromthe cancellation of orders placed by our customers’ products to alternative technologies could materially and adversely impact our future resultscustomers.

15

We have a concentrated customer base, located primarily in a limited number of regions, which operateoperates in highly concentrated industries.

Our customer base continues to be highly concentrated. Orders from a relatively limited number of customers have accounted for, and likely will continue to account for, a substantial portion of our net sales, which may leadallow customers to demand pricing and other terms less favorable to us.us (including extended warranties, indemnification commitments, and the obligation to continue production of older products). Customer consolidation activity involving some of our largest customers could result in an even greater concentration of our sales in the future. Management changes at key customer accounts could result in a loss of future sales due to vendor preferences or other reasons and may introduce new challenges in managing customer relationships.

If athese principal customer discontinues itscustomers discontinue their relationship with us or sufferssuffer economic setbacks, our business, financial condition, and operating results could be materially and adversely affected. Our ability to increase sales in the future will depend in part upon our ability to obtain orders from new customers and we cannot be certain that we will be successful in these efforts. In addition, because a relatively small number of large manufacturers, many of whom are our customers, dominate the industries in which they operate, it may be especially difficult for us to replace these customers if we lose their business. A significant portion of orders in our backlog are orders from our principal customers.

In addition, a substantial investment is required by customers to install and integrate capital equipment into a production line. As a result, once a manufacturer has selected a particular vendor to supply capital equipment, the manufacturer will often attempt to consolidate its other capital equipment requirements with the same vendor. Accordingly, if a customer selects a competitor’s product over ours, we could experience difficulty selling to that customer for a significant period of time.

Furthermore, we typically do not have long-term contracts with our customers. As a result, our agreements with our customers do not provide assurance of future sales, and we are exposed to competitive price pressures on new orders we attempt to obtain.

Our customer base is also highly concentrated in terms of geography, and the majority of our sales are to customers located in a limited number of countries. Dependence upon sales emanating from a limited number of regions increases our risk of exposure to local difficulties and challenges, such as those associated with regional economic downturns, political instability, trade wars and other trade disruptions, fluctuating currency exchange rates, natural disasters, social unrest, pandemics such as COVID-19, terrorism, and acts of war. Our reliance upon customer demand arising primarily from a limited number of countries could materially and adversely impact our future results of operations.

A further reduction or elimination of foreign government subsidies and economic incentives may adversely affect the future order rate for our MOCVD equipment.

We generate a significant portion of our revenue in China. In recent years, the Chinese government has provided various incentives to encourage the development of the LED industry, including subsidizing a portion of the purchase cost of MOCVD equipment. These subsidies have enabled and encouraged certain customers in this region to purchase more of our MOCVD equipment than these customers might have purchased without these subsidies. The availability and amount of these subsidies has been reduced over time and may end at some point in the future. A further reduction or elimination of these incentives may result in a reduction in future orders for our MOCVD equipment in this region, which could materially and adversely affect our business, financial condition, and results of operations. In addition, in an effort to promote Chinese competition, the Chinese government could impose restrictions on the receipt of these subsidies, including requirements that the purchased equipment be sourced locally.

A related risk pertains to the fact that many customers use or had planned to use Chinese government subsidies, in addition to other incentives from the Chinese government, to build new manufacturing facilities or to expand existing manufacturing facilities. Delays in the start-up of these facilities or the cancellation of construction plans altogether, together with other related issues pertaining to customer readiness, could adversely impact the timing of our revenue recognition, could result in order cancellations, a reduction in our order backlog, and could have other negative effects on our business, financial condition, and results of operations.

The cyclicality of the industries we serve directly affects our business.

Our business depends in large part upon the capital expenditures of manufacturers in the LED, mobile communication, data storage,our four end-markets: Semiconductor; Compound Semiconductor; Data Storage; and other device markets.Scientific & Other. We are subject to the business cycles of these industries, the timing, length, and volatility of which are difficult to predict. These industries have historically been highly cyclical and have experienced significant economic downturns in the last decade. As a capital equipment provider, our revenue depends in large part on the spending patterns of these customers, who often delay expenditures or cancel or reschedule orders in reaction to variations in their businesses or general economic conditions. In downturns, we must be able to quickly and effectively align our costs with prevailing market conditions, as well as motivate and retain key employees. However, because a portion of our costs are fixed, our ability to reduce expenses quickly in response to revenue shortfalls may be limited. Downturns in one or more of these industries have had, and will likely have, a material adverse effect on our business, financial condition, and operating results. Alternatively, during periods of rapid growth, we must be able to acquire and develop sufficient manufacturing capacity to meet customer demand and attract, hire, assimilate, and retain a sufficient number of qualified people. Our net sales and operating results may be negatively affected if our customers experience economic downturns or slowdowns in their businesses.

The timing of our orders, shipments,we fail to accurately predict and revenue recognition may cause our quarterly operating results to fluctuate significantly.effectively respond.

We derive a substantial portion of our net sales in any fiscal period from the sale of a relatively small number of high-priced systems. As a result, the timing of recognition of revenue for a single transaction could have a material effect on our sales and operating results for a particular fiscal period. As is typical in our industry, orders, shipments, and customer acceptances often occur during the last few weeks of a quarter. As a result, a delay of only a week or two can impact which period revenue is reported and can cause volatility in our revenue for a given reporting period. Our quarterly results have fluctuated significantly in the past and we expect this trend to continue. If our orders, shipments, net sales, or operating results in a particular quarter do not meet expectations, our stock price may be adversely affected as well.

Our sales cycle is long and unpredictable.

Historically, we have experienced long and unpredictable sales cycles (the period between our initial contact with a potential customer and the time that we recognize revenue for resulting sales to that customer). Our sales cycle can exceed twelve months. The timing of an order often depends on our customer’s capital expenditure budget, over which we have no control. In addition, the time it takes us to build a product to customer specifications typically ranges from three to six months. When coupled with the fluctuating amount of time required for shipment, installation, and final acceptance, our sales cycles often vary widely, and these variations can cause fluctuations in our operating results. As a result of our lengthy sales cycles, we may incur significant research, development, selling, general, and administrative expenses before we generate revenue for these products. We may never generate the anticipated revenue if a customer cancels or otherwise changes its purchase plans, which could have an adverse effect on our business.

Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed.

Customer purchase orders may be cancelled or rescheduled by the customer, sometimes with limited or no penalties, which may result in increased or unrecoverable costs for the Company. We adjust our backlog for such cancellations, contract modifications, and delivery delays that result in a delivery period in excess of one year, among other items. A downturn in one or more of our businesses could result in an increase in order cancellations and postponements.

We write-off excess and obsolete inventory based on historical trends, future usage forecasts, and other factors including the amount of backlog we have on hand. If our backlog is canceled or modified, our estimates of future product demand may prove to be inaccurate, in which case we may have understated the write-off required for excess and obsolete inventory. In the future, if we determine that our inventory is overvalued, we will be required to recognize associated costs in our financial statements at the time of such determination. In addition, we place orders with our suppliers based on our customers’ orders. If our customers cancel their orders with us, we may not be able to cancel our orders with our suppliers. Any such charges could be materially adverse to our results of operations and financial condition.

Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand.

The success of our business depends in part on our ability to accurately forecast and supply equipment and services that

16

meet the rapidly changing technical and volume requirements of our customers. To meet these demands, we depend on the timely delivery of parts, components, and subassemblies from our suppliers. Uncertain worldwide economic conditions and market instabilities make it difficult for us (and our customers) to accurately forecast future product demand. If actual demand for our products is different than expected, we may purchase more or fewer parts than necessary or incur costs for canceling, postponing, or expediting delivery of parts. If we overestimate the demand for our products, excess inventory could result which could be subject to heavy price discounting, which could become obsolete, and which could subject us to liabilities to our suppliers for products no longer needed. Similarly, we may be harmed in the event that our competitors overestimate the demand for their products and engage in heavy price discounting practices as a result. In addition, the volatility of demand for capital equipment increases capital and otherposes risks for companies in our supply chain.chain, including challenges associated with inventory management and fluctuating working capital requirements.

Furthermore, certain key parts may be subject to long lead-times or may be obtainable only from a single supplier or limited group of suppliers, and some sourcing and assembly is provided by suppliers located in countries other than the United States. We may experience significant interruptions in our manufacturing operations, delays in our ability to timely deliver products or services, increased costs, or customer order cancellations as a result of:

the failure or inability of our suppliers to timely deliver quality parts;
volatility in the availability and cost of materials;
difficulties or delays in obtaining required import or export approvals;
information technology or infrastructure failures;
natural disasters and other events beyond our control, such as earthquakes, tsunamis, fires, floods, storms, power outages and potential impacts of climate change; or
other causes such as regional or global economic downturns or recessions, international trade disruptions, pandemics such as COVID-19, political instability, terrorism, or acts of war, which could result in delayed deliveries, manufacturing inefficiencies, increased costs, or order cancellations.

·                  the failure or inability of our suppliers to timely deliver quality parts;

·                  volatility in the availability and cost of materials;

·                  difficulties or delays in obtaining required import or export approvals;

·                  information technology or infrastructure failures;

·                  natural disasters such as earthquakes, tsunamis, floods, or storms; or

·                  other causes such as regional economic downturns, pandemics, political instability, terrorism, or acts of war, that could result in delayed deliveries, manufacturing inefficiencies, increased costs, or order cancellations.

In addition, in the event of an unanticipated increase in demand for our products, our need to rapidly increase our business and manufacturing capacity may be limited by our working capital constraints and those of our suppliers, which may cause or exacerbate interruptions in our manufacturing and supply chain operations. Any or all of these factors could materially and adversely affect our business, financial condition, and results of operations.

Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations.

To better align our costs with market conditions, increase the percentage of variable costs relative to total costs, and to increase productivity and operational efficiency, we have outsourced certain functions to third parties, including the manufacture of several of our systems. While we maintain some level of internal manufacturing capability for these systems, we rely heavily on our outsourcing partners to perform their contracted functions to allow us flexibility to adapt to changing market conditions, including periods of significantly diminished order volumes. If our outsourcing partners do not perform as required, or if our outsourcing model does not allow us to realize the intended cost savings and flexibility, our results of operations (and those of our third party providers) may be adversely affected. Disputes and possibly litigation involving third party providers could result and we could suffer damage to our reputation. Dependence on contract manufacturing and outsourcing may also adversely affect our ability to bring new products to market. Although we attempt to select reputable providers, it is possible that one or more of these providers could fail to perform as we expect. If we do not effectively manage our outsourcing strategy or if third party providers do not perform as anticipated, we may not realize the benefits of productivity improvements and we may experience operational difficulties, increased costs, manufacturing and installation interruptions or delays, inefficiencies in the structure and operation of our supply chain, loss of intellectual property rights, quality issues, increased product time-to-market, and an inefficient allocation of our human resources, any or all of which could materially and adversely affect our business, financial condition, and results of operations.

We rely on a limited number of suppliers, some of whom are our sole source for particular components.

Certain of the parts, components, and sub-assemblies included in our products are obtained from a single source or a limited group of suppliers. Our inability to develop alternative sources, as necessary, could result in a prolonged interruption in our ability to supply related products, a failure on our part to meet the demands our customers, and a significant increase in the price of related products, which could adversely affect our business, financial condition, and results of operations.

Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations.

To better align our costs with market conditions, increase the percentage of variable costs relative to total costs, and to increase productivity and operational efficiency, we have outsourced certain functions to third parties, including the manufacture of several of our systems. While we maintain some level of internal manufacturing capability for these systems, we rely on our outsourcing partners to perform their contracted functions to allow us flexibility to adapt to changing market conditions, including periods of significantly diminished order volumes. If our outsourcing partners do not perform as required, or if our outsourcing efforts do not allow us to realize the intended cost savings and flexibility, our results of operations (and those of our third-party providers) may be adversely affected. Disputes and possibly litigation involving third party providers could result and we could suffer damage to our reputation. Dependence on outsourcing may also adversely affect our ability to bring new products to market. Although we attempt to select reputable providers, one or more of these providers could fail to perform as we expect. If we do not effectively manage our outsourcing efforts or if third party providers do not perform as anticipated, we may not realize the benefits of productivity improvements and we may experience operational difficulties, increased costs, manufacturing and

17

installation interruptions or delays, inefficiencies in the structure and operation of our supply chain, loss of intellectual property rights, quality issues, increased product time-to-market, and an inefficient allocation of our human resources, any or all of which could materially and adversely affect our business, financial condition, and results of operations.

The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly.

We derive a substantial portion of our net sales in any fiscal period from the sale of a relatively small number of high-priced systems. As a result, the timing for the recognition of revenue for a single transaction could have a material effect on our sales and operating results for a particular fiscal period. As is typical in our industry, orders and shipments often occur during the last few weeks of a quarter. As a result, a delay of only a week or two can impact which period revenue is reported and can cause volatility in our revenue for a given reporting period. Our inabilityquarterly results have fluctuated significantly in the past and we expect this trend to attract, retain,continue.

Our sales cycle is long and motivate employeesunpredictable.

Historically, we have experienced long and unpredictable sales cycles (the period between our initial contact with a potential customer and the time that we recognize revenue from resulting sales to that customer). It is not uncommon for our sales cycle to exceed twelve months. The timing of an order often depends on our customer’s capital expenditure budget, over which we have no control. In addition, the time it takes us to procure and build a product to customer specifications typically ranges from three to twelve months. When coupled with the fluctuating amount of time required for shipment and installation, our sales cycles often vary widely, and these variations can cause fluctuations in our operating results. As a result of our lengthy sales cycles, we may incur significant research and development, selling, general, and administrative expenses before we generate revenue for these products. We may never generate the anticipated revenue if a customer cancels or otherwise changes its purchase plans, or if our evaluation systems do not satisfy customer requirements (which could result in working capital constraints, excess inventory or inventory obsolescence, and other harm to the Company). These risks are particularly prevalent in the semiconductor market, which is often characterized by long customer qualification times, typically twelve to eighteen months. Once qualified, the ramp to volume production can take an additional extended period of time, often twelve to twenty-four months. During these periods, little to no revenue will be recognized by us, while we will continue to incur research and development costs. Despite our efforts, our products may never be qualified and may never achieve design-tool-of-record (“DTOR”) or production-tool-of-record (“PTOR”) status, and our financial condition and results of operations may be materially and adversely affected.

Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed.

Customer purchase orders may be cancelled or rescheduled by the customer, sometimes with limited or no penalties, which may result in increased or unrecoverable costs for the Company. We adjust our backlog for such cancellations and contract modifications, among other items. A downturn in one or more of our businesses could result in an increase in order cancellations and postponements.

We write-off excess and obsolete inventory based on historical trends, future usage forecasts, and other factors including the amount of backlog we have on hand. If our backlog is canceled or modified, our estimates of future product demand may prove to be inaccurate, in which case we may have understated the write-off required for excess and obsolete inventory. In the future, if we determine that our inventory is overvalued, we will be required to recognize associated costs in our financial statements at the time of such determination. In addition, we place orders with our suppliers based on our customers’ orders. If our customers cancel their orders with us, we may not be able to cancel our orders with our suppliers. Resulting charges could have a material adverse effect on our business.

Our success depends in part upon our ability to attract, retain, and motivate employees, including those in executive, managerial, finance, engineering, and marketing positions, as well as highly skilled and qualified technical personnel. Attracting, retaining, and motivating such qualified personnel may be difficult due to challenging industry conditions, competition for such personnel by other technology companies, consolidations and relocationsresults of operations and workforce reductions, and there can be no assurance that we will be successful in recruiting or retaining key personnel. We have entered

into employment agreements with certain key personnel but our inability to attract, retain, and motivate key personnel could have a material adverse effect on our business, financial condition, and results of operations.condition.

We are exposed to risks associated with business combinations, acquisitions, strategic investments and strategic investments.divestitures.

We have completed several significant acquisitions and investments in the past (including our recent acquisition of Epiluvac AB, a producer of SiC-based products and technology), and we will consider new opportunities in the future. Acquisitions,

18

investments and investmentsother business combinations involve numerous risks, many of which are unpredictable and beyond our control, including the following:

the failure of the transaction to advance our business strategies and the failure of its anticipated benefits to materialize;
difficulties and costs, including the diversion of management’s attention, in integrating new personnel, operations, technologies, and products;
the inability to complete the proposed transaction in a timely manner, if at all, due to our inability to obtain required government or other approvals without burdensome conditions, or due to other reasons, resulting in obligations to pay professional and other expenses, including any applicable termination fees;
unknown, underestimated, and undisclosed commitments or liabilities;
increased amortization expenses relating to intangible assets; and
other adverse effects on our business, including the potential impairment and write-down of amounts capitalized as intangible assets and goodwill as part of the transaction, as a result of such matters as technological advancements or worse-than-expected performance by an acquired company.

·                  difficulties and increased costs in integrating the personnel, operations, technologies, and products of acquired companies;

·                  diversion of management’s attention and disruption of ongoing businesses;

·                  the inability to complete proposed transactions as anticipated, resulting in obligations to pay professional and other expenses, including any applicable termination fees;

·                  potential loss of key employees of acquired companies, especially if a relocation or change in responsibilities is involved;

·                  difficulties in managing geographically dispersed operations in a cost effective manner;

·                  the failure to realize expected synergies;

·                  unknown, underestimated, and undisclosed commitments or liabilities;

·                  increased amortization expenses relating to intangible assets; and

·                  other adverse effects on our business, including the potential impairment and write-down of amounts capitalized as intangible assets and goodwill as part of the acquisition, as a result of such matters as technological advancements or worse-than-expected performance by the acquired company.

As discussed above with respect to our recent acquisition of Ultratech, our inability to effectively manage these risks could materially and adversely affect our business, financial condition, and results of operations. In addition, ifIf we issue equity securities to pay for an acquisition or investment, the ownership percentage of our then-current shareholders would be reduced and the value of the shares held by these shareholders could be diluted, which could adversely affect the price of our stock. If we use cash to pay for an acquisition or investment, the payment could significantly reduce the cash that would be available to fund our operations, pay our indebtedness, or be used for other purposes, which could have a negative effect on our business.

In addition, we continually assess the strategic fit of our businesses and may from time to time seek to divest portions of our Company that no longer fit our strategic plan. Divestitures involve significant risks and uncertainties, including the ability to sell such businesses at satisfactory prices, on acceptable terms, and in a timely manner. Divestitures may also disrupt other parts of our businesses, distract the attention of our management, result in a loss of key employees or customers, and require that we allocate internal resources that would otherwise be devoted to operating our existing businesses. Divestitures may expose us to unanticipated liabilities (including those arising from representations and warranties made to a buyer regarding the businesses) and to ongoing obligations to support the businesses following such divestitures, any and all of which could adversely affect our financial condition and results of operations.

As a general principle, we seek to invest our capital in areas that we believe best align with our business strategy and will help optimize future returns. Our capital investments may not generate the expected returns or hoped-for results. We may not be able to obtain necessary grants, investment tax credits, or other governmental incentives, including funding through the U.S. CHIPS and Science Act of 2022. Significant judgment is required when assessing and selecting capital investments, and we could invest in projects that are ultimately less profitable than other projects which we do not select, ultimately harming our business, results of operations and financial condition.

Risks Associated with Operating a Global Business

We are exposed to risks of operating businesses outside the United States.

A majority of our sales are to customers, and significant elements of our supply chain are from suppliers, who are located outside of the United States, which we expect to continue. Our percentage revenue from the sale of products and the provision of services to non-U.S. customers was 76%, 69% and 62% for fiscal years 2023, 2022 and 2021, respectively. Our non-U.S. sales and operations are subject to risks inherent in conducting business outside the United States, many of which are beyond our control including:

political and social attitudes, laws, rules, regulations, and policies within countries that favor local companies over U.S. companies, including government-supported efforts to promote local competitors;
global trade issues and uncertainties with respect to trade policies, including tariffs, trade sanctions, and international trade disputes, and the ability to obtain required import and export licenses;
differing legal systems and standards of trade which may not honor our intellectual property rights and which may place us at a competitive disadvantage;

19

pressures from foreign customers and foreign governments for us to increase our operations and sourcing in the foreign country, which may necessitate the sharing of sensitive information and intellectual property rights;
multiple conflicting and changing governmental laws and regulations, including varying labor laws and tax regulations;
reliance on various information systems and information technology to conduct our business, making us vulnerable to cyberattacks by third parties or breaches due to employee error, misuse, or other causes, that could result in business disruptions, loss of or damage to our intellectual property and confidential information (and that of our customers and other business partners), reputational harm, transaction errors, processing inefficiencies, or other adverse consequences;
regional or global economic downturns or recessions, varying foreign government support, unstable political environments, and other changes in foreign economic conditions;
the impact of public health epidemics, such as the COVID-19 pandemic, on employees, suppliers, customers and the global economy;
difficulties in managing a global enterprise, including staffing, managing distributors and representatives, and repatriating cash;
longer sales cycles and difficulties in collecting accounts receivable; and
different customs and ways of doing business.

To date, our operations have not been materially adversely affected by global conflicts including Russia’s invasion of Ukraine, the current Israel/Palestine conflict, or the recent attacks on merchant ships in the Red Sea. However, further escalation of these or other conflicts could result in, among other negative consequences, a disruption to the global economy and supply chain leading to a shortage of parts, materials and services needed to manufacture and timely deliver our products (and we note that the Ukraine-Russia geographic region is a significance source of critical raw materials, including neon and palladium, used for semiconductor manufacturing). Any such shortages could negatively impact our suppliers’ ability to meet our demand requirements and, in turn, our ability to satisfy our customer demand. Parts shortages may and have required, and may continue to require, that we plan ahead further than usual, and increase our purchase commitments to secure critical components in a timely manner. These challenges, together with other challenges associated with operating an international business, may adversely affect our ability to recognize revenue, our gross margins on the revenue we do recognize, and our other operating results.

Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition.

The U.S. government has implemented, and may continue to implement, changes in trade policy which have adversely affected and could continue to adversely affect the Company’s ability to sell and service its products to and for customers located in China and in certain other countries.

On October 7, 2022, the U.S. Commerce Department, Bureau of Industry and Security (“BIS”) announced new rules aimed in part at restricting China’s ability to obtain advanced computing chips and manufacture advanced semiconductors. Previous changes in trade policy by BIS have included, without limitation, the elimination of license exception CIV, the implementation of new regulations governing the sale of equipment to defined “Military End Users” and for defined “Military End Uses”, the addition of several companies to the U.S. Commerce Department’s Unverified List and Entity List (including Semiconductor Manufacturing International Corporation and certain related entities), and the expansion of the “foreign direct product rule” to restrict the sale of certain products if Huawei Technologies Co., Ltd. or its affiliates are parties to a transaction involving the products.

The effect of these changes, among others, is that U.S. companies are now required to obtain export licenses – now at times with a presumption of denial -- before providing commodities, software, and technology (which are subject to the regulations) to customers for whom licensing requirements did not previously apply. These changes have had, and will likely continue to have, a negative effect on our ability to sell and service certain equipment in China. The heightened export restrictions may also result in shipping delays, as the new regulations are interpreted and applied, and may inhibit technical discussions with existing or prospective customers, negatively impacting our ability to pursue sales opportunities. The administrative processing, attendant delays and risk of ultimately not obtaining required export approvals pose a particular disadvantage to the Company relative to our non-U.S. competitors who are not required to comply with U.S.

20

export controls. This difficulty and uncertainty has adversely affected our ability to compete for and win business from customers in China. Foreign customers affected by these and future U.S. government sanctions or threats of sanctions may respond by developing their own solutions to replace our products or by utilizing our foreign competitors’ products. This “trade war” with China, together with the prospect of additional governmental action related to export controls restrictions, international sanctions, and/or tariffs, has adversely affected, and is likely to continue to adversely affect, demand for our products and the results of our operations.

The changes in U.S. trade policy and export controls, as well as sanctions imposed by the U.S. against certain Chinese companies, have triggered retaliatory action by China and could trigger further retaliation (including the possible escalation of geopolitical tensions between China and Taiwan). In addition, China has provided, and is expected to continue to provide, significant assistance, financial and otherwise, to its domestic industries, including some of our competitors. We face increasing competition as a result of significant investment in the semiconductor industry by the Chinese government and various state-owned or affiliated entities that is intended to advance China’s stated national policy objectives (including a heightened focus on the production of legacy node and mature chips in response to U.S. and foreign government regulation impeding the production of advanced node chips). In addition, the Chinese government may restrict us from participating in the China market or may prevent us from competing effectively with Chinese companies.

Further, we hold inventory of products that may be affected by the recent U.S. government actions, including potential order cancellations. While we continue to take steps to mitigate our exposure to this developing situation, if the sale of these products is delayed or we are unable to return or dispose of our inventory on favorable economic terms, we may incur additional carrying costs for the inventory or otherwise record charges associated with this inventory.

We may be unable to obtain required export licenses for the sale of our products.

ProductsWhether with respect to sales to customers located in China or otherwise, products which (i) are either manufactured in the United States, (ii) incorporate controlled U.S. origin parts, technology, or software, or (iii) are based on U.S. technology, are subject to the U.S. Export Administration Regulations (“EAR”) when exported to and re-exported from international jurisdictions, in addition to the local jurisdiction’s export regulations applicable to individual shipments. Currently, our laser annealing, MOCVD, MBE, SiC and certain other systems and products are controlled for export under the EAR. Licenses or proper license exceptions may be required for the shipment of our products to certain customers or countries. Obtaining an export license or determining whether an export license exception exists often requires considerable effort by us and cooperation from the customer, which can add time to the order fulfillment process. We may be unable to obtain required export licenses or unable to qualify for export license exceptions and, as a result, we may be unable to export products to our customers. The administrative processing, potential delay and risk of ultimately not obtaining required export approvals pose a particular disadvantagecustomers and/or meet their servicing needs (requiring us to us relativerefund customer prepayments for products we are unable to our non-U.S. competitors who are not required to comply with U.S. export controls.ship). Non-compliance with the EAR or other applicable export regulations could result in a wide range of penalties including the denial of export privileges, fines, criminal penalties, and the seizure of commodities. In the event that an export regulatory body determines that any of our shipments violate applicable export regulations, we could be fined significant sums and our export capabilities could be restricted, which could have a material adverse impact on our business.business and reputation.

We are exposed to various risks associated with global regulatory requirements.

As a public company with global operations, we are subject to the laws of the United States and multiple foreign jurisdictions, and the rules and regulations of various governing bodies, which may differ among jurisdictions. We are required to comply with legal and regulatory requirements pertaining to such matters as data privacy (including the European Union General Data Protection Regulation and similar laws), anti-corruption (such as the Foreign Corrupt Practices Act and other local laws prohibiting improper payments to governmental officials), labor laws, immigration, customs, trade, taxes, corporate governance, conflict minerals, and antitrust regulations, among others. In addition, we are required to comply with laws and regulations pertaining to carbon emissions, and other regulatory requirements addressing climate change concerns. These laws and regulations, which are ever-evolving and at times complex and inconsistent, impose costs on our business and divert management time and attention from revenue-generating activities. Changes to or ambiguities in these laws and regulations may create uncertainty regarding our compliance requirements. While we intend to comply with these regulatory requirements, if we are found by a court or regulatory agency to have failed in these efforts, our business, financial condition, and results of operations could be adversely affected.

21

Risks Related to Intellectual Property and Cybersecurity

Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us.

We are increasingly dependent on information technology systems and infrastructure, including mobile technologies, to operate our business. In the ordinary course of our business, we collect, store, process and transmit significant amounts of sensitive information, including intellectual property, proprietary business information, personally-identifiable information of individuals, and other confidential information, including that of our customers and other business partners. It is critical that we do so in a secure manner to maintain the confidentiality, integrity, and availability of this sensitive information. We have also outsourced elements of our operations (including elements of our information technology infrastructure) to third parties, and as a result, we manage a number of third-party vendors who have access to our computer networks and our confidential information.

All information systems are subject to breach and disruption. Potential vulnerabilities can be exploited from inadvertent or intentional actions of our employees, third-party vendors, business partners, or by malicious third parties. Attacks of this nature are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of expertise and motives (including industrial espionage), including organized criminal groups, nation states, and others. In addition to the extraction ofsensitive information, attacks could include the deployment of harmful malware, ransomware, or other means which could affect service reliability and threaten the confidentiality, integrity, and availability of information. These risks have been exacerbated by an increase in employees working from home, ongoing geopolitical tensions and conflicts, and by the possible use of artificial intelligence (“AI”) to directly attack information systems with greater speed and efficiency than human bad actors.

We have experienced, and our third-party providers have experienced, cybersecurity attacks, some of which have been, and may continue to be, successful. Significant disruptions in our information technology systems (or those of our key suppliers, contract manufacturers, distributors, sales agents and other partners) or other data security incidents could adversely affect our business operations and result in the loss or misappropriation of, and unauthorized access to, sensitive information. Future or ongoing disruptions or incidents, whether from attacks on our technology environment or from computer viruses, natural disasters, terrorism, war or other causes, could result in a material disruption in our business operations, force us to incur significant costs and engage in litigation, harm our reputation, and subject us to liability under laws, regulations, and contractual obligations.

We may be unable to effectively enforce and protect our intellectual property rights.

Our success as a company depends in part upon the protection of our intellectual property rights. We rely primarily on patent, copyright, trademark, and trade secret laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary information, technologies, processes, and brand identity. We own various U.S. and international patents and have additional pending patent applications relating to certain of our products and technologies. The process of seeking patent protection is lengthy and expensive, and we cannot be certain that pending or future applications will result in issued patents or in patents which provide meaningful protection or commercial advantage. In addition, our intellectual property rights may be circumvented, invalidated, or rendered obsolete by the rapid pace of technological change, or through efforts by others to reverse engineer our products or design around patents that we own. Policing unauthorized use of our products and technologies is difficult and time consuming and the laws of other countries may not protect our proprietary rights as fully or as readily as U.S. laws. Given these limitations, our success will depend in part upon our ability to innovate ahead of our competitors.

In addition, our outsourcing efforts require that we share certain portions of our technology with our outsourcing partners, which poses additional risks of infringement and trade secret misappropriation. Infringement of our rights by a third party, possibly for purposes of developing and selling competing products, could result in uncompensated lost market and revenue opportunities. Similar exposure could result in the event that former employees seek to compete with us through their unauthorized use of our intellectual property and proprietary information. We cannot be certain that

22

the protective steps and measures we have taken will prevent the misappropriation or unauthorized use of our proprietary information and technologies, nor can we be certain that applicable intellectual property laws, regulations, and policies will not be changed in a manner detrimental to the sale or use of our products.

Litigation has been required in the past, and may be required in the future, to enforce our intellectual property rights, protect our trade secrets, and to determine the validity and scope of proprietary rights of others. As a result of any such litigation, we could lose our ability to enforce one or more patents, incur substantial costs, and jeopardize relationships with current or prospective customers or suppliers. Any action we take to enforce or defend our intellectual property rights could absorb significant management time and attention, and could otherwise negatively impact our operating results.

We may be subject to claims of intellectual property infringement by others.

We receive communications from time to time from other parties asserting the existence of patent or other rights which they believe cover certain of our products. We also periodically receive notices from customers who believe that we are required to indemnify them for damages they may incur related to infringement claims made against these customers by third parties. Our customary practice is to evaluate such assertions and to consider the available alternatives, including whether to seek a license, if appropriate. However, we cannot ensure that licenses can be obtained or, if obtained, will be on acceptable terms or that costly litigation or other administrative proceedings will not occur. If we are not able to resolve a claim, negotiate a settlement of the matter, obtain necessary licenses on commercially reasonable terms, or successfully prosecute and defend our position, our business, financial condition, and results of operations could be materially and adversely affected.

Financial, Accounting and Capital Market Risks

Our operating results may be adversely affected by tightening credit markets.

As a global company with worldwide operations, we are subject to volatility and adverse consequences associated with economic downturns and recessions in different parts of the world. In the event of a downturn, many of our customers may delay or further reduce their purchases of our products and services. If negative conditions in the credit markets, including a recommencement of increases in interest rates, prevent our customers from obtaining credit or necessary financing, product orders in these channels may decrease, which could result in lower revenue. In addition, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, and attendant pricing pressures. If our suppliers face challenges in obtaining credit, in selling their products, or otherwise in operating their businesses, their ability to continue to supply materials to us may be negatively affected.

In addition, we finance some of our sales through trade credit. In addition to ongoing credit evaluations of our customers’ financial condition, we seek to mitigate our credit risk by obtaining deposits and letters of credit on certain of our sales arrangements. We could suffer significant losses if a customer whose accounts receivable we have not secured fails or is otherwise unable to pay us, or if financial institutions providing letters of credit become insolvent. A loss in collections on our accounts receivable would have a negative impact on our financial condition and results of operations.

We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws.

We are subject to the Foreign Corrupt Practices Act of 1977 (“FCPA”) and other laws that prohibit improper payments or offers of paymentsforeign currency exchange risks.

We are exposed to foreign government officials, as defined bycurrency exchange rate risks that are inherent in our anticipated sales, purchase commitments, and assets and liabilities that are denominated in currencies other than the statute, forU.S. dollar. Although we attempt to mitigate our exposure to fluctuations in currency exchange rates, hedging activities may not always be available or adequate to mitigate the purpose of obtaining or retaining business. In addition, manyimpact of our customers have policies limitingexchange rate exposure. Failure to sufficiently hedge or prohibiting us from providing certain types or amounts of entertainment, meals, or gifts to their employees. It is our policy to implement safeguards to discourage these practices by our employeesotherwise manage foreign currency risks properly could materially and representatives. However, our safeguards may prove to be ineffective and our employees, consultants, sales agents, or distributors may engage in conduct for which we may be held responsible. In addition, we may acquire a company that has engaged in unlawful conduct in the past, and be held responsible for this conduct through successor liability principles. Violations of the FCPA or similar laws or similar customer policies may result in severe criminal or civil sanctions or the loss of supplier privileges to a customer and we may be subject to other liabilities, which could negatively affect our business, financial condition, and results of operations.

We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act and any delays or difficulties in satisfying these requirements or negative reports concerning our internal controls could adversely affect our futurefinancial condition, results of operations, and our stock price.liquidity.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we must include in our Annual Report on Form 10-K a report by management on the effectiveness of our internal control over financial reporting. Ongoing compliance with this requirement is complex, costly, time-consuming, and is subject to significant judgment. If our internal controls are ineffective or if our management does not timely assess the adequacy of such internal controls, our ability to file timely and accurate periodic reportsWe may be impeded. Any delaysrequired to take impairment charges on assets.

We are required to assess goodwill and indefinite-lived intangible assets annually for impairment, or on an interim basis whenever certain events occur or circumstances change, such as an adverse change in filing may cause us to facebusiness climate or a decline in the following risks and concerns, among others:

23

overall industry, that would more likely than not reduce the fair value below its carrying amount.

·                  concern on theAs part of our customers, partners, investors, and employees aboutlong term strategy, we may pursue future acquisitions of, or investments in, other companies or assets which could potentially increase our financial condition and filing delay status, including the potential loss of business opportunities;

·                  significant time and expenseassets. We are required to complete delayed filings and the distractiontest certain of our senior management teamassets, including acquired intangible assets, property, plant, and boardequipment, and equity investments without readily observable market prices, for recoverability and impairment whenever there are indicators of directorsimpairment such as we work to complete delayed filings;

·                  investigationsan adverse change in business climate. Adverse changes in business conditions or worse-than-expected performance by the SECthese acquired companies could negatively impact our estimates of future operations and other regulatory authorities of the Company and our management;

·                  limitations on our ability to raise capital;

·                  suspension or termination of our stock listing on The NASDAQ Stock Market and the removal of our stock as a component of certain stock market indices; and

·                  general reputational harm.

Any or all of the foregoing could result in the commencement of stockholder lawsuits against the Company. Any such litigation, as well as any proceedings that could arise as a result of a filing delay and the circumstances which gave riseimpairment charges to it, may be time consuming and expensive, may divert management attention from the conduct of our business, could have a

material adverse effect on our business, financial condition, and results of operations, and may expose us to costly indemnification obligations to current or former officers, directors, or other personnel, regardless of the outcome of such matters, which may not be adequately covered by insurance.these assets.

Changes in accounting pronouncements or taxation rules, practices, or practicesrates may adversely affect our financial results.

Changes in, or newly enacted, accounting pronouncements or taxation rules, practices or practicesrates can have a significant effect onmaterially affect our reported results. New accounting pronouncements and taxation rules can have a material impact onrevenue recognition practices, effective tax rates, results of operations, and our financial condition. On December 22, 2017, President Trump signed into law the statute commonly referred to as the Tax Cuts and Jobs Act (“2017 Tax Act”), which makes broad and complex changes to the U.S. tax code. As we collect and prepare necessary data, and interpret the 2017 Tax Act and any additional guidance issued by the IRS or other standard-setting bodies, we may make adjustments to the provisional amounts in accordance with Staff Accounting Bulletin No. 118 (“SAB 118”), which provides SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. This change could materially affect our financial position and tax attributes carryforward. In addition, varying interpretations of accounting pronouncements or taxation practices, and the questioning of our current or past practices, (such as those associated with our transfer pricing), may adversely affect our reported financial results.

The “Tax Relief for American Families and Workers Act of 2024” is currently under Senate consideration. The passage of this bill as proposed would have a material impact to our income tax provision, specifically due to the immediate expensing of Sec 174 R&D expenses, which will lower our Foreign-Derived Intangible Income (“FDII”) deductions and thus increase our effective tax rate. Additionally, recommendations made pursuant to the Organization for Economic Cooperation and Development’s (“OECD”) Base Erosion and Profit Shifting (“BEPS”) project have led to changes in tax laws in numerous countries and could increase our tax obligations in countries where we do business. As part of BEPS 2.0, the OECD has focused on ensuring multinational businesses with consolidated global revenues in excess of 750 million euros pay their tax in the 'right place' (Pillar 1) and at least at a 'minimum rate' (Pillar 2), including ensuring that multinational enterprises are paying tax at an effective rate of 15% or higher in every jurisdiction in which they operate, regardless of the local headline tax rate or the impact of local tax reliefs. We may be subject to the Pillar Two requirements in the future should our global revenues exceed the Pillar Two thresholds. While we do not currently expect Pillar Two to have a material impact on our effective tax rate, we are in the process of assessing and monitoring potential impacts and developments. These and other developments or changes in federal or international tax laws, rules, practices or rates (including future changes or modifications to existing practices) could have an adverse material impact on our ability to utilize our deferred tax attributes, our effective tax rate and results of operations including cash flows and financial position.

Our

In addition, as of each reporting date, we evaluate the realizability of our deferred tax assets which may result in the recognition and/or release of a valuation allowance. Any changes in the valuation allowance will have a direct impact on our effective tax rate.The realization of net deferred tax assets relies on our ability to generate future taxable income, taxesand, as such, if the Company is unable to generate sufficient future taxable income, we may change.not obtain the full benefit of these deferred tax assets.

WeFinally, we are subject to income tax on a jurisdictional or legal entity basis and significant judgment is required in certain instances to allocate our taxable income to a jurisdiction and to determine the related income tax expense and benefits. Losses in one jurisdiction generally may not be used to offset profits in other jurisdictions. As a result, changes in the mix of our earnings (or losses) between jurisdictions, among other factors, could alter our overall effective income tax rate, possibly resulting in significant tax rate increases.

We Furthermore, we are regularly audited by various tax authorities. Income tax audit assessments or changes in tax laws, regulations, or other interpretationsauthorities, and these audits may result in increased tax provisions which could materiallynegatively affect our operating results in the period or periods in which such determinations are made or changes occur.

Our current debt facilities may contain certain restrictions, covenants and repurchase provisions that may limit our ability to raise the funds necessary to meet our working capital needs, which may include the cash conversion of the Notes or repurchase of the Notes for cash upon a fundamental change.

As of December 31, 2023, we had $26.5 million in principal amounts outstanding in 2025 Notes, $25.0 million in principal amounts outstanding in 2027 Notes, and $230.0 million in principal amounts outstanding in 2029 Notes

24

(together, the “Notes”). In addition, as of December 31, 2023, we had an undrawn senior secured revolving credit facility (the “Credit Facility”) in an aggregate principal amount of $150.0 million, including a $15.0 million letter of credit sublimit.

These debt facilities (collectively, the “Debt Facilities”), contain certain covenant and other restrictions that may limit our ability to, among other things, incur additional debt or create liens, sell certain assets, and merge or consolidate with third parties, which may, in turn, preclude us from responding to changes in business and economic conditions, engaging in transactions that might otherwise be beneficial to us. Our ability to comply with some of these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control such as prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Debt Facilities, which could accelerate the debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.

In addition, our effective tax rateability to repurchase or to pay cash upon conversion of the Notes, or maturity of the Credit Facility, may be limited by law, by regulatory authority or by agreements governing our indebtedness that exist at the time of repurchase, conversion, or maturity. Our failure to settle the debt as required would constitute a default under the applicable debt facility and may lead to a default under the other debt facilities. If the payment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness.

Finally, holders of the Notes will have the right to require us to repurchase all or any portion of their Notes upon the occurrence of a fundamental change before the maturity date. Additionally, in the event the conditional conversion features of the Notes are triggered (as is currently the case for the 2027 Notes through March 31, 2024), holders of Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert the Notes, or if a fundamental change occurs before maturity, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the Notes being converted, which could increase ifadversely impact our liquidity. Additionally, we determine that it is no longer more likely thanmay not thathave enough available cash or be able to obtain financing at the time we are ablerequired to realizemake repurchases of the Notes surrendered therefor or pay cash with respect to the Notes being converted. In addition, even if holders do not elect to convert the Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which could result in a material reduction of our remaining net deferredworking capital.

Issuance of our common stock, if any, upon conversion of the Notes, as well as the capped call transactions and the hedging activities of the option counterparties, may impair or reduce our ability to utilize our foreign tax assets, if we are unablecredits or our research and development credits carryforwards in the future.

Pursuant to generate sufficient futureU.S. federal and state tax rules, a corporation is generally permitted to deduct from taxable income in certain jurisdictions, or ifany year net operating losses (“NOLs”) carried forward from prior years and to reduce from tax liabilities in any year foreign tax credits and R&D credits carried forward from prior years.

As of December 31, 2023, we are otherwise requiredhad U.S. federal R&D credits carryforwards of approximately $34.9 million expiring in varying amounts between 2030 and 2043. If we were to increase our valuation allowances against our deferredexperience a “change in ownership” under Section 382 of the Internal Revenue Code (“Section 382”), the federal credits carry forward limitation under Section 383 of the Internal Revenue Code would impose an annual limit on the amount of tax assets.

Weliabilities that may be requiredoffset by R&D credits generated prior to take additional impairment charges on assets.the change in ownership. If an ownership change were to occur, we may be unable to use a significant portion of our R&D credit carryforwards to offset future tax liabilities.

WeThe shares of common stock, if any, issued upon conversion of the Notes will, upon such issuance, be taken into account when determining the cumulative change in our ownership for Section 382 purposes. As a result, any conversion of the Notes that we elect to settle in shares may materially increase the risk that we could experience an ownership change for these purposes in the future.

25

The capped call transactions may affect the value of the 2027 Notes and our common stock.

With respect to the 2027 Notes, we have entered into capped call transactions with certain option counterparties. The capped call transactions were expected generally to reduce the potential dilution upon conversion of the 2027 Notes and/or offset any cash payments we are required to assess goodwill and indefinite-lived intangible assets annually for impairment, make in excess of the principal amount of converted 2027 Notes, as the case may be, with such reduction and/or on an interim basis whenever certain events occuroffset subject to a cap.

The option counterparties or circumstances change, such as an adverse changetheir affiliates may enter into or modify hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in business climate orsecondary market transactions prior to the maturity of the 2027 Notes (and are likely to do so during any observation period related to a decline inconversion of the overall industry, that would more likely than not reduce the fair value below its carrying amount. We are2027 Notes). This activity could also required to test our long-lived assets, including acquired intangible assets and property, plant, and equipment, for recoverability and impairment whenever there are indicators of impairment such as an adverse change in business climate.

As part of our long term strategy, we may pursue future acquisitions of other companies or assets which could potentially increase our assets. Adverse changes in business conditions could materially impact our estimates of future operations and result in impairment charges to these assets. A significant declinecause fluctuations in the market price of our common stock and the 2027 Notes, which could indicateaffect the ability of the noteholders to convert the 2027 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2027 Notes, it could affect the number of shares and value of the consideration that noteholders will receive upon conversion of the 2027 Notes.

General Risk Factors

The price of our common shares is volatile and could decrease.

The stock market in general and the market for technology stocks in particular has experienced significant volatility. The trading price of our common shares has fluctuated significantly and could decline independent of the overall market, and shareholders could lose all or a substantial part of their investment. For example, in 2023 our stock price ranged from a closing high of $31.65 to a closing low of $17.81. The market price of our common shares could continue to fluctuate in response to several factors, including among others:

difficult macroeconomic conditions, economic recessions, international trade disputes, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crisis and a failure of large financial institutions;
actual or anticipated variations in our results of operations;
issues associated with the performance of our products, or the performance of our internal systems such as our customer relationship management (“CRM”) system or our enterprise resource planning (“ERP”) system;
announcements of financial developments or technological innovations;
our failure to meet the performance estimates of investment research analysts;
changes in recommendations and financial estimates by investment research analysts, and decisions by investment research analysts to cease coverage of our Company;
margin trading, short sales, hedging and derivative transactions involving our common stock;
our failure to successfully implement cost reduction initiatives and restructuring activities, if and when required;
our failure to maintain an effective system of disclosure controls and internal control over financial reporting, which may result in our inability to timely and accurately report our financial results or difficulties in satisfying internal control evaluations and attestation requirements of Section 404 of the Sarbanes Oxley Act of 2002;
the commencement of, and rulings on, litigation and legal proceedings; and
the occurrence of major catastrophic events.

Securities class action litigation is often brought against a company following periods of volatility in the fairmarket price of its securities. These lawsuits, if and when brought, can result in substantial costs and a diversion of management’s attention and resources, which can adversely affect our financial condition, results of operations, and liquidity.

Our inability to attract, retain, and motivate employees could have a material adverse effect on our business.

26

Our success depends largely on our ability to attract, retain, and motivate employees, including those in executive, managerial, engineering and marketing positions, as well as highly skilled and qualified technical personnel. Competition for qualified design and technical personnel is intense, particularly in the semiconductor industry and especially when business cycles are improving. Competitors may try to recruit, and may succeed in recruiting, our most valuable technical employees. To attract and retain key employees, we must provide competitive compensation packages, including cash and stock-based compensation, among other benefits. If the value of our reporting unit such that goodwill becomes impaired. Ifstock-based incentive awards decreases, or if our assetstotal compensation packages are impaired,not viewed as competitive, our ability to attract and retain key employees could suffer. We do not have key person life insurance on any of our executives, and we may not be able to readily replace key departed employees. Our inability to attract, retain, and motivate key personnel could have a significant negative effect on our business, financial condition, and results of operations could be materiallyoperations.

We are subject to risks of non-compliance with environmental, health, and adversely affected.safety regulations.

We have indebtednessare subject to environmental, health, and safety regulations in the form of convertible senior notes which could adversely affectconnection with our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders.

In January of 2017, we issued $345 million of 2.70% Convertible Senior Notes due 2023 (“Convertible Senior Notes”). The Convertible Senior Notes are convertible into Company common stock at an initial conversion rate of 24.98 shares of Company common stock per $1,000 principal amount of the Convertible Senior Notes. The Company is obligated to repurchase the Convertible Senior Notes upon the occurrence of certain events described in the indenture relating to the Convertible Senior Notes. The degree to which we are leveraged could have negative consequences,business operations, including but not limited to regulations relating to the following:

·                  we may be more vulnerabledevelopment, manufacture and use of our products, recycling and disposal of related materials, and the operation and use of our facilities and real property. Failure or inability to economic downturns, less ablecomply with existing or future environmental, health and safety regulations – including, for example, those relating to withstand competitive pressures,carbon emissions, climate change, and less flexiblethe use and sale of products containing per- and polyfluoroalkyl substances (“PFAS”) -- could result in responding to changing business and economic conditions;

·significant remediation liabilities, the imposition of fines, the suspension or termination of research, development, or use of certain of our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate,products, and other purposes may be limited;

·                  a substantial portion of our cash flows from operations inharm to the future may be required for the payment of the principal amount of our existing indebtedness when it becomes due; and

·                  we may elect to make cash payments upon any conversion of the Convertible Senior Notes, which would reduce our cash on hand.

Our ability to meet our payment obligations under the Convertible Senior Notes depends on our ability to generate significant cash flow in the future. This, to some extent, is subject to general economic, financial, competitive, legislative, regulatory, and other factors that are beyond our control. There can be no assurance that our business will generate cash flow from operations, or that additional capital will be available to us, in an amount sufficient for us to meet our debt payment obligations and to fund other liquidity needs. If we are unable to generate sufficient cash flow to service our debt obligations, we may need to refinance or restructure our debt, sell assets, reduce or delay capital investments, or seek to raise additional capital. If we were unable to implement one or more of these alternatives, we may be unable to meet our debt payment obligations,Company, which could have a material adverse effect on our business, financial condition, and results of operations.

In addition, changes in environmental laws and regulations, including those relating to greenhouse gas emissions and other climate change matters, could require us (and/or our key suppliers, contract manufacturers and other partners) to install new equipment, alter operations to incorporate new technologies, or implement new processes, among other measures, which may cause us to incur significant costs and financial condition.divert management attention.

We are committed to ensuring safe working conditions, treating our employees with dignity and respect, and sourcing, manufacturing, and distributing our products in a responsible and environmentally friendly manner, and any failure on our part to do so may cause reputational and other harm for the Company. Furthermore, if the Convertible Senior Notes are converted into shares of Company common stock, the issuance of additional shares of Company common stock would dilute the ownership interestsome of our existing shareholdersoperations involve the storage, handling, and could have a dilutive effect on our net income per share to the extent that the priceuse of our common stock exceeds the conversion price of the Convertible Senior Notes. In addition, any sales in the public market of our common stock issuable upon conversion of the Convertible Senior Notes could adversely affect prevailing market prices of our common stock.

The accounting method for convertible debt securitieshazardous materials that may pose a risk of fire, explosion, or environmental release. Such events could result from acts of terrorism, natural disasters, or operational failures and may result in injury or loss of life to our employees and others, local environmental contamination, and property damage. These events may cause a temporary shutdown of an affected facility, or portion thereof, and we could be settled in cash, suchsubject to penalties or claims as the Convertible Senior Notes,a result. Each of these events could have a material adverse effect on our reportedbusiness, financial results.condition, and results of operations.

Under Accounting Standards Codification 470-20, Debt with Conversion and Other Options (“ASC 470-20”), an entity must separately account for the liability and equity components of certain convertible debt instruments (such as the Convertible Senior Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the Convertible Senior Notes is that the equity component is required to be included in the additional paid-in capital section of stockholders’ equity on our consolidated balance sheet, and the value of the equity component would be treated as original issue discount for purposes of accounting for the debt component of the Convertible Senior Notes. As a result, we will be required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the Convertible Senior Notes to their face amount over the term of the Convertible Senior Notes. We will report lower net income in our financial results because ASC 470-20 will require interest to include both the current period’s amortization of the debt discount and the instrument’s coupon interest, which could adversely affect our financial results, the trading price of our common stock, and the trading price of the Convertible Senior Notes.

In addition, under certain circumstances convertible debt instruments (such as the Convertible Senior Notes) that may be settled entirely or partly in cash can be accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the Convertible Senior Notes are not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Convertible Senior Notes exceeds their principal amount. Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. We cannot be sure that the accounting standards in the future will continue to permit the use of the treasury stock method or that we will continue to expect to settle the principal balance in cash. If we are unable to use the treasury stock method in accounting for the shares issuable upon conversion of the Convertible Senior Notes, our diluted earnings per share could be adversely affected.

We are subject to foreign currency exchange risks.

We are exposed to foreign currency exchange rate risks thatassociated with the increased attention by our stakeholders to environmental, social and governance (“ESG”) matters.

Our stakeholders, including customers, investors, advisory firms, employees, and suppliers, among others, have increasingly focused on our ESG initiatives, including those regarding climate change, human rights, inclusion and diversity, among others. These expectations can extend, and have extended, to our corporate practices, initiatives, and disclosures, as well as stakeholder standards or preferences for investments or doing business. Third-party rating agencies have also established standards for a range of ESG-related factors, which may be inconsistent and are inherentsubject to change. These expectations and stakeholder requirements may impact the attractiveness of our business, the manner in which we do business, our anticipated sales, salesreputation, the costs of doing business, and purchasethe willingness of our stakeholders to engage with, invest in, or retain us. We may be further impacted by the adoption of ESG-related regulation and legislation in the jurisdictions in which we do business – including, for example, the SEC’s proposed rule published in March of 2022 which would require companies to include significantly enhanced climate-related disclosures in their Reports on Form 10-K -- which could result in increased compliance, operational, and other costs.

From time to time the Company communicates its strategies, commitments and assetstargets relating to ESG matters. These strategies, commitments and liabilities that are denominated in currencies other than the U.S. dollar. Althoughtargets reflect our current plans and aspirations, and we attempt to mitigate our exposure to fluctuations in currency exchange rates, hedging activities may not always be available or adequate to mitigate the impact of our exchange rate exposure. Failure to sufficiently hedge or otherwise manage foreign currency risks properly could materially and adversely affect our financial condition, results of operations, and liquidity.

Our previously announced share repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at anyunable to achieve them. In

27

addition, the standards for measuring and reporting sustainability metrics may change over time which mayand could result in a decrease in the trading price of our common stock.

Repurchases pursuantsignificant revisions to our share repurchase programstrategies, commitments and targets, or our ability to achieve them. Any failure to satisfy or achieve ESG-related requirements or targets could affectadversely impact the demand for our stock priceproducts, subject us to significant costs and increase its volatility. The existence of a share repurchase program could alsoliabilities, cause our stock price to be higher than it would be in the absence of such a programdecline, and could potentially reduce the market liquidity for our stock. There can be no assurance that any share repurchases will enhance stockholder value because the market price of our common stock may decline below the levels at which we repurchased shares of common stock. Although our share repurchase program is intended to enhance long term stockholder value, short term stock price fluctuations could reduce the program’s effectiveness. Furthermore, the program does not obligate the Company to repurchase any dollar amount or number of shares of common stock, and may be suspended or discontinued at any time and any suspension or discontinuation could cause the market price of our stock to decline.

If we are subject to cyber-attacks we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our operations.

We manage, store, and transmit proprietary information and sensitive data relating to our operations. We may be subject to breaches of the information technology systems we use for these purposes. Experienced computer programmers and hackers may be able to penetrate our network security and misappropriate and compromise our confidential information (and third party confidential information), create system disruptions, or cause shutdowns. Computer programmers and hackers also may be able to develop and deploy viruses, worms, and other malicious software programs that attack our systems or our products, or that otherwise exploit security vulnerabilities.

The costs to address the foregoing security problems and security vulnerabilities before or after a cyber-incident could be significant. Our remediation efforts may not be successful and could result in interruptions, delays, a cessation of service, and a loss of existing or potential customers, impeding our sales, manufacturing, distribution, and other critical functions. In addition, breaches of our security measures and the unapproved dissemination of proprietary information or sensitive data about us, our customers or other third parties, could expose us, our customers and others to a risk of loss or misuse of this information, result in litigation and potential liability for us, damage our reputation, and otherwise harm our business.reputational harm.

We have adopted certain measures that may have anti-takeover effects, which may make an acquisition of our Company by another company more difficult.

We have adopted, and may in the future adopt, certain measures that may have the effect of delaying, deferring, or preventing a takeover or other change in control of our Company, which a holder of our common stock mightmay not consider to be in the holder’s best interest. These measures include:

·                  “blank check” preferred stock;

·                  a classified board of directors; and

·                  certain other certificate of incorporation and bylaws provisions.

OurFor example, our board of directors has the authority to issue up to 500,000 shares of preferred stock and to fix the rights (including voting rights), preferences and privileges of these shares (“blank check” preferred)preferred stock). Such preferred stock may have rights, including economic rights, senior to our common stock. As a result, the issuance of the preferred stock could have a material adverse

effect on the price of our common stock and could make it more difficult for a third party to acquire a majority of our outstanding common stock.

OurIn addition, our board of directors is divided into three classes with each class serving a staggered three-year term. The existence of a classified board makes it more difficult for our shareholders to change the composition of our board of directors, and therefore the Company’s policies, in a relatively short period of time.

We Furthermore, we have adopted certain certificate of incorporation and bylaws provisions which have anti-takeover effects. These include: (a) requiring certain actions to be taken at a meeting of shareholders rather than by written consent, (b) requiring a super-majority of shareholders to approve certain amendments to our bylaws, (c) limiting the maximum number of directors, and (d) providing that directors may be removed only for “cause.”cause. These measures and those described above may have the effect of delaying, deferring, or preventing a takeover or other change in control of our Company that a holder of our common stock mightmay not consider to be in the holder’s best interest.

In addition, we are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from engaging in any business combination, including mergers and asset sales, with an interested stockholder (generally, a 15% or greater stockholder) for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. The operation of Section 203 may have anti-takeover effects, which could delay, defer, or prevent a takeover attempt that a holder of our common stock mightmay not consider to be in the holder’s best interest.

Despite the above measures, an activist shareholder could undertake action to implement governance, strategic, or other changes to the Company which a holder of our common stock mightmay not consider to be in the holder’s best interest. Such activities could interfere with our ability to execute our strategic plans, be costly and time consuming, disrupt our operations, and divert the attention of management and our employees.

We are subject to risks of non-compliance with environmental, health, and safety regulations.

We are subject to environmental, health, and safety regulations in connection with our business operations, including but not limited to regulations related to the development, manufacture and use of our products, recycling and disposal of related materials, and the operation and use of our facilities and real property. Failure or inability to comply with existing or future environmental and safety regulations, which vary from jurisdiction to jurisdiction, could result in significant remediation liabilities, the imposition of fines, and the suspension or termination of research, development, or use of certain of our products, each of which could have a material adverse effect on our business, financial condition, and results of operations. In addition, some of our operations involve the storage, handling, and use of hazardous materials that may pose a risk of fire, explosion, or environmental release. Such events could result from acts of terrorism, natural disasters, or operational failures and may result in injury or loss of life to our employees and others, local environmental contamination, and property damage. These events might cause a temporary shutdown of an affected facility, or portion thereof, and we could be subject to penalties or claims as a result. Each of these events could have a material adverse effect on our business, financial condition, and results of operations.

Regulations related to conflict minerals will force us to incur additional expenses, may make our supply chain more complex, and may harm our relationships with customers.

Under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”), the SEC adopted requirements for companies that manufacture products that contain certain minerals and metals, known as conflict minerals. These rules require public companies to perform diligence and to report annually to the SEC whether such minerals originate from the Democratic Republic of Congo and adjoining countries. The implementation of these requirements could adversely affect the sourcing, availability, and pricing of minerals we use in the manufacture of our products. In addition, we have incurred and will continue to incur additional costs to comply with the disclosure requirements, including costs related to determining the source of any of the relevant minerals used in our products. Given the complexity of our supply chain, we may not be able to ascertain the origins of these minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. We may also face difficulties in satisfying customers who require that our products be certified as conflict mineral free, which could harm our relationships with these customers and lead to a loss of revenue. These requirements could limit the pool of suppliers that can provide conflict-free minerals, and we may be unable

to obtain conflict-free minerals at competitive prices, which could increase our costs and adversely affect our manufacturing operations and our profitability.

We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism, or other significant disruption.

Our operations in the United States, in the Asia-Pacific region, and in other areas could be subject to natural disasters or other significant disruptions, including earthquakes, tsunamis, fires, hurricanes, floods, water shortages, other extreme weather conditions, medical epidemics, power shortages and blackouts, telecommunications failures, and other natural and manmade disasters or disruptions. In the event of such a natural disaster or other disruption, we could experience disruptions or interruptions to our operations and to the operations of our suppliers, distributors, resellers and customers, destruction of facilities and loss of life, all of which could materially increase our costs and expenses and materially and adversely affect our business, financial condition, and results of operations. In addition, various regions of the world in which we do business are subject to the threat of terrorism and acts of war. Any act of terrorism or war that affects the economy or the industries in which we operate could result in significant harm to us, including the loss of life and property, manufacturing and transportation delays, disruptions in our supply chain, the need to comply with enhanced security measures, and other increased costs.

Item 1B. Unresolved Staff Comments

None.

ITEM 1C. Cybersecurity

Cybersecurity represents a critical component of the Company’s overall approach to risk management. Our cybersecurity practices are integrated into the Company’s enterprise risk management (“ERM”) approach, and cybersecurity risks are among the core enterprise risks identified for oversight by our Board of Directors and the Board’s Audit Committee through our annual ERM assessment. Our cybersecurity policies and practices follow the cybersecurity framework of the National Institute of Standards and Technology and other applicable industry standards. We generally approach cybersecurity threats through a cross-functional, multi-layered approach, with the specific goals of: (i) identifying, preventing and mitigating cybersecurity threats to the Company; (ii) maintaining the confidence of our customers, clients and business partners; (iii) preserving the confidentiality of our employee’s information; and (iv) protecting the Company’s intellectual property.

Consistent with the Company’s overall ERM practices, our cybersecurity program focuses on the following areas:

28

Vigilance: The Company maintains a global presence, with cybersecurity threat operations operating 24/7 around the world with a specific goal of detecting, containing and responding to cybersecurity threats and incidents.
Collaboration: The Company has established collaboration mechanisms with public and private entities, including intelligence and enforcement agencies, industry groups and third-party service providers to identify and assess cybersecurity risks.
Systems Safeguards: The Company deploys technical safeguards that are designed to protect the Company’s information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality, access controls and ongoing vulnerability assessments.
Third-Party Management: The Company maintains a comprehensive, risk-based approach to identifying and overseeing cybersecurity risks presented by third parties, such as vendors, service providers and other users of the Company’s systems.
Education: The Company provides periodic training for personnel regarding cybersecurity threats, with such training scaled to reflect the roles, responsibilities, and access of the relevant Company personnel.
Incident Response Planning: The Company has established and maintains incident response plans that address the Company’s response to a cybersecurity incident, and such plans are tested on an ongoing basis.
Communication and Coordination: The Company utilizes a cross-functional approach to address the risk from cybersecurity threats and has formed an Information Security Leadership Group which includes management personnel from information technology, operations, legal, internal audit and other key business functions. The Information Security Leadership Group typically meets on a monthly basis, and more frequently as necessary.
Governance: Pursuant to the Company’s ERM practices, oversight of cybersecurity risk management has been assigned to the full Board and to the Board’s Audit Committee. Quarterly updates are provided by Company management, including the Company’s Chief Information Security Officer, to the Audit Committee (three times per year) and the full Board (annually), to help ensure an ongoing dialogue regarding the Company’s cybersecurity initiatives, threats and incidents.

A key part of the Company’s strategy for managing risks from cybersecurity threats is the ongoing assessment and testing of the Company’s processes and practices through auditing, assessments, tabletop exercises and other exercises focused on evaluating effectiveness. The Company regularly engages third parties to perform assessments on our cybersecurity measures, including information security maturity assessments and independent reviews of our information security control environment and operating effectiveness and adjusts its cybersecurity processes and practices as necessary.

The Audit Committee oversees the management of risks from cybersecurity threats, including the policies, processes and practices that the Company’s management implements to address risks from cybersecurity threats. Management’s quarterly presentations include reports on a wide range of topics including, for example, recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends and information security considerations arising with respect to the Company’s peers and vendors. The Board also receives prompt and timely information regarding any cybersecurity incident that could pose a significant risk to the Company and receives ongoing updates regarding such incident until it has been addressed. At least once each year, and more frequently as required, the Board discusses the Company’s approach to cybersecurity risk management with the Company’s Chief Information Security Officer.

The Company’s Chief Information Security Officer is the member of the Company’s management that is principally responsible for overseeing the Company’s cybersecurity risk management program, in partnership with other members of the Information Security Leadership Group. Our Chief Information Security Officer has served in various roles in information technology and information security for over twenty years. Our Chief Information Security Officer holds graduate degrees in cybersecurity and business administration and has attained multiple professional certifications including CISSP, CISA and CISM.

29

The Company’s Chief Information Security Officer, in coordination with the Information Security Leadership Group, works collaboratively across the Company to implement a program designed to protect the Company’s information systems from cybersecurity threats and to promptly respond to any cybersecurity incidents. To facilitate the success of this program, multi-disciplinary teams throughout the Company are deployed to address cybersecurity threats and to respond to cybersecurity incidents in accordance with the Company’s incident response plan. Through ongoing communications with these teams, the Chief Information Security Officer and the Information Security Leadership Group monitor the prevention, detection, mitigation and remediation of cybersecurity incidents in real time, and report such incidents to the Board when appropriate, as addressed above.

While we and our third-party providers have in the past experienced cybersecurity incidents, we are not aware of any current incidents or new types of threats which have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition.

Item 2. Properties

Our corporate headquarters and principal research and development, manufacturing, and sales and service facilities are:as of December 31, 2023 are as follows:

    

Approximate

    

    

Owned Facilities Location

Size (sq. ft.)

Use

Plainview, NY

 

80,000

 

Corporate Headquarters; R&D; Sales & Service; Administration

Somerset, NJ

 

80,000

 

R&D; Manufacturing; Sales & Service; Administration

St. Paul, MN

 

43,000

 

R&D; Manufacturing; Sales & Service; Administration

Somerset, NJ

 

38,000

 

R&D; Sales & Service; Administration

 

 

Approximate

 

 

 

Lease

 

Leased Facilities Location

 

Size (sq. ft.)

 

Use

 

Expires

 

San Jose, CA

 

100,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2021

 

Somerset, NJ

 

57,000

 

Warehouse

 

2020

 

Kingston, NY (1)

 

52,000

 

Manufacturing

 

2018

 

Horsham, PA

 

49,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2024

 

Singapore

 

23,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2023

 

Waltham, MA

 

19,000

 

R&D; Sales & Service; Administration

 

2023

 

Hsinchu City, Taiwan

 

13,000

 

Sales & Service; Administration

 

2020

 

Shanghai, China

 

10,000

 

Sales & Service; Administration

 

2020

 

    

Approximate

    

    

    

Lease

Leased Facilities Location

Size (sq. ft.)

Use

Expiration

San Jose, CA

 

100,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2037

Somerset, NJ

 

57,000

 

Warehouse

 

2027

Horsham, PA

 

49,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2024

Waltham, MA

 

17,000

 

R&D; Sales & Service; Administration

 

2030

Solvegatan, Sweden

 

4,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2025


(1) Manufacturing site has been consolidated into Somerset, we expect to vacate this location during 2018.

In addition to the above, we lease a small office in Edina, Minnesota and Malta, New York for sales and service and our foreign sales and service subsidiaries lease office space in China, Germany, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Taiwan and the United Kingdom. We believe our facilities are adequate to meet our current needs.

Item 3. Legal Proceedings

On September 21, 2017, Blueblade Capital Opportunities LLC et al., on behalf of purported beneficial owners of 440,100 shares of Ultratech common stock, filed an action against Ultratech in Delaware Court of Chancery requesting an appraisal ofThe discussion under the value of their Ultratech stock pursuant to 8 Del. C. §262. We believe that the merger price, which was the product of

arms-length negotiations, was fairheading Legal Proceedings within Note 10, “Commitments and reasonable, and intend to contest the appraisal claim. Discovery in the matter has commenced and a trial on the action is scheduled to begin in December 2018.

On April 12, 2017, we filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLC and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment. The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted our motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using our patented technology without our express authorization.

On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that our MOCVD products infringed a Chinese utility model patent relatingContingencies” to the synchronous movement engagement mechanism in a chemical vapor deposition reactor and seeking injunctive relief and monetary damages against Veeco Shanghai. On December 7, 2017, without providing notice to us and without hearing our position on alleged infringement, the Fujian High Court issued a preliminary injunction, applicable in China, that requires Veeco Shanghai to stop importing, making, selling, and offering to sell Veeco EPIK 700 model MOCVD systems and to stop importing, selling, and offering to sell wafer carriers used as supplies for the EPIK 700 MOCVD system.Consolidated Financial Statements is incorporated herein by reference.

On February 8, 2018, Veeco, AMEC, and SGL announced that they had mutually agreed to settle the pending litigation among the parties and to amicably resolve all pending disputes, including AMEC’s lawsuit against Veeco before the Fujian High Court in China and Veeco’s lawsuit against SGL before the U.S. District Court for the Eastern District of New York. As part of the settlement, all legal actions worldwide (in court, patent offices, and otherwise), between Veeco, AMEC, and SGL, and their affiliates, will be dismissed and/or otherwise withdrawn. As a result, all business processes, including sales, service, and importation, will be continued.

We are involved in various other legal proceedings arising in the normal course of business. We do not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Item 4. Mine Safety Disclosures

Not Applicable.

30

PART II

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is quoted on The NASDAQ StockGlobal Select Market under the symbol “VECO.” The 2017 and 2016 high and low closing bid prices by quarter are as follows:

 

 

2017

 

2016

 

 

 

High

 

Low

 

High

 

Low

 

First Quarter

 

$

30.05

 

$

24.85

 

$

20.64

 

$

16.89

 

Second Quarter

 

34.20

 

27.40

 

19.72

 

15.79

 

Third Quarter

 

32.95

 

18.60

 

20.98

 

15.91

 

Fourth Quarter

 

22.25

 

11.90

 

29.95

 

19.75

 

OnAs of February 14, 2018, the closing price for13, 2024, there were approximately 122 stockholders of record of our common stock.Because many of our shares of common stock are held by brokers and other institutions on The NASDAQ Stock Market was $18.70, andbehalf of stockholders, we had 124 shareholdersare unable to estimate the total number of record.

stockholders represented by these record holders. We have not paid dividends on our common stock. The Board of Directors will determine future dividend policy based on our consolidated results of operations, financial condition, capital requirements, and other circumstances.

31

Share repurchase activity during the three months ended December 31, 2017 is as follows:

Period

 

Total Number of
Shares Purchased

 

Average Price
Paid Per Share

 

Total Number of
Shares Purchased
as Part of
Publicly Announced
Plans or Programs

 

Approximate Dollar
Value of Shares
That May Yet Be
Purchased Under the
Plans or Programs

 

 

 

(in thousands, except average price paid per share)

 

October 2, 2017

October 29, 2017

 

 

$

 —

 

 

$

  —

 

October 30, 2017

December 3, 2017

 

 

 

 

 —

 

December 4, 2017

December 31, 2017

 

203

 

14.83

 

203

 

96,982

 

During fiscal year 2017, 2016, and 2015, we repurchased 0.2 million shares, 0.7 million shares, and 0.5 million shares of our common stock for $3.0 million, $13.1 million, and $9.2 million, respectively, through our share repurchase programs. On December 11, 2017, our Board of Directors authorized a program to repurchase up to $100 million of the Company’s outstanding common stock to be completed through December 11, 2019, after completion of the previous program on October 28, 2017. Repurchases may be made from time to time on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. The timing and amount of future repurchases, if any, will depend upon market conditions, SEC regulations, and other factors. The repurchases would be funded using available cash balances and cash generated from operations. The program does not obligate us to acquire any particular amount of common stock and may be modified or suspended at any time at our discretion.

Stock Performance Graph

Graphic

ASSUMES $100 INVESTED ON DEC. 31, 20122018

ASSUMES DIVIDENDS REINVESTED

FISCAL YEAR ENDING DEC. 31

 

2012

 

2013

 

2014

 

2015

 

2016

 

2017

 

    

2018

    

2019

    

2020

    

2021

    

2022

    

2023

Veeco Instruments Inc.

 

100.00

 

111.60

 

118.28

 

69.72

 

98.85

 

50.36

 

 

100.00

 

198.18

 

234.28

 

384.21

 

250.74

 

418.76

S&P Smallcap 600

 

100.00

 

141.31

 

149.45

 

146.50

 

185.40

 

209.94

 

 

100.00

 

122.78

 

136.64

 

173.29

 

145.39

 

168.73

RDG MidCap Technology

 

100.00

 

161.83

 

159.04

 

138.67

 

123.87

 

132.83

 

 

100.00

 

135.47

 

183.68

 

207.06

 

151.73

 

190.98

Item 6. Selected Financial Data[Reserved]

32

The information set forth below should be read in conjunction with the “Results of Operations” section included in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

 

Year ended December 31,

 

 

 

2017 (1) 

 

2016

 

2015

 

2014 (2)

 

2013

 

 

 

(in thousands, except per share data)

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

  484,756

 

$

  332,451

 

$

  477,038

 

$

  392,873

 

$

  331,749

 

Operating income (loss)

 

(63,778

)

(120,402

)

(23,232

)

(79,209

)

(71,812

)

Income (loss) from continuing operations, net of tax

 

(44,793

)

(122,210

)

(31,978

)

(66,940

)

(42,263

)

Basic income (loss) per common share from continuing operations

 

(1.01

)

(3.11

)

(0.80

)

(1.70

)

(1.09

)

Diluted income (loss) per common share from continuing operations

 

(1.01

)

(3.11

)

(0.80

)

(1.70

)

(1.09

)


(1) During the second quarter of 2017, the Company acquired Ultratech. The results of operations of Ultratech have been included in the consolidated financial statements since that date.

(2) During the fourth quarter of 2014, the Company acquired PSP. The results of operations of PSP have been included in the consolidated financial statements since that date.

 

 

December 31,

 

 

 

2017

 

2016

 

2015

 

2014

 

2013

 

 

 

(in thousands)

 

Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

279,736

 

$

277,444

 

$

269,232

 

$

270,811

 

$

210,799

 

Short-term investments

 

47,780

 

66,787

 

116,050

 

120,572

 

281,538

 

Working capital

 

373,536

 

357,999

 

379,904

 

387,254

 

485,452

 

Total assets

 

1,387,287

 

758,532

 

890,789

 

929,455

 

947,969

 

Long-term debt (less current installments)

 

275,630

 

826

 

1,193

 

1,533

 

1,847

 

Total equity

 

840,713

 

594,595

 

714,615

 

738,932

 

780,230

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

On May 26, 2017, we completed the acquisition of Ultratech. Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. With the addition of Ultratech, we establish ourselves as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications, as well as greatly increasing our critical mass in the front-end semiconductor market. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

We categorize our revenue by the key market segments into which we sell. Our four key markets are: Advanced Packaging, MEMS & RF Filters; LED Lighting, Display & Compound Semiconductor; Front-End Semiconductor; and Scientific & Industrial.

We are a technology company that develops, manufactures, sells, and supportsan innovative manufacturer of semiconductor process equipment aligned to meet the demands of key global trends such as enhanced mobility, increased connectivity, and energy efficiency.equipment. Our primary technologies include metal organic chemical vapor deposition, advanced packaging lithography, wet etch and clean,proven ion beam, laser annealing, ion beam, molecular beam epitaxy,lithography, MOCVD, CVD, and single wafer inspection, and atomic layer deposition systems. Thesewet processing technologies play an integral role in producing LEDs for solid-state lighting and displays, and in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, we holdVeeco holds leading technology leadership positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

The Veeco United team executed well during 2023, accomplishing a number of milestones, including:

Solidly executing our multi-year growth strategy, with progress made towards advancing our product roadmaps for the Semiconductor and Compound Semiconductor markets, including shipment of two next generation nanosecond annealing evaluation systems to Tier 1 logic customers, shipment of two IBD300 evaluation systems to Tier 1 memory customers, and the continued development of our CVD SiC technology;

Achieved year-on-year revenue growth for the Company, including record revenue in the Semiconductor market, which grew 12% year-on-year despite a decline in Wafer Fabrication Equipment (“WFE”) spending;

Shipped multiple Laser Annealing systems to a new Tier 1 logic customer and a new Tier 1 memory customer, and expanded adoption of Laser Annealing systems with mature node customers;

Gross margin improvement enabled 16% growth in operating income year-over-year;

Successfully refinanced a portion of our convertible notes in order to strengthen our balance sheet and financial profile by extending the average maturity of our notes, reducing future annual cash interest payments, and lowering share dilution;

Capital allocation toward organic growth initiatives in the Semiconductor and Compound Semiconductor markets remained a top priority, including strategic R&D investment and investment in our evaluation program.

We believe these accomplishments enabled us to exit 2023 well positioned to execute on our growth plans for 2024.

Business Update

Macroeconomic challenges across the industry have been well publicized, including an inflationary and high-interest rate environment, heightened China export regulations, uncertainty in the banking industry, and an uncertain outlook in the semiconductor and related markets due to softness in consumer, smartphone and PC applications, all of which are contributing to increased uncertainty.

Furthermore, on October 17, 2023, the US Department of Commerce, Bureau of Industry and Security (“BIS”), issued an update to export regulations previously issued on October 7, 2022, to modify and reinforce the prior restrictions while placing additional entities on the BIS Entity List. While these served markets.new regulations have not had a material impact to our business, the export regulation landscape is fluid and evolving, and it is possible that the issuance of additional export controls could further restrict our ability to sell to customers in China and lead to future revenue loss. If we are not able to replace these sales with sales to other customers, it could have a material adverse impact on our business and financial position.

33

Finally, we continue to see reduced demand for certain products such as advanced packaging lithography, spare parts, and upgrades due to low customer utilization rates, as well as instances where customers have requested order cancellations, delayed shipments, or delayed payments. Consequently, we are monitoring the situation very closely and have been taking early actions to limit the pace at which we increase spending while maintaining our growth trajectory. We also have seen improvements in our supply chain, as evidenced by a significant decline in lead times and a further improvement to suppliers on time deliveries. Material lead times have improved significantly and have generally returned to pre-pandemic levels. We will continue to work with our suppliers to identify and mitigate potential gaps in an effort to ensure continuity of supply, as well as continue to focus our efforts on cost containment initiatives.

While we work to overcome these macroeconomic challenges, we continue to serve our customers in the following four end markets: Semiconductor; Compound Semiconductor; Data Storage; and Scientific & Other.

Sales in the Semiconductor market grew 12% in 2023, driven by our laser annealing systems for both advanced and mature node devices. While our growth strategy is predominately focused on advanced node logic and memory applications, 2023 revenue has been strong for mature node applications in China. We continue to build momentum for our laser annealing solutions in advanced node logic by winning application steps and new customers. In 2023, we penetrated our 3rd Tier 1 logic customer and shipped multiple systems to this customer. As it relates to the memory market, we announced that a Tier 1 memory customer placed several LSA orders for high volume production of High Bandwidth Memory (“HBM”) and advanced DRAM devices following a successful evaluation program, and we shipped several systems to this customer in 2023. Our Laser Annealing roadmap reached a key milestone during the fourth quarter upon shipment of our first two Nanosecond Annealing evaluation systems to Tier 1 logic customers. Nanosecond annealing provides Veeco with an opportunity to expand laser annealing adoption for new advanced node applications. The ongoing adoption of EUV Lithography for advanced node semiconductor manufacturing continues to drive demand for our Ion Beam mask blank deposition systems. We reached another significant milestone in the fourth quarter upon shipment of our first two IBD300 evaluation systems to Tier 1 memory customers for 300mm front end semiconductor applications. Additionally, our lithography systems for Advanced Packaging MEMS & RF Filter markets were driven by Lithography and PSP systems,are used for packaging approaches such as the market continues to be influenced by the mobility trend and increasing functionality in mobile devices. Advanced Packaging opportunities slowed in 2017 as customers temporarily delayed adoption of fan-outfan out wafer level packaging (“FOWLP”)and other advanced packaging applications, while our wet processing systems are used for Photoresist Strip, Solvent Cleans, and flux removal. Overall, our technology and market strategy are well aligned with trends such as artificial intelligence, mobile connectivity and high-performance computing that drive the Semiconductor market. Given our current backlog and visibility, we expect Semiconductor revenue to be up in favor2024.

We address the Compound Semiconductor market with a broad portfolio of cheaper flip chip solutions. Our versatile PSP product architecture has allowed us totechnologies, including Wet Processing and MOCVD, along with MBE and Ion Beam, in emerging applications such as 5G driven RF device/filter manufacturing, GaN power electronics, and photonics applications including edge-emitting lasers, specialty LEDs and micro-LEDs. Sales in the Compound Semiconductor market declined by 28% in 2023, driven by a decline in systems for 5G driven RF device/filter manufacturing. We continue to generate solid business in the MEMS and RF Filter portion of this category. We remain well positionedinvest for future growth in thesethe Compound Semiconductor market in areas like Power Electronics and Micro-LED. Power Electronics markets supportedare served by trendsGaN equipment, and also by SiC epitaxy equipment. We are working to penetrate the GaN power market, which is driven by applications such as mobile connectivity, automotive electronics, big data processing and 5G infrastructure deployment, as well aswireless charging in consumer electronics. In addition to our GaN system offerings, on January 31, 2023 Veeco acquired SiC technology to address the longer term growthhigh-growth SiC power epitaxy equipment market, which is primarily driven by adoption of FOWLP and other Advanced Packaging applications.electric vehicles. With this acquisition, Veeco is accelerating its entry into this market. We expect revenue in the Compound Semi market to grow in 2024.

Sales in the LED Lighting, Display & Compound SemiconductorData Storage market wereincreased slightly in 2023. Demand for our Ion Beam products is driven by cloud-based storage. As reported, the continued shipmenthard disk drive industry experienced contraction in exabyte shipments in 2022 and 2023 with uncertainty as to the timing of MOCVDa recovery; however, recent analyst and PSP systemsindustry forecasts predict nearline hard disk drive exabyte shipments to customersgrow at an approximate 20% CAGR over the coming years from a lower base in China, Malaysia, and Europe. The largest applications for LEDs are solid state lighting, followed by TV displays. Over the past several quarters, demand has increased for larger LCD TV displays, which require relatively more LEDs2023 due to backlight than smaller display sizes. More recently, we have seen an increase in demand in non general-lighting applications such as 3D sensors, VCSELs, laser diodes, and RF devices. Our broad portfolio of MOCVD and PSP technologies have been developed to support these significant industry trends, driving an increase in demand for our MOCVD and PSP equipment. Our product mixlong-term growth in the LED market is expected to shift, andcloud. Despite current industry challenges, we expect to see a decline in gross marginsrevenue in the first half of 2018. We expect margins in the second half of 2018Data Storage market to be higher than the first half.flat to up in 2024.

Sales in the Front-End Semiconductor market were primarily driven by Laser Annealing systems, an IBD Photomask system for EUV applications, and IBE systems sold into STT-MRAM applications. We see strong interest from customers for our laser melt anneal systems which are being qualified in 7nm and 5nm applications, as well as our 3D inspection systems which are being evaluated at several high volume manufacturing fabs.

Sales in the Scientific & Industrial markets were supportedOther market are largely driven by shipments of Ion Beam systems for optical coatings and data storage applications, as well as shipments of MBE systemssales to governments, universities, and laboratories. While equipment demand from each individualresearch institutions. We address the Scientific & Other market may fluctuatewith several technologies, including MBE, ALD, MOCVD, Wet Processing, & IBD/IBE, which support scientific, optical coating and other applications, such as Micro-Electromechanical Systems

34

(MEMS) applications. Sales in this market increased as compared to the prior quarter and the prior year quarter. We expect sales in this market to quarter,grow in the diverse customer base has historically provided a relatively stable revenue stream for the Company.long run, in line with GDP.

Results of Operations

Years Ended December 31, 20172023 and 20162022

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 20172023 and 20162022 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment, including the Ultratech business acquired.segment.

 

 

For the year ended December 31,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

484,756

 

100%

 

$

332,451

 

100%

 

$

152,305

 

46%

 

Cost of sales

 

300,438

 

62%

 

199,593

 

60%

 

100,845

 

51%

 

Gross profit

 

184,318

 

38%

 

132,858

 

40%

 

51,460

 

39%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

81,987

 

17%

 

81,016

 

24%

 

971

 

1%

 

Selling, general, and administrative

 

100,250

 

21%

 

77,642

 

23%

 

22,608

 

29%

 

Amortization of intangible assets

 

35,475

 

7%

 

19,219

 

6%

 

16,256

 

85%

 

Restructuring

 

11,851

 

2%

 

5,640

 

2%

 

6,211

 

110%

 

Acquisition costs

 

17,786

 

4%

 

 

0%

 

17,786

 

*

 

Asset impairment

 

1,139

 

0%

 

69,520

 

21%

 

(68,381

)

(98)%

 

Other, net

 

(392

)

(0)%

 

223

 

0%

 

(615

)

*

 

Total operating expenses, net

 

248,096

 

51%

 

253,260

 

76%

 

(5,164

)

(2)%

 

Operating income (loss)

 

(63,778

)

(13)%

 

(120,402

)

(36)%

 

56,624

 

*

 

Interest income (expense), net

 

(17,122

)

(4)%

 

958

 

0%

 

(18,080

)

*

 

Income (loss) before income taxes

 

(80,900

)

(17)%

 

(119,444

)

(36)%

 

38,544

 

*

 

Income tax expense (benefit)

 

(36,107

)

(7)%

 

2,766

 

1%

 

(38,873

)

*

 

Net income (loss)

 

$

(44,793

)

(9)%

 

$

(122,210

)

(37)%

 

$

77,417

 

*

 

For the year ended December 31,

Change

 

2023

2022

Period to Period

 

(dollars in thousands)

 

Net sales

    

$

666,435

100

%  

$

646,137

100

%  

$

20,298

3

%

Cost of sales

 

381,376

57

%  

 

382,989

59

%  

 

(1,613)

(0)

%

Gross profit

 

285,059

43

%  

 

263,148

41

%  

 

21,911

8

%

Operating expenses, net:

 

  

  

 

  

 

  

Research and development

 

112,853

17

%  

 

103,565

16

%  

 

9,288

9

%

Selling, general, and administrative

 

92,756

14

%  

 

88,952

14

%  

 

3,804

4

%

Amortization of intangible assets

 

8,481

1

%  

 

10,018

2

%  

 

(1,537)

(15)

%

Other operating expense (income), net

 

1,029

%  

 

317

%  

 

712

225

%

Total operating expenses, net

 

215,119

32

%  

 

202,852

31

%  

 

12,267

6

%

Operating income (loss)

 

69,940

10

%  

 

60,296

9

%  

 

9,644

16

%

Interest income (expense), net

 

(1,187)

(0)

%  

 

(9,311)

(1)

%  

 

8,124

(87)

%

Other income (expense), net

(97,091)

(15)

%  

%

(97,091)

*

Income (loss) before income taxes

 

(28,338)

(4)

%  

 

50,985

8

%  

 

(79,323)

*

Income tax expense (benefit)

 

2,030

%  

 

(115,957)

%  

 

117,987

*

Net income (loss)

$

(30,368)

(5)

%  

$

166,942

26

%  

$

(197,310)

*


*

Not meaningful

Net Sales

The following is an analysis of sales by marketend-market and by region:

 

 

Year ended December 31,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

253,785

 

52%

 

$

144,675

 

44%

 

$

109,110

 

75%

 

Advanced Packaging, MEMS & RF Filters

 

69,353

 

14%

 

68,304

 

21%

 

1,049

 

2%

 

Scientific & Industrial

 

120,788

 

25%

 

111,198

 

33%

 

9,590

 

9%

 

Front-End Semiconductor

 

40,830

 

9%

 

8,274

 

2%

 

32,556

 

393%

 

Total

 

$

484,756

 

100%

 

$

332,451

 

100%

 

$

152,305

 

46%

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

94,936

 

20%

 

$

85,637

 

26%

 

$

9,299

 

11%

 

China

 

107,844

 

22%

 

85,834

 

26%

 

22,010

 

26%

 

EMEA

 

76,636

 

16%

 

83,410

 

25%

 

(6,774

)

(8)%

 

Rest of World

 

205,340

 

42%

 

77,570

 

23%

 

127,770

 

165%

 

Total

 

$

484,756

 

100%

 

$

332,451

 

100%

 

$

152,305

 

46%

 

Year ended December 31,

Change

 

2023

2022

Period to Period

 

(dollars in thousands)

 

Sales by end-market

    

  

  

    

  

  

    

  

  

Semiconductor

$

412,724

62

%  

$

369,369

57

%  

$

43,355

12

%

Compound Semiconductor

 

87,258

13

%  

 

121,194

19

%  

 

(33,936)

(28)

%

Data Storage

 

88,473

13

%  

 

87,544

13

%  

 

929

1

%

Scientific & Other

 

77,980

12

%  

 

68,030

11

%  

 

9,950

15

%

Total

$

666,435

100

%  

$

646,137

100

%  

$

20,298

3

%

Sales by geographic region

 

  

  

 

  

  

 

  

  

United States

$

162,790

24

%  

$

197,433

31

%  

$

(34,643)

(18)

%

EMEA

 

76,697

12

%  

 

87,837

14

%  

 

(11,140)

(13)

%

China

217,942

33

%  

123,703

19

%  

94,239

76

%

Rest of APAC

 

208,693

31

%  

 

235,735

36

%  

 

(27,042)

(11)

%

Rest of World

 

313

%  

 

1,429

%  

 

(1,116)

(78)

%

Total

$

666,435

100

%  

$

646,137

100

%  

$

20,298

3

%

35

Total sales increased across all market categories for the year ended December 31, 20172023 against the comparable prior year period driven by ongoing improvements in LED industry conditions, as well as additional sales of approximately $65.5 million from the Ultratech business acquired in May 2017, primarily in the Front-End Semiconductor and Advanced Packaging, MEMS, and RF Filters markets. Pricing was notScientific & Other markets, partially offset by a significant driver ofdecline in the change in total sales.Compound Semiconductor market. By geography, sales increased in the China region, partially offset by a decrease in the United States, China,EMEA, and Rest of World regions, offset by a slight decrease in the EMEA region. The most significant increase occurred inAPAC regions. Included within the Rest of WorldAPAC region which was attributable to the increased sales in the LED Lighting, Display & Compound Semiconductor market in Malaysia, as well as additional sales from the Ultratech business acquired. Sales into Malaysia for the year ended December 31, 2017 was approximately $78.22023 were sales in Japan, Taiwan, and Singapore of $74.7 million, compared to $6.6$62.7 million, and $32.2 million, respectively, while sales within Rest of APAC region for the year ended December 31, 2016. Sales in China increased principally due to increased2022 included sales in the LED Lighting, Display,sales in Taiwan, South Korea, Singapore, and Compound Semiconductor market.Japan of $105.0 million, $40.3 million, $38.4 million, and $30.8 million, respectively. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

Orders increased to $570.7 million in 2017, an increase of $196.5 million, or 53% compared with 2016. The LED Lighting, Display, and Compound Semiconductor and Scientific & Industrial markets increased 51% and 56%, respectively, driven by overall improvements in industry conditions. The Advanced Packaging, MEMS, and RF Filters and Front-End Semiconductor markets increased 52% and 49%, respectively, driven by the additional bookings from the Ultratech acquisition.

One In light of the performance measuresglobal nature of our business, we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period dividedare impacted by revenue recognizedconditions in the same period. A ratio greater than one indicatesvarious countries in which we are adding orders faster than we are recognizing revenue. In 2017, the ratio was 1.2, a rise compared to the 2016 ratio of 1.1. Our backlog at December 31, 2017 was $334.3 million, which was higher than the ending backlog at December 31, 2016 of $209.2 million. During the year ended December 31, 2017, we increased backlog by approximately $41.6 million relating to backlog acquired from Ultratech, while adjusting for a decrease in backlog of approximately $2.0 million relating to orders that no longer metand our bookings criteria. For certain sales arrangements, we require a deposit for a portion of the sales price prior to manufacturing a system for a customer. At December 31, 2017 and 2016, we had customer deposits of $41.5 million and $22.2 million, respectively.customers operate.

Gross Profit

In 2017,2023, gross profit increased compared to 20162022 primarily due to an increase in sales volume including the acquisition of Ultratech, partially offset by decreasedand higher gross margins. Gross margins decreased principallyincreased due to an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisition. Our product mix of sales in the LED market is expected to shift, and weperiod, as well as favorable service spending. We expect to see a decline inour gross margins in the first half of 2018. We expect margins in the second half of 2018 to be higher than the first half.fluctuate each period due to product mix and other factors.

Research and developmentDevelopment

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses remained relatively flatincreased in 20172023 compared to 2016,2022 primarily due to personnel-related expenses as the addition of the acquired Ultratech relatedwe invest in new research and development projects was offset byand additional applications for our decisiontechnology in order to reduce investmentsbe well-positioned to capitalize on emerging global megatrends and support longer term growth in certain technology, as well as decreases in other personnel-related expensesSemiconductor and professional fees, as a result of our initiative to streamline operations, enhance efficiency,Compound Semiconductor markets.

Selling, General, and reduce costs.

Selling, general, and administrativeAdministrative

Selling, general, and administrative expenses increased slightly in 2023 compared to 2022. However, expenses as a percentage of revenue have remained flat when compared to the prior period. Given the uncertainty regarding the impacts on our business resulting from the general macroeconomic environment, we are focused on the proactive management of expenses.

Amortization Expense

Amortization expense decreased in 2023 compared to 2022 primarily due to the addition of the acquired Ultratech related selling, general, and administrative costs, as well as increased professional and legal fees.

Amortization expense

The increasechanges in amortization expense is a result of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of the certain technology assets in the prior year

as well as certain other intangible assets becoming fully amortized during 2016.

Restructuring expense

During 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technology development, which together impacted approximately 75 employees. These activities were substantially completed in 2017. In addition, during 2017, we began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Restructuring expense for the year ended December 31, 2017 included non-cash charges of $1.9 million related to accelerated share-based compensation for employee terminations.

Acquisition costs

Acquisition costs are non-recurring charges incurred in connection with the acquisition of the Ultratech business, which included $4.2 million of non-cash charges related to accelerated share-based compensation for employee terminations for the year ended December 31, 2017.

Asset impairment

During 2016, we recorded non-cash impairment charges of $57.6 million relating to our decision to reduce investments in certain technologies, $5.7 million relating to our assessments of the fair market value of assets held for sale, and $6.2 million relating to the disposalreflect expected cash flows of certain lab equipment. Impairment charges for the year ended December 31, 2017, primarily relate to further reductions to the fair market value of assets held for sale upon disposal.

Interest Income (Expense)

For the year ended December 31, 2017, we recorded net interest expense of $17.1 million, including non-cash interest expense of $10.4 million, compared with net interest income of $1.0 million in the prior year period. The change primarily relates to the Convertible Senior Notes issued in January 2017.

Income Taxes

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (“2017 Tax Act’), which makes broad and complex changes to the U.S. tax code. Certain income tax effects of the 2017 Tax Act are reflected in our financial results in accordance with SAB 118. SAB 118 provides SEC staff guidance regarding the application of Accounting Standards Codification Topic 740 (“ASC 740”) Income Taxes, and the required disclosures due to the enactment of the 2017 Tax Act. The income tax effects of the 2017 Tax Act include a provisional $11.3 million income tax benefit related to the re-measurement of our deferred tax assets and liabilities at the reduced rate of 21 percent and a reduction in our U.S. valuation allowance attributable to indefinite lived intangibles becoming a source of future taxable income for certain deferred tax assets that are expected to have an indefinite life due to the 2017 Tax Act. Refer to Note 17, “Income Taxes,” in the Notes to the Consolidated Financial Statements for further information on the financial statement impact of the 2017 Tax Act.

The 2017 income tax benefit of $36.1 million is comprised of: (i) a $24.2 million income tax benefit related to domestic losses incurred during the year ended December 31, 2017, as the deferred tax liability created by the issuance of the Convertible Senior Notes and recorded as a component of APIC is treated as a source of income in fiscal 2017, (ii) a $11.3 million income tax benefit recorded in connection with the 2017 Tax Act, primarily due to the re-measurement of our deferred tax assets and liabilities at the new federal statutory rate of 21 percent, as well as a reduction in our valuation allowance attributable to deferred tax liabilities associated with indefinite-lived intangible assets that became available as a source of income to offset existing deferred tax assets, and (iii) $0.6 million income tax benefit from non-U.S. operations primarily attributable to a reduction in uncertain tax positions and the recognition of a deferred tax asset for certain non-U.S. net operating losses generated in prior years that have become realizable on a more-likely-than-not basis, offset by tax expense attributed to the profitable non-U.S. operations, as well as withholding taxes recorded as we now expect to repatriate certain foreign earnings as a result of changes in tax laws under the 2017 Tax Act.

The 2016 income tax expense of $2.8 million is comprised of three components: (i) a $1.9 million tax expense related primarily to U.S. tax amortization of our indefinite-lived intangible assets that is not available to offset existing deferred tax assets and related valuation allowance, as well as state and local income taxes, (ii) a $0.4 million tax benefit associated with the termination of a pension plan, and (iii) $1.3 million in net tax expense related primarily to our profitable foreign operations. The current period non-U.S. tax expense is attributable to the profitable non-U.S. operations.

Years Ended December 31, 2016 and 2015

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2016 and 2015 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

 

 

For the year ended December 31,

 

Change

 

 

 

2016

 

2015

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

332,451

 

100%

 

$

477,038

 

100%

 

$

(144,587

)

(30)%

 

Cost of sales

 

199,593

 

60%

 

299,797

 

63%

 

(100,204

)

(33)%

 

Gross profit

 

132,858

 

40%

 

177,241

 

37%

 

(44,383

)

(25)%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

81,016

 

24%

 

78,543

 

16%

 

2,473

 

3%

 

Selling, general, and administrative

 

77,642

 

23%

 

90,188

 

19%

 

(12,546

)

(14)%

 

Amortization of intangible assets

 

19,219

 

6%

 

27,634

 

6%

 

(8,415

)

(30)%

 

Restructuring

 

5,640

 

2%

 

4,679

 

1%

 

961

 

21%

 

Asset impairment

 

69,520

 

21%

 

126

 

0%

 

69,394

 

*

 

Other, net

 

223

 

0%

 

(697

)

(0)%

 

920

 

*

 

Total operating expenses, net

 

253,260

 

76%

 

200,473

 

42%

 

52,787

 

26%

 

Operating income (loss)

 

(120,402

)

(36)%

 

(23,232

)

(5)%

 

(97,170

)

*

 

Interest income (expense), net

 

958

 

0%

 

586

 

0%

 

372

 

63%

 

Income (loss) before income taxes

 

(119,444

)

(36)%

 

(22,646

)

(5)%

 

(96,798

)

*

 

Income tax expense (benefit)

 

2,766

 

1%

 

9,332

 

2%

 

(6,566

)

(70)%

 

Net income (loss)

 

$

(122,210

)

(37)%

 

$

(31,978

)

(7)%

 

$

(90,232

)

*

 


* Not Meaningful

Net Sales

The following is an analysis of sales by market and by region:

 

 

Year ended December 31,

 

Change

 

 

 

2016

 

2015

 

Period to Period

 

 

 

(dollars in thousands)

 

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

144,675

 

44%

 

$

291,133

 

61%

 

$

(146,458

)

(50)%

 

Advanced Packaging, MEMS & RF Filters

 

68,304

 

21%

 

61,935

 

13%

 

6,369

 

10%

 

Scientific & Industrial

 

111,198

 

33%

 

118,132

 

25%

 

(6,934

)

(6)%

 

Front-End Semiconductor

 

8,274

 

2%

 

5,838

 

1%

 

2,436

 

42%

 

Total

 

$

332,451

 

100%

 

$

477,038

 

100%

 

$

(144,587

)

(30)%

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

85,637

 

26%

 

$

86,627

 

18%

 

$

(990

)

(1)%

 

China

 

85,834

 

26%

 

242,442

 

51%

 

(156,608

)

(65)%

 

EMEA

 

83,410

 

25%

 

64,019

 

13%

 

19,391

 

30%

 

Rest of World

 

77,570

 

23%

 

83,950

 

18%

 

(6,380

)

(8)%

 

Total

 

$

332,451

 

100%

 

$

477,038

 

100%

 

$

(144,587

)

(30)%

 

Total sales decreased in 2016 from 2015 primarily due to reduced sales in LED Lighting, Display & Compound Semiconductor driven by an oversupply of LED units in the market. Pricing was not a significant driver of the change in total sales. By geography, sales decreased in all regions, except EMEA. The largest sales decline was in China, which was attributable to the decline in LED Lighting, Display & Compound Semiconductor.

Between 2016 and 2015, orders decreased $10.2 million, or 3%, to $374.2 million. The decrease in orders was primarily attributable to a 43% decrease in orders in Advanced Packaging, MEMS & RF Filters as well as a 16% decrease in Scientific & Industrial. These decreases were offset by increases in LED Lighting, Display & Compound Semiconductor and Front-End Semiconductor. In the second half of 2016, we saw some improvements in LED industry conditions.

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. In 2016, the ratio was 1.1, a rise compared to 2015, when it was 0.8. Our backlog at December 31, 2016 was $209.2 million, which was higher than the ending backlog at December 31, 2015 of $186.0 million. During the year ended December 31, 2016, we recorded backlog adjustments of approximately $17.9 million primarily relating to a partial cancellation of a prior period customer order. For certain sales arrangements, we require a deposit for a portion of the sales price prior to manufacturing a system for a customer. At December 31, 2016 and 2015, we had customer deposits of $22.2 million and $28.2 million, respectively.

Gross Profit

Gross profit decreased compared to 2015 due to sharp decline in sales volume, partially offset by improved gross margins. Gross margins increased despite the decline in overall sales volume principally due to favorable product and region mix of sales in the period and from the benefits associated with ongoing cost reduction activities.

Research and development

R&D expenses increased in 2016 compared to 2015 as a result of a reduction in external funding used to offset the cost of R&D activities, as well as the additional use of third party contractors to accelerate the development of products for the LED Lighting, Display & Compound Semiconductor market. We also incurred increased depreciation of research and development-related property, plant, and equipment. These increases were partially offset by decreased personnel-related incentive compensation.

Selling, general, and administrative

Selling, general, and administrative expenses decreased primarily due to reductions in sales commissions and incentive compensation as a result of the decline in our financial performance, as well as a decrease in personnel-related expenses as a result of our initiative to streamline operations, enhance efficiency, and reduce costs in response to market conditions.

Amortization expense

The decrease in amortization expense is a result of the impairment of certain technology assets, as well as certain other intangible assets becoming fully amortized during 2016.in 2022.

Restructuring expenseInterest Income (Expense)

During 2016, additional accruals were recognized and payments madeFor the year ended December 31, 2023, we recorded net interest expense of $1.2 million, compared to $9.3 million for the comparable prior period. The decrease in net interest expense was primarily related to previous years’ restructuring initiatives.an increase of interest income of approximately $8.4 million due to higher interest rates for 2023 compared to 2022.

Other Income (Expense)

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes, we repurchased and retired approximately $106.0 million in aggregate principal amount of our outstanding 2025 Notes, with a carrying amount of $105.4 million, for approximately $106.0 million of cash and 0.7 million shares of our common stock for the 2025 Notes. Also, we repurchased and retired approximately $100.0 million in aggregate principal amount of our outstanding 2027 Notes with a carrying amount of $98.5 million, for approximately $92.8 million of cash and 3.8 million shares of our common stock for the 2027 Notes. We accounted for the partial settlement of the 2025 Notes and 2027 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $16.5 million and $80.6 million, respectively, for the year ended December 31, 2023.

36

Income Taxes

At each reporting date, we consider new evidence, both positive and negative, that could affect our view of the future realization of our deferred tax assets. As of December 31, 2023, we achieved three years of cumulative pretax income for our United States (“domestic”) operations. In addition, during 2016, we undertookevaluated additional restructuring activities as part ofpositive evidence and concluded that it is more likely than not our initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technology development, which together impacted approximately 75 employees.

Asset impairment

During 2016, we recorded non-cash impairment charges of $57.6 million relating to our decision to reduce investments in certain technologies, $5.7 million relating to our assessments ofdeferred tax assets are realizable on a more likely than not basis with the fair market value of assets held for sale, and $6.2 million relating to the disposalexception of certain lab equipment.state tax attributes.

Income Taxes

The 20162023 income tax expense isof $2.0 million was primarily comprised of three components: (i) $1.91) a $16.2 million income tax expense on pre-tax income from operations; and 2) a $2.0 million income tax expense related primarily to U.S.share-based compensation, partially offset by 3) a $7.5 million tax amortization of our indefinite-lived intangible assets that is not availablebenefit related to offset existing deferredForeign-Derived Intangible Income; 4) a $7.7 million tax assetsbenefit associated with research and related valuation allowance as well as statedevelopment tax credits; and local income taxes, (ii)5) a $0.4$1.0 million tax benefit associated with the terminationloss on extinguishment of convertible notes under Section 249 of the pension plan, and (iii) $1.3Internal Revenue Code of 1986, as amended (Section 249).

The 2022 income tax benefit of $116.0 million was primarily comprised of a $117.0 million domestic tax benefit primarily in netconnection with release of $105.5 million valuation allowance, partially offset by a $1.0 million income tax expense related primarily to our profitable foreign operations. The 2015 income tax expense is comprised of two components: (i) $1.8 million related primarily to U.S. tax amortization

Years Ended December 31, 2022 and 2021

See Part II, Item 7 of our indefinite-lived intangible assets that is not available to offset existing deferred tax assetsAnnual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on February 22, 2023, for Management’s Discussions and related valuation allowanceAnalysis of Financial Condition and state and local income taxes and (ii) $7.5 million in tax expense relating to our profitable foreign operations. Our 2016 and 2015 effective tax rate is different thanResults of Operations for the statutory rate primarily due to our inability to recognize our U.S. deferred tax assets on a more-likely-than-not basis with respect to the pre-tax U.S. operating losses in those years.fiscal year ended December 31, 2021.

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments are as follows:

December 31,

December 31,

    

2023

    

2022

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Cash and cash equivalents

 

$

279,736

 

$

277,444

 

$

158,781

$

154,925

Restricted cash

 

847

 

 

 

339

 

547

Short-term investments

 

47,780

 

66,787

 

 

146,664

 

147,488

Total

 

$

328,363

 

$

344,231

 

$

305,784

$

302,960

A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. At December 31, 20172023 and 2016,2022, cash and cash equivalents of $214.3$46.8 million and $149.2$28.4 million, respectively, were held outside the United States. As of December 31, 2017,2023, we had $155.8$22.0 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided. Approximately $7.7 million of which approximately $140.2 million wasundistributed earnings would be subject to the one-time transition tax on foreign earnings required by the 2017 Tax Act. We do not expect to incur a current U.S. tax liability for the one-time transition tax duewithholding taxes if distributed back to the utilization of foreign tax

credits and research and development credits. We expect to repatriate accumulated undistributed earnings from certain non-U.S. subsidiaries and have recognized applicable withholding taxes of $6.2 million.United States. We believe that our projected cash flow from operations, combined with our cash and short termshort-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our Convertible Senior Notes issued in January 2017.convertible senior notes.

37

A summary of the cash flow activity for the year ended December 31, 20172023 and 20162022 is as follows:

Cash Flows from Operating Activities

    

For the year ended December 31,

    

2023

    

2022

 

For the year ended December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(30,368)

$

166,942

Non-cash items:

 

 

 

 

 

Depreciation and amortization

 

50,095

 

32,650

 

 

24,966

 

25,645

Non-cash interest expense

 

10,446

 

 

 

1,118

 

962

Deferred income taxes

 

(33,875

)

940

 

 

(2,211)

 

(118,040)

Share-based compensation expense

 

24,396

 

15,741

 

 

28,558

 

22,994

Asset impairment

 

1,139

 

69,520

 

Other

 

99

 

(259

)

Loss on extinguishment of debt

97,091

Provision for bad debts

316

Change in contingent consideration

 

701

 

Changes in operating assets and liabilities

 

26,639

 

(20,226

)

 

(58,497)

 

9,980

Net cash provided by (used in) operating activities

 

$

34,146

 

$

(23,844

)

$

61,674

$

108,483

Net cash provided by operating activities was $34.1$61.7 million for the year ended December 31, 20172023 and was due to the net loss of $44.8$30.4 million offset byand adjustments for non-cash items of $52.3$150.5 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $58.5 million. The changes in operating assets and liabilities were largely attributable to increases in inventories largely related to evaluation systems at customer facilities, contract assets, prepaid expenses and other current assets, and decreases in accounts payable, and contract liabilities.

Net cash provided by operating activities was $108.5 million for the year ended December 31, 2022 and was due to net income of $166.9 million and an increase in cash flow from operating activities due to changes in operating assets and liabilities of $26.6 million. The changes in operating assets and liabilities were largely attributable to increases in accounts payable and accrued expenses and customer deposits and deferred revenue, decreases in accounts receivable and inventory and deferred cost of sales, partially offset by increases in prepaid expenses and other current and non-current assets, and decreases in income tax payables.

Net cash used in operating activities was $23.8 million in 2016 and was due to the net loss of $122.2 million plus a decline in cash flow from operating activities due to changes in operating assets and liabilities of $20.2$10.0 million, partially offset by adjustments for non-cash items of $118.6$68.5 million. The changes in operating assets and liabilities was largely attributable to a decrease in accounts payable and accrued expenses, an increase in accounts receivable, andcontract liabilities, partially offset by an increase in inventories and deferred cost of sales, partially offset by a decrease in prepaid expenses and other current assets and an increase in customer deposits and deferred revenue.accounts receivables.

Cash Flows from Investing Activities

For the year ended December 31,

    

2023

    

2022

 

For the year ended December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Acquisitions of businesses, net of cash acquired

 

$

(401,828

)

$

 

$

(30,373)

$

Capital expenditures

 

(24,272

)

(11,479

)

(27,930)

(24,604)

Changes in investments, net

 

65,980

 

48,907

 

 

4,973

 

(44,276)

Other

 

2,284

 

9,282

 

Net cash provided by (used in) investing activities

 

$

(357,836

)

$

46,710

 

$

(53,330)

$

(68,880)

The net cash used in investing activities during the year ended December 31, 20172023 was primarily attributable to the net cash used in the acquisition of UltratechEpiluvac, and capital expenditures, partially offset by changes in net investment activity. The cash used in investing activities during the year ended December 31, 2022 was attributable to the net change in investments, as well as capital expenditures, offset by the net changes in investments. In 2017, as partexpenditures.

38

Cash Flows from Financing Activities

 

 

 

 

For the year ended December 31,

 

 

 

 

 

2017

 

2016

 

 

 

 

 

(in thousands)

 

Settlement of equity awards, net of withholding taxes

 

 

 

 

$

(5,749

)

$

(945

)

Purchases of common stock

 

 

 

(2,869

)

(13,349

)

Proceeds from long-term debt borrowings

 

 

 

335,752

 

 

Repayments of long-term debt

 

 

 

(1,194

)

(340

)

Net cash provided by (used in) financing activities

 

 

 

 

$

325,940

 

$

(14,634

)

For the year ended December 31,

    

2023

    

2022

(in thousands)

Proceeds from issuance of 2029 Notes, net of issuance costs

$

223,202

$

Extinguishment of Convertible Notes

(218,991)

Contingent consideration payment

(2,500)

Settlement of equity awards, net of withholding taxes

(6,391)

(4,550)

Net cash provided by (used in) financing activities

$

(4,680)

$

(4,550)

The cash provided byused in financing activities for the year ended December 31, 20172023 was primarily related to the netpartial repurchase of the 2025 Notes and 2027 Notes, repayment of the 2023 Notes, contingent consideration payment related to the Epiluvac acquisition, as well as cash used to settle taxes related to employee equity programs, partially offset by proceeds received from the issuance of the Convertible Senior Notes in January 2017.2029 Notes. The net cash used in financing activities for 2016the year ended December 31, 2022 was primarily related to the share repurchase program, which commenced in November 2015.settlement of equity awards.

Convertible Senior Notes and Revolving Credit Facility

On January 10, 2017, we issued $345.0We have $26.5 million outstanding principal balance of 2.70% Convertible Senior Notes. We received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes3.50% convertible senior notes that bear interest at a rate of 2.70%3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notesand mature on January 15, 2023,2025, unless earlier purchased by the Company, redeemed, or converted. In addition, we have $25.0 million outstanding principal balance of 3.75% convertible senior notes that bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted. The 2027 Notes are currently convertible by shareholders until March 31, 2024. In addition, we have $230.0 million outstanding principal balance of 2.875% convertible senior notes that bear interest at a rate of 2.875% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2029, unless earlier purchased by the Company, redeemed, or converted.

We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.these debts. In addition, we have access to a $150.0 million revolving credit facility (including an ability to request an additional $75.0 million, for a total commitment of no more than $225.0 million) to provide for our working capital needs and reimburse drawings under letters of credit and for other general corporate purposes. The Company has no immediate plans to draw down on the facility, which expires in December of 2026.Interest under the Facility is variable based on the Company’s secured net leverage ratio and is expected to bear interest based on SOFR plus a range of 150 to 225 basis points, if drawn. There is a yearly commitment fee of 25 to 35 basis points, based on the Company’s secured net leverage ratio, charged on the unused portion of the Facility.

Business Combination

As discussed above, on May 26, 2017, the Company acquired 100% of Ultratech, Inc., a leading supplier of lithography, laser-processing, and inspection systems used to manufacture semiconductor devices and LEDs. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.business, as well as existing cash and cash equivalents and short-term investments. In addition, we have bank guarantees and letters of credit issued by a financial institution on our behalf as needed. At December 31, 2023, outstanding bank guarantees and letters of credit totaled $19.6 million and unused bank guarantees and letters of credit of $13.0 million were available to be drawn upon.

39

The following table summarizes our contractual arrangements at December 31, 2017,2023 and the timing and effect that those commitments are expected to have on our liquidity and cash flow in future periods. The effect of unrecognized tax benefits, which total $0.6 million at December 31, 2017, have been excluded from the table since we are unable to reasonably estimate the period of potential cash settlement, if any, with the respective tax authorities.

 

 

Payments due by period

 

 

 

 

 

Less than

 

1 – 3

 

3 – 5

 

More than

 

 

 

Total

 

1 year

 

years

 

years

 

5 years

 

 

 

(in thousands)

 

Principal payments on long-term debt

 

$

345,000

 

$

 

$

 

$

 

$

345,000

 

Cash interest on debt

 

46,963

 

9,315

 

18,630

 

18,630

 

388

 

Operating leases

 

24,251

 

5,655

 

11,061

 

4,616

 

2,919

 

Bank guarantees

 

6,498

 

6,498

 

 

 

 

Purchase commitments(1)

 

181,032

 

181,032

 

 

 

 

Total

 

$

603,744

 

$

202,500

 

$

29,691

 

$

23,246

 

$

348,307

 


(1)              Purchase commitments are primarily for inventory used in manufacturing our products. We generally do not enter  into purchase commitments extending beyond one year. We have $7.6 million of offsetting supplier deposits against these purchase commitments as of December 31, 2017.

Payments due by period

Less than

1 – 3

3 – 5

More than

    

Total

    

1 year

    

years

    

years

    

5 years

  (in thousands)

Principal payments on long-term debt

$

281,500

$

$

26,500

$

25,000

$

230,000

Cash interest on debt

 

41,042

 

8,478

 

15,564

 

13,694

 

3,306

Operating leases

 

49,794

 

3,692

 

8,217

 

7,061

 

30,824

Purchase commitments(1)

 

200,425

 

177,026

 

23,399

 

 

Total

$

572,761

$

189,196

$

73,680

$

45,755

$

264,130

(1)Purchase commitments are generally for inventory used in the manufacturing of our products, as well as equipment and project materials used to support research and development activities. We generally do not enter into purchase commitments extending beyond one year. However, material shortages and supply chain challenges have caused some of these commitments to extend beyond one year. At December 31, 2023, we have $19.4 million of offsetting supplier deposits that will be applied against these purchase commitments.

In December 2017, we entered into a Receivable Purchase Agreement with a financial institution to sell certain of our trade receivables from customers without recourse, up to $23.0 million at any point in time for a term of one year. Under the terms of the agreement, we may offer to sell certain eligible accounts receivable (the “Receivables”) to the financial institution (“the Purchaser”), which may accept such offer, and purchase the offered Receivables. The Purchaser will assume credit risk of the Receivables purchased; provided, however, that we will service the Receivables, and as such servicer, collect and otherwise enforce the Receivables on behalf of the Purchaser. Pursuant to this agreement, we sold $15.0 million of Receivables during the year ended December 31, 2017 and maintained $8.0 million available under the agreement for additional sales of Receivables as of December 31, 2017. The net sale of accounts receivable, under the agreement is reflected as a reduction of accounts receivable in our Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, results of operations, liquidity, capital expenditures, or capital resources other than operating leases, bank guarantees, and purchase commitments disclosed in the preceding “Contractual Obligations and Commitments” table.

Application of Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requirerequires a high degree of judgment, either in the application and interpretation of existing accounting literature or in the development of estimates that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, weWe continuously evaluate our estimates and judgments based on historical experience, as well as other factors that we believe to be reasonable under the circumstances. The results of our evaluation form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. These estimates may change in the future if underlying assumptions or factors change, and actual results may differ from these estimates.

We consider the following significant accounting policies to be critical because of their complexity and the high degree of judgment involved in implementingmaintaining them.

Revenue Recognition

We recognize revenue when persuasive evidenceupon the transfer of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, collectability is reasonably assured, and, for system sales, we have received customer acceptance or we have otherwise objectively demonstrated that the delivered system meets allcontrol of the agreed-topromised product or service to the customer specifications. Each sales arrangement may contain commercial termsin an amount that differ from other arrangements. In addition,reflects the consideration we frequently enter into contracts that contain multiple deliverables. Judgment is requiredexpect to properly identifyreceive in exchange for such product or service. We perform the accounting unitsfollowing five steps to determine when to recognize revenue: (1) identification of the multiple deliverable transactionscontract(s) with customers, (2) identification of the performance obligations in the contract, (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations in the contract, and to determine the manner in which

(5) recognition of revenue should be allocated among the accounting units. Moreover, judgmentwhen, or as, a performance obligation is satisfied. Judgment is used in interpreting the commercial terms and determiningfollowing areas in the determination of when all criteria have been met in order to recognize revenue in the appropriate accounting period. The maximum revenue we recognize on a delivered element is limited to the amount that is not contingent upon the deliveryrevenue:

Identification of performance obligations and allocation of contract price: Our contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. We allocate revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which we separately sell the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, we estimate stand-alone selling prices generally using an expected cost plus margin approach. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations.

40

Combination of contracts: Judgment is required when evaluating whether multiple transactions with the same customer or related parties should be considered part of a single contract. This evaluation includes an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

Variable consideration: Our contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, we estimate the amount of variable consideration and determine what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price.

Transfer of control: Judgment may be required in the determination of when transfer of control occurs. This judgment may include the interpretation of commercial terms and consideration of the customer’s post-delivery acceptance provisions. Our system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. When we objectively demonstrate that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or our historical experience of our tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where we cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. We recognize such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

Any material changes in the identification of performance obligations, determination and allocation of the estimated salestransaction price betweento performance obligations, and determination of when transfer of control occurs to the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocationscustomer, could impact the timing and amount of revenue recognition, which could have a material effect on our financial condition and results of operations. We generally recognize revenue related to sales of components and spare parts upon shipment. We generally recognize revenue related to maintenance and service contracts ratably over the applicable contract term. See Note 1, “Significant Accounting Policies,” in the Notes to the Consolidated Financial Statements for a description of our revenue recognition policy.

Inventory Valuation

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter we assess the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; finished goods; and finished goods.evaluation inventory at customer facilities. Obsolete inventory or inventory in excess of our estimated usage requirements is written down to its estimated net realizable value if less than cost. We evaluate usage requirements by analyzing historical andusage, anticipated demand, and anticipated demand is estimated based upon current economic conditions, utilization requirements related to current backlog, current sales trends,alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for our products may require a write down of inventory that could materially affect our operating results.

Goodwill and Intangible Assets

Goodwill is tested for impairment at least annually in the beginning of the fourth quarter of our fiscal year.year, which may require significant judgment. We may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, we then quantitatively compare the fair value of our reporting unit to its carrying amount. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. If the carrying amount of the reporting unit exceeds its fair value, we then record an impairment loss equal to the difference, up to the carrying value of goodwill.

We determine the fair value of our reporting unit based on a reconciliation of the aggregate fair value of our reporting unit to our adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of our common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The determination of a reasonable control premium may require significant judgment and is estimated using historical transactions in similar industries.

41

The carrying values of long-lived assets, including identifiable intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability on a quarterly basis. The facts and circumstances considered include the recoverability of the cost of other intangible assets from futuretest is performed utilizing undiscounted cash flows expected to be derived from the use of thegenerated by that asset or asset group.group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals. It is not possible for us to predict the likelihood of any possible future impairments or, if such an impairment were to occur, the magnitude of any impairment.

Intangible assets with finite useful lives, including purchased technology, customer-related intangible assets, patents, trademarks, covenants not-to-compete, backlog, and software licenses, are subject to amortization over the expected period of economic benefit to us. We evaluate whether events or circumstances have occurred that warrant a revision to the remaining useful lives of intangible assets. In cases where a revision is deemed appropriate, the remaining carrying amounts of the intangible assets are amortized over the revised remaining useful life.

Intangible assets related to in-process research and development (“IPR&D&D”) projects are considered to be indefinite-lived until the completion or abandonment of the associated R&D efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Indefinite-lived intangible assets are tested for impairment at least annually in the beginning of the fourth quarter of our fiscal year. In testing indefinite-lived intangible assets for impairment, we may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, we then quantitatively compare the fair value of the indefinite-lived intangible asset to its carrying amount. We determine the fair value of our indefinite-lived intangible assets using a discounted cash flow method.

Accounting for Business Combinations

The allocationWe allocate the fair value of the purchase price forof our acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the identifiable tangible assets acquired, liabilities assumed, and intangible assets acquired including in-process research and development and liabilities assumed based on their respective fair values.value at acquisition date. The estimates we make include expected cash flows, expected cost savings, andexcess of the appropriate weighted average cost of capital. We complete these assessments as

soon as practical after the acquisition closing dates. Any excessfair value of the purchase price over the estimated fair valuesvalue of the identifiablethese net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based on assumptions believed to be reasonable, but such estimates and assumptions are inherently uncertain and subject to refinement. We believe assumptions and estimates we have made in the past have been reasonable and appropriate, they are based, in part, on historical experience and information obtained from management of the acquired companies, and inherently uncertain. The Company uses a discounted cash flow model to estimate the fair value of acquired intangible assets. Additionally, the Company estimates the fair value of contingent consideration included as part of the purchase price by assigning probabilities and discount factors to each of the various defined performance milestones, while using a Monte-Carlo simulation model to determine the most likely outcome for payments to be based on value of orders received. These valuation models utilize critical estimates, including, but not limited to, estimates of future revenues, gross margins, operating expenses, and cash flows, as well as discount rates that reflect the risk factors associated with the projected cash flows. Unanticipated events and circumstances may occur that could affect either the accuracy or validity of such assumptions, estimates or actuals results.

Income Taxes

We estimate our income taxes in each of the jurisdictions in which we operate. Deferred income taxes reflect the net tax effect of temporary differences between the asset and liability balances recognized for financial reporting purposes and the balances used for income tax purposes, as well as the tax effect of carry forwards. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income.

42

We recognize the effect of income tax positions for only those positions which are estimated to more likely than not be sustained if challenged. We reflect changes in recognition or measurement in the period in which our change in judgment occurs. We record interest and penalties related to uncertain tax positions in income tax expense.

Because of Income taxes related to the complexity of the new global intangible low-taxed income (“GILTI”) rules we are continuing to evaluate this provision of the 2017 Tax Act and the application of ASC 740. Under U.S. GAAP, we are allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTIexpensed as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into our measurement of our deferred taxes (the “deferred method”). Our selection of an accounting policy with respect to the new GILTI tax rules will depend, in part, on analyzing our global income to determine whether we expect to have future U.S. inclusions in taxable income related to GILTI, and if so, what the impact will be. This assessment depends not only on our current structure and estimated future results of global operations, but also on our intent and ability to modify our structure and/or our business. We are not yet able to reasonably estimate the effect of this provision of the 2017 Tax Act, and therefore we have not made any adjustments related to potential GILTI tax in our consolidated financial statements and have not made a policy decision regarding whether to record deferred taxes on GILTI.incurred.

Recent Accounting Pronouncements

The FASB issued ASU 2014-09, as amended: Revenue from Contracts with Customers, which has been codified as Accounting Standards Codification 606 (“ASC 606”). ASC 606 requires our revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606 for reporting periods beginning after December 15, 2017. The most significant financial statement impacts of adopting ASC 606 will be the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance as well as the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, will generally be recognized at the time we transfer control of the system to the customer, which is earlier than under our current revenue recognition model. The new performance obligation related to installation services under the new standard will generally be recognized as the installation services are performed, which is later than under our current revenue recognition model. Taken together, we do not believe these changes will have a material impact on the consolidated financial statements. We plan to adopt using the full retrospective method.

In January 2016, the FASB issued ASU 2016-01: Financial Instruments — Overall, which requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. For equity investments without readily observable market prices, entities have the option to either measure these investments at fair value every quarter, or measure at cost adjusted for changes in observable prices minus impairment. Changes in measurement under either alternative must be recognized in net income. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017; early adoption is permitted. We do not expect this ASU will have a material impact on the consolidated financial statements upon adoption, and will monitor our cost method investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

In February 2016, the FASB issued ASU 2016-02: Leases, which generally requires our operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. In addition, interest on lease liabilities is to be

recognized separately from the amortization of right-of-use assets in the Statement of Operations. Further, payments of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilities and variable lease payments are to be classified as operating activities in the Statement of Cash Flows. When the standard isWe adopted we will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is2020-06 effective for fiscal years beginning after December 15, 2018, with early application permitted. We are evaluating the anticipated impact of adopting the ASU on the consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments, which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. We do not expect this ASU will have a material impact on the consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory, which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. We do not expect this ASU will have a material impact on the consolidated financial statements.

January 1, 2022. We are also evaluating other pronouncements recently issued but not yet adopted.adopted, including ASU 2023-09. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements. Refer to Note 1, “Significant Accounting Policies,” for additional information.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $47.8$146.7 million at December 31, 2017.2023. These securities are subject to interest rate risk and, based on our investment portfolio at December 31, 2017,2023, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.1$0.8 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

From time to time, we manage our risks and exposures toChanges in currency exchange rates throughcould affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts with the useintent of derivative financial instruments (e.g., forward contracts).mitigating a portion of this risk. We mainlyonly use derivative financial instruments in the context of hedging and generally do not use them for speculative purposes. During fiscal 2017, we had an immaterial amount of foreign exchange derivativespurposes and have not designated as hedges. During fiscal 2016, we did not designateour foreign exchange derivatives as hedges. Accordingly, most foreign exchange derivatives are recorded in our Consolidated Balance Sheets at fair value and changes in fair value from these contracts are recordedincluded in “Other operating expense (income), net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 80%76%, 74%69%, and 82%62% of our total net sales in 2017, 2016,2023, 2022, and 2015,2021, respectively. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our net sales denominated in currencies other than the U.S. dollar represented approximately 1%4%, 4%3%, and 2%3% of total net sales in 2017, 2016,2023, 2022, and 2015,2021, respectively.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 8. Financial Statements and Supplementary Data

Our Consolidated Financial Statements are listed in the Index to Consolidated Financial Statements and Financial Statement Schedule filed as part of this Form 10-K.

43

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Management’s Report on Internal Control over Financial Reporting

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of December 31, 2017.2023. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is

accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Our principal executive and financial officers are responsible for establishing and maintaining adequate internal control over financial reporting, which is a process designed and put into effect to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Using the criteria established in the Internal Control — Integrated Framework (2013) published by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), Management has evaluated, assessed, and concluded that internal control over financial reporting is effective as of December 31, 2017.2023.

We acquired Ultratech, Inc. (“Ultratech”) on May 26, 2017, and the results of Ultratech from the acquisition date through December 31, 2017 are included in our 2017 consolidated financial statements. The results of Ultratech constituted 50 percent of total assets and 14 percent of net sales as of and for the year ended December 31, 2017. We have excluded Ultratech from our annual assessment of the effectiveness of our internal control over financial reporting.

KPMG LLP, an independent registered public accounting firm, has audited the consolidated financial statements included in this Annual Report on Form 10-K and, as part of their audit, has issued their report, included herein, on the effectiveness of our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

During the quarter ended December 31, 2017,2023, there were no changes in internal control that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

44

Report of Independent Registered Public Accounting Firm

TheTo the Stockholders and Board of Directors and Stockholders of

Veeco Instruments Inc.:

Opinion on Internal Control Over Financial Reporting

We have audited Veeco InstrumentInstruments Inc.’s and subsidiaries (the “Company”)subsidiaries' the (Company) internal control over financial reporting as of December 31, 2017,2023, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017,2023, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the consolidated balance sheets of the Company as of December 31, 20172023 and 2016,December 31, 2022, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017,2023, and the related notes and financial statement Scheduleschedule II — Valuation- valuation and Qualifying Accountsqualifying accounts (collectively, the consolidated financial statements), and our report dated February 21, 201816, 2024 expressed an unqualified opinion on those consolidated financial statements.

The Company acquired Ultratech, Inc. (“Ultratech”) on May 26, 2017, and the results of Ultratech from the acquisition date through December 31, 2017 are included in the 2017 consolidated financial statements. The results of Ultratech constituted 50% of total assets and 14% of net sales as of and for the year ended December 31, 2017. Management has excluded Ultratech from its annual assessment of the effectiveness of the Company’s internal control over financial reporting. Our audit of internal control over financial reporting of the Company also excluded an evaluation of the internal control over financial reporting of Ultratech.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Overover Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of

unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Melville, New York
Santa Clara, California
February 21, 201816, 2024

45

Item 9B. Other Information

None.

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information required by this Item that will appear under the headings Governance,“Governance,” “Executive Officers,” and “Section“Delinquent Section 16(a) Beneficial Ownership Reporting Compliance”Reports” in the definitive proxy statement to be filed with the SEC relating to our 20182024 Annual Meeting of Stockholders is incorporated herein by reference.

We have adopted a Code of Ethics for Senior Officers (the “Code”) which applies to our chiefprincipal executive officer, principal financial officer, principal accounting officer andor controller, or persons performing similar functions. A copy of the Code can be found on our website (www.veeco.com). We intend to disclose on our website the nature of any future amendments to and waivers of the Code that apply to the chief executive officer, principal financial officer, principal accounting officer, or persons performing similar functions. We have also adopted a Code of Business Conduct which applies to all of our employees, including those listed above, as well as to our directors. A copy of the Code of Business Conduct can be found on our website (www.veeco.com). The website address above is intended to be an inactive, textual reference only. None of the material on this website is part of this report.

Item 11. Executive Compensation

Information required by this Item that will appear under the heading “Compensation” in the definitive proxy statement to be filed with the SEC relating to our 20182024 Annual Meeting of Stockholders is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information required by this Item that will appear under the headings “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” in the definitive proxy statement to be filed with the SEC relating to our 20182024 Annual Meeting of Stockholders is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information required by this Item that will appear under the headings Certain“Certain Relationships and Related Transactions” and “Independence of Board” in the definitive proxy statement to be filed with the SEC relating to our 20182024 Annual Meeting of Stockholders is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services

Information required by this Item that will appear under the heading “Proposal 4 — Ratification of Appointment of KPMG”“Independent Auditor Fees and Other Matters” in the definitive proxy statement to be filed with the SEC relating to our 20182024 Annual Meeting of Stockholders is incorporated herein by reference.

46

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)   (1)  The Registrant’s financial statements together with a separate table of contents are annexed hereto

(2)  Financial Statement Schedules are listed in the separate table of contents annexed hereto.

(3)  Exhibits

Unless otherwise indicated, each of the following exhibits has been previously filed with the Securities and Exchange Commission by the Company under File No. 0-16244.

Filed or

Exhibit

Incorporated by Reference

Furnished

Number

    

Exhibit Description

    

Form

    

Exhibit

    

Filing Date

    

Herewith

1.1

Conflict Minerals Report of Veeco Instruments Inc.

 

 SD

 

1.01

 

5/30/2023

3.1

Amended and Restated Certificate of Incorporation of Veeco dated December 1, 1994, as amended June 2, 1997 and July 25, 1997.

10-Q

3.1

8/14/1997

3.2

Amendment to Certificate of Incorporation of Veeco dated May 29, 1998.

10-K

3.2

3/14/2001

3.3

Amendment to Certificate of Incorporation of Veeco dated May 5, 2000.

10-Q

3.1

8/14/2000

3.4

Amendment to Certificate of Incorporation of Veeco dated May 16, 2002.

10-Q

3.1

10/26/2009

3.5

Amendment to Certificate of Incorporation of Veeco dated May 18, 2010.

10-K

3.8

2/24/2011

3.6

Seventh Amended and Restated Bylaws of Veeco effective January 9, 2023.

8-K

3.1

1/10/2023

3.7

Certificate of Designation, Preferences, and Rights of Series A Junior Participating Preferred Stock of Veeco dated March 14, 2001.

10-Q

3.1

5/9/2001

4.1

Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

8-K

4.1

1/18/2017

4.2

First Supplemental Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

8-K

4.2

1/18/2017

4.3

Indenture, dated as of May 18, 2020, between Veeco Instruments Inc. and U.S. Bank National Association, as trustee.

8-K

4.1

5/18/2020

4.4

Form of 3.75% Convertible Senior Notes due 2027.

8-K

4.1

5/18/2020

4.5

Indenture, dated as of November 17, 2020, between Veeco Instruments Inc. and U.S. Bank National Association, as trustee.

8-K

4.1

11/17/2020

4.6

Form of 3.50% Convertible Senior Notes due 2025.

8-K

4.1

11/17/2020

4.7

Indenture, dated as of May 19, 2023, between Veeco Instruments Inc. and U.S. Bank Trust Company, National Association, as trustee.

10-Q

4.1

8/7/2023

4.8

Form of 2.875% Convertible Senior Notes due 2029.

10-Q

4.2

8/7/2023

 

 

 

 

 

 

 

 

 

 

Filed or

Exhibit

 

 

 

Incorporated by Reference

 

Furnished

Number

 

Exhibit Description

 

Form

 

Exhibit

 

Filing Date

 

Herewith

2.1

 

Agreement and Plan of Merger dated as of February 2, 2017 among Ultratech, Inc., Veeco Instruments Inc. and Ulysses Acquisition Subsidiary Corp.

 

8-K

 

2.1

 

2/3/2017

 

 

2.2

 

Securities Purchase Agreement, dated December 4, 2014, by and among Solid State Equipment Holdings LLC, certain securityholders thereof, Veeco Instruments Inc. and certain other parties thereto.

 

10-K

 

2.1

 

2/24/2015

 

 

2.3

 

Agreement and Plan of Merger, dated September 18, 2013, by and among Veeco, Veeco Wyoming Inc., Synos Technology, Inc., certain stockholders of Synos Technology, Inc., and Shareholder Representative Services LLC.

 

10-K

 

2.1

 

2/28/2014

 

 

3.1

 

Amended and Restated Certificate of Incorporation of Veeco dated December 1, 1994, as amended June 2, 1997 and July 25, 1997.

 

10-Q

 

3.1

 

8/14/1997

 

 

3.2

 

Amendment to Certificate of Incorporation of Veeco dated May 29, 1998.

 

10-K

 

3.2

 

3/14/2001

 

 

3.3

 

Amendment to Certificate of Incorporation of Veeco dated May 5, 2000.

 

10-Q

 

3.1

 

8/14/2000

 

 

3.4

 

Amendment to Certificate of Incorporation of Veeco dated May 16, 2002.

 

10-Q

 

3.1

 

10/26/2009

 

 

3.5

 

Amendment to Certificate of Incorporation of Veeco dated May 18, 2010.

 

10-K

 

3.8

 

2/24/2011

 

 

3.6

 

Fifth Amended and Restated Bylaws of Veeco effective February 5, 2016.

 

8-K

 

3.1

 

2/10/2016

 

 

3.7

 

Certificate of Designation, Preferences, and Rights of Series A Junior Participating Preferred Stock of Veeco.

 

10-Q

 

3.1

 

5/9/2001

 

 

4.1

 

Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

 

8-K

 

4.1

 

1/18/2017

 

 

4.2

 

First Supplemental Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

 

8-K

 

4.2

 

1/18/2017

 

 

10.1

 

Loan Agreement dated as of December 15, 1999 between Applied Epi, Inc. and Jackson National Life Insurance Company.

 

10-Q

 

10.2

 

11/14/2001

 

 

10.2

 

Promissory Note dated as of December 15, 1999 issued by Applied Epi, Inc. to Jackson National Life Insurance Company.

 

10-Q

 

10.3

 

11/14/2001

 

 

47

Table of Contents

 

 

 

 

 

 

 

 

 

 

Filed or

Exhibit

 

 

 

Incorporated by Reference

 

Furnished

Number

 

Exhibit Description

 

Form

 

Exhibit

 

Filing Date

 

Herewith

10.3

 

Amendment to Loan Documents effective as of September 17, 2001 between Applied Epi, Inc. and Jackson National Life Insurance Company (executed in June 2002).

 

10-Q

 

10.2

 

8/14/2002

 

 

10.4*

 

Veeco Amended and Restated 2000 Stock Incentive Plan, effective July 20, 2006.

 

10-Q

 

10.4

 

8/4/2006

 

 

10.5*

 

Amendment No. 1 effective April 18, 2007 (ratified by the Board August 7, 2007) to Veeco Amended and Restated 2000 Stock Incentive Plan.

 

10-Q

 

10.1

 

8/7/2007

 

 

10.6*

 

Amendment No. 2 dated January 22, 2009 to Veeco Amended and Restated 2000 Stock Incentive Plan.

 

10-K

 

10.41

 

3/2/2009

 

 

10.7*

 

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 14, 2010.

 

Def 14A

 

Appendix A

 

11/4/2013

 

 

10.8*

 

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 5, 2016.

 

S-8

 

10.1

 

6/2/2016

 

 

10.9

 

Veeco Amended and Restated 2010 Stock Incentive Plan, effective March 3, 2017.

 

10-Q

 

10.1

 

11/3/2017

 

 

10.10

 

Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan (as Amended and Restated as of May 31, 2011).

 

S-8

 

10.1

 

5/26/2017

 

 

10.11*

 

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2015.

 

10-Q

 

10.1

 

8/3/2015

 

 

10.12*

 

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.

 

10-Q

 

10.1

 

11/1/2016

 

 

10.13*

 

Form of Notice of Critical Priorities Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.

 

10-Q

 

10.2

 

11/1/2016

 

 

10.14*

 

Veeco 2013 Inducement Stock Incentive Plan, effective September 26, 2013.

 

10-Q

 

10.1

 

11/4/2013

 

 

10.15*

 

Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.

 

S-8

 

10.9

 

6/2/2016

 

 

10.16*

 

Form of Support Agreement (issued in connection with the Agreement and Plan of Merger with Ultratech, Inc. dated February 2, 2017).

 

8-K

 

10.1

 

2/3/2017

 

 

10.17

 

Form of Amended and Restated Indemnification Agreement entered into between Veeco and each of its directors and executive officers (August 2017).

 

10-Q

 

10.2

 

8/3/2017

 

 

10.18*

 

Veeco Amended and Restated Senior Executive Change in Control Policy, effective as of January 1, 2014.

 

10-K

 

10.22

 

2/28/2014

 

 

10.19*

 

Employment Agreement effective as of July 1, 2007 between Veeco and John R. Peeler.

 

10-Q

 

10.3

 

8/7/2007

 

 

10.20*

 

Amendment effective December 31, 2008 to Employment Agreement between Veeco and John R. Peeler.

 

10-K

 

10.38

 

3/2/2009

 

 

10.21*

 

Second Amendment effective June 11, 2010 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.1

 

7/29/2010

 

 

10.22*

 

Third Amendment effective April 25, 2012 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.2

 

5/9/2012

 

 

10.23*

 

Amendment dated June 12, 2014 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.3

 

7/31/2014

 

 

10.24

 

Amendment dated June 12, 2017 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.1

 

8/3/2017

 

 

10.25*

 

Letter Agreement dated April 8, 2014 between Veeco and Shubham Maheshwari.

 

10-Q

 

10.1

 

7/31/2014

 

 

10.26*

 

Letter Agreement dated January 30, 2012 between Veeco and Dr. William J. Miller.

 

10-K

 

10.30

 

2/22/2012

 

 

Filed or

Exhibit

Incorporated by Reference

Furnished

Number

    

Exhibit Description

    

Form

    

Exhibit

    

Filing Date

    

Herewith

4.9

Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.

10-K

4.3

2/21/2020

10.1

Lease dated February 18, 2021 between Veeco Instruments Inc. and Trimble-Junction Ventures LLC.

8-K

10.1

2/24/2021

10.2*

Veeco Severance Benefits Policy, effective May 1, 2009.

10-K

10.1

2/22/2021

10.3*

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 5, 2016.

S-8

10.1

6/2/2016

10.4*

Veeco Amended and Restated 2010 Stock Incentive Plan, effective March 3, 2017.

10-Q

10.1

11/3/2017

10.5*

Veeco Instruments Inc. 2019 Stock Incentive Plan.

S-8

10.1

5/7/2019

10.6*

Amendment No. 1 to the Veeco Instruments Inc.2019 Stock Incentive Plan.

S-8

4.8

5/20/2022

10.7

Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan (as Amended and Restated as of May 31, 2011)

S-8

10.1

5/26/2017

10.8

Form of Capped Call Confirmation.

8-K

10.1

5/18/2020

10.9

Exchange Agreement.

8-K

10.1

11/17/2020

10.10

Note Purchase Agreement, dated as of November 5, 2021, by and between Veeco Instruments Inc. and Lynrock Lake LLP.

8-K

10.1

11/8/2021

10.11

Loan and Security Agreement, dated as of December 16, 2021, by and among Veeco Instruments Inc., as borrower, the guarantors party thereto, the lenders from time to time party thereto, HSBC Bank USA, National Association, as administrative agent, collateral agent, joint lead arranger, and joint bookrunner, Barclays bank PLC, as joint lead arranger and joint bookrunner, and Santander Bank, N.A.

8-K

10.1

12/20/2021

10.12

Guaranty, dated as of December 16, 2021, by the guarantors, identified therin in favor of HSBC Bank USA, National Association, as agent.

8-K

10.2

12/20/2021

10.13

First Amendment to Loan and Security Agreement, dated as of May 19, 2023, by and among Veeco Instruments Inc., as borrower, the guarantors party thereto, the lenders from time to time party thereto and HSBC Bank USA, National Association, as administrative agent, collateral agent, joint lead arranger, and joint bookrunner, Barclays Bank PLC, as joint lead arranger and joint bookrunner, and Santander Bank, N.A.

10-Q

10.1

8/7/2023

10.14*

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019.

10-Q

 

10.1

 

5/7/2019

10.15*

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019 (time-based version A).

10-Q

 

10.2

 

5/7/2019

48

Filed or

Exhibit

Incorporated by Reference

Furnished

Number

    

Exhibit Description

    

Form

    

Exhibit

    

Filing Date

    

Herewith

10.16*

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019 (time-based version B).

10-Q

Filed or

10.3

5/7/2019

Exhibit10.17*

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2020.

Incorporated by Reference10-K

Furnished10.16

2/22/2021

Number10.18*

Exhibit DescriptionForm of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2020.

Form10-K

Exhibit10.17

Filing Date2/22/2021

Herewith

10.19*

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2021.

10-Q

10.1

5/4/2021

10.20*

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2021.

10-Q

10.2

5/4/2021

10.21*

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2022.

10-Q

10.1

5/9/2022

10.22*

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2022.

10-Q

10.2

5/9/2022

10.23*

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2023.

10-Q

10.1

5/8/2023

10.24*

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2023.

10-Q

10.2

5/8/2023

10.25*

Veeco 2013 Inducement Stock Incentive Plan, effective September 26, 2013.

10-Q

10.1

11/4/2013

10.26*

Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.

S-8

10.9

6/2/2016

10.27*

Letter dated December 22, 2015 fromFirst Amendment to Veeco to Dr. William J. Miller.Instruments Inc. 2016 Employee Stock Purchase Plan.

10-KS-8

10.2110.11

2/25/20165/7/2019

10.28*

Second Amendment to Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.

S-8

10.1

5/11/2021

10.29*

Form of Amended and Restated Indemnification Agreement entered into between Veeco and each of its directors and executive officers (August 2017).

10-Q

10.2

8/3/2017

10.30*

Veeco Amended and Restated Senior Executive Change in Control Policy, effective as of January 1, 2014.

10-K

10.22

2/28/2014

10.31*

Letter Agreement dated January 30, 2012 between Veeco and Dr. William J. Miller.

10-K

10.30

2/22/2012

10.32*

Letter Agreement dated August 29, 2018 between Veeco and Dr. William J. Miller.

8-K

10.2

9/4/2018

49

Filed or

Exhibit

Incorporated by Reference

Furnished

Number

Exhibit Description

Form

Exhibit

Filing Date

Herewith

10.33*

Amendment dated March 22, 2019 to the Letter Agreement between Veeco and William J. Miller, Ph.D.

10-Q

10.4

5/7/2019

10.34*

Letter Agreement dated January 21, 2004 between Veeco and John P. Kiernan.

10-K

10.38

3/12/2004

10.29*10.35*

Amendment effective June 9, 2006 to Letter Agreement between Veeco and John P. Kiernan.

10-Q

10.3

8/4/2006

10.30*10.36*

Amendment effective December 31, 2008 to Letter Agreement between Veeco and John P. Kiernan.

10-K

10.40

3/2/2009

10.31*10.37*

Letter dated January 1, 2020 from Veeco to John P. Kiernan.

8-K

99.2

1/2/2020

10.38*

Letter Agreement effective as of June 19, 2009dated March 20, 2019 between Veeco and John P. Kiernan.Adrian Devasahayam.

10-Q10-K

10.210.30

7/30/20092/22/2021

10.39*

Letter Agreement dated August 4, 2017 between Veeco and Peter Porshnev.

10-K

10.31

2/22/2021

10.40*

Letter Agreement dated March 9, 2020 between Veeco and Susan Wilkerson.

10-K

10.32

2/22/2021

21.1

Subsidiaries of the Registrant.

X

23.1

Consent of KPMG LLP.

X

31.1

Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

X

31.2

Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of theSecurities and Exchange Act of 1934.

X

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

X

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

X

97

Compensation Recoupment Policy for Executive Officers

X

101.INS

XBRL Instance.Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline. XBRL document.

**

101.XSD

XBRL Schema.

**

101.PRE

XBRL Presentation.

**

101.CAL

XBRL Calculation.

**

101.DEF

XBRL Definition.

**

101.LAB

XBRL Label.

**

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

**


*    Indicates a management contract or compensatory plan or arrangement, as required by Item 15(a) (3) of Form 10-K.

**  Filed herewith electronically

SIGNATURES

50

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 21, 2018.16, 2024.

Veeco Instruments Inc.

By:

/S/ JOHN R. PEELERs/ WILLIAM J. MILLER, Ph.D.

John R. PeelerWilliam J. Miller, Ph.D.

Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated, on February 21, 2018.16, 2024.

Signature

    

Title

/s/ JOHN R. PEELERWILLIAM J. MILLER, Ph.D.

Chairman and Chief Executive Officer and Director

John R. PeelerWilliam J. Miller, Ph.D.

(principal executive officer)

/s/ SHUBHAM MAHESHWARIJOHN P. KIERNAN

ExecutiveSenior Vice President and Chief Financial Officer

Shubham MaheshwariJohn P. Kiernan

(principal financial & accounting officer)

/s/ JOHN P. KIERNANRICHARD A. D’AMORE

Senior Vice President, Finance, Chief Accounting Officer, and TreasurerChairman

John P. KiernanRichard A. D’Amore

(principal accounting officer)

/s/ KATHLEEN A. BAYLESS

Director

Kathleen A. Bayless

/s/ SUJEET CHAND, Ph.D.

Sujeet Chand, Ph.D.

/s/ RICHARD A. D’AMORE

Director

Richard A. D’Amore

/s/ GORDON HUNTER

Director

Gordon Hunter

/s/ KEITH D. JACKSON

Director

Keith D. Jackson

/s/ PETER J. SIMONELENA NICOLAIDES, Ph.D.

Director

Peter J. SimoneLena Nicolaides, Ph.D.

/s/ MARY JANE RAYMOND

Director

Mary Jane Raymond

/s/ THOMAS ST. DENNIS

Director

Thomas St. Dennis

51


Report of Independent Registered Public Accounting Firm

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

TheTo the Stockholders and Board of Directors and Stockholders of

Veeco Instruments Inc.:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Veeco Instruments Inc. and subsidiaries (the “Company”)Company) as of December 31, 20172023 and 2016,December 31, 2022, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017,2023, and the related notes and financial statement Scheduleschedule II — Valuation- valuation and Qualifying Accountsqualifying accounts (collectively, the “consolidatedconsolidated financial statements”)statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 20172023 and 2016,December 31, 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2017,2023, in conformity with U.S. generally accepted accounting principlesprinciples.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the Company’s internal control over financial reporting as of December 31, 2017,2023, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission”,Commission, and our report dated February 21, 201816, 2024 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Change in Accounting Principle

As discussed in Note 1 to the consolidated financial statements, the Company has changed its method of accounting for the convertible senior notes as of January 1, 2022 due to the adoption of Accounting Standards Update No. 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, using the modified retrospective method.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

F-2

Assessment of the value of excess and obsolete inventory

As discussed in Note 1 of the consolidated financial statements, the Company assesses the valuation of its inventories, including materials, work-in-process, and finished goods, each reporting period. Obsolete inventory or inventory in excess of the Company’s estimated usage requirement is written down to its estimated net realizable value if less than cost. Estimates of usage include the Company’s analysis of anticipated demand, possible alternative uses of its inventory, as well as other qualitative factors. As of December 31, 2023, the Company’s inventories totaled $237.6 million.

We identified the assessment of the value of excess and obsolete inventory as a critical audit matter. Subjective auditor judgement was required to evaluate the Company’s estimates of anticipated demand, which can be affected by market and economic conditions outside the Company’s control.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s inventory valuation process. This included controls related to the development of estimates of anticipated demand of inventory. We evaluated current year estimates of anticipated demand used to assess the value of excess and obsolete inventory when they differed significantly from historical sales volumes. For certain inventory items, we compared the prior year estimate of anticipated demand to actual results to assess the Company’s ability to accurately forecast.

Acquisition-date fair value of a developed technology intangible asset and contingent consideration in the acquisition of Epiluvac AB

As discussed in Note 5 to the consolidated financial statements, on January 31, 2023, the Company acquired Epiluvac AB (Epiluvac) in a business combination for total purchase consideration of $56.4 million, including contingent consideration. In connection with the transaction, the purchase price was allocated to the assets and liabilities assumed by the Company based on their fair values as of the acquisition date, primarily comprised of developed technology with the estimated fair value of $28.0 million. The acquisition date fair value of the contingent consideration was approximately $26.1 million, which includes payments up to $15.0 million based on the timely completion of certain defined milestones tied to strategic targets, and up to $20.0 million based on the percentage of orders received during the defined earn-out period. The Company estimated the fair value of the developed technology based on a discounted cash flow model. The Company estimated the fair value of the contingent consideration by assigning probabilities and discount factors to each of the various defined performance milestones, while using a Monte-Carlo simulation model to determine the most likely outcome for payments to be based on value of orders received.

We identified the evaluation of the acquisition-date fair value of developed technology and the acquisition-date fair value of the contingent consideration related to the orders received during the defined earn-out period as a critical audit matter. A higher degree of auditor judgment was required to evaluate the Company’s determination of certain projected revenues used in the fair value of the developed technology and the fair value of the contingent consideration because there was limited observable market information. Additionally, specialized skills and knowledge were required to evaluate the discount rates used to determine in the fair value of the developed technology and the fair value of the contingent consideration. Changes in certain projected revenues and discount rates could have a significant impact on the fair value of the acquired developed technology and the contingent consideration liability.

The following are the primary procedures we performed to address the critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s acquisition-date valuation process, including controls over the determination of certain projected revenues and discount rates. We evaluated the Company’s determination of certain projected revenues by (1) inquiring of individuals outside of the accounting function about the underlying assumptions used to determine certain projected revenues and the process used to develop them, (2) comparing the underlying assumptions to relevant industry reports, (3) and comparing the underlying assumptions to relevant competitor investor presentation materials. In addition, we involved valuation professionals with specialized skills and knowledge who assisted in:

F-3

evaluating the discount rate applied to the developed technology intangible asset by reconciling it to the weighted average cost of capital that was calculated using publicly available market data

evaluating the discount rate applied to the contingent consideration by comparing it to a discount rate that was independently developed using publicly available market data

developing a fair value estimate of the contingent consideration using a parallel Monte-Carlo simulation and comparing it to the Company’s estimate.

/s/ KPMG LLP

We have served as the Company’s auditor since 2015.

Melville, New York

February 21, 2018

F-2Santa Clara, California

February 16, 2024


F-4


Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

 

 

December 31,

 

December 31,

 

 

 

2017

 

2016

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

279,736

 

$

277,444

 

Restricted cash

 

847

 

 

Short-term investments

 

47,780

 

66,787

 

Accounts receivable, net

 

98,866

 

58,020

 

Inventories

 

120,266

 

77,063

 

Deferred cost of sales

 

16,060

 

6,160

 

Prepaid expenses and other current assets

 

33,437

 

16,034

 

Total current assets

 

596,992

 

501,508

 

Property, plant, and equipment, net

 

85,058

 

60,646

 

Intangible assets, net

 

369,843

 

58,378

 

Goodwill

 

307,131

 

114,908

 

Deferred income taxes

 

2,953

 

2,045

 

Other assets

 

25,310

 

21,047

 

Total assets

 

$

1,387,287

 

$

758,532

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

50,318

 

$

22,607

 

Accrued expenses and other current liabilities

 

60,339

 

33,201

 

Customer deposits and deferred revenue

 

108,953

 

85,022

 

Income taxes payable

 

3,846

 

2,311

 

Current portion of long-term debt

 

 

368

 

Total current liabilities

 

223,456

 

143,509

 

Deferred income taxes

 

36,845

 

13,199

 

Long-term debt

 

275,630

 

826

 

Other liabilities

 

10,643

 

6,403

 

Total liabilities

 

546,574

 

163,937

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.

 

 

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 48,229,251 and 40,714,790 shares issued at December 31, 2017 and December 31, 2016, respectively; 48,144,416 and 40,588,194 shares outstanding at December 31, 2017 and December 31, 2016, respectively.

 

482

 

407

 

Additional paid-in capital

 

1,053,079

 

763,303

 

Accumulated deficit

 

(213,376

)

(168,583

)

Accumulated other comprehensive income

 

1,812

 

1,777

 

Treasury stock, at cost, 84,835 and 126,596 shares at December 31, 2017 and 2016, respectively.

 

(1,284

)

(2,309

)

Total stockholders’ equity

 

840,713

 

594,595

 

Total liabilities and stockholders’ equity

 

$

1,387,287

 

$

758,532

 

December 31,

December 31,

    

2023

    

2022

Assets

Current assets:

Cash and cash equivalents

$

158,781

$

154,925

Restricted cash

339

547

Short-term investments

 

146,664

 

147,488

Accounts receivable, net

 

103,018

 

124,221

Contract assets

24,370

16,507

Inventories

 

237,635

 

206,908

Prepaid expenses and other current assets

35,471

18,305

Total current assets

 

706,278

 

668,901

Property, plant, and equipment, net

 

118,459

 

107,281

Operating lease right-of-use assets

24,377

26,467

Intangible assets, net

43,945

23,887

Goodwill

 

214,964

 

181,943

Deferred income taxes

117,901

116,349

Other assets

 

3,117

 

3,355

Total assets

$

1,229,041

$

1,128,183

Liabilities and stockholders' equity

Current liabilities:

Accounts payable

$

42,383

$

52,049

Accrued expenses and other current liabilities

 

57,624

 

56,031

Contract liabilities

 

118,026

 

127,223

Income taxes payable

 

 

2,432

Current portion of long-term debt

 

 

20,169

Total current liabilities

 

218,033

 

257,904

Deferred income taxes

 

6,552

 

1,285

Long-term debt

 

274,941

 

254,491

Long-term operating lease liabilities

31,529

33,581

Other liabilities

 

25,544

 

3,098

Total liabilities

 

556,599

 

550,359

Stockholders' equity:

Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 56,364,131 shares issued and outstanding at December 31, 2023 and 51,660,409 shares issued and outstanding at December 31, 2022

 

564

 

517

Additional paid-in capital

 

1,202,440

 

1,078,180

Accumulated deficit

 

(532,169)

 

(501,801)

Accumulated other comprehensive income

 

1,607

 

928

Total stockholders' equity

 

672,442

 

577,824

Total liabilities and stockholders' equity

$

1,229,041

$

1,128,183

See accompanying Notes to the Consolidated Financial Statements.

F-3F-5



Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

Net sales

 

$

484,756

 

$

332,451

 

$

477,038

 

Cost of sales

 

300,438

 

199,593

 

299,797

 

Gross profit

 

184,318

 

132,858

 

177,241

 

Operating expenses, net:

 

 

 

 

 

 

 

Research and development

 

81,987

 

81,016

 

78,543

 

Selling, general, and administrative

 

100,250

 

77,642

 

90,188

 

Amortization of intangible assets

 

35,475

 

19,219

 

27,634

 

Restructuring

 

11,851

 

5,640

 

4,679

 

Acquisition costs

 

17,786

 

 

 

Asset impairment

 

1,139

 

69,520

 

126

 

Other, net

 

(392

)

223

 

(697

)

Total operating expenses, net

 

248,096

 

253,260

 

200,473

 

Operating income (loss)

 

(63,778

)

(120,402

)

(23,232

)

Interest income

 

2,335

 

1,180

 

1,050

 

Interest expense

 

(19,457

)

(222

)

(464

)

Income (loss) before income taxes

 

(80,900

)

(119,444

)

(22,646

)

Income tax expense (benefit)

 

(36,107

)

2,766

 

9,332

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

Diluted

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

 

44,174

 

39,340

 

39,742

 

Diluted

 

44,174

 

39,340

 

39,742

 

For the year ended December 31,

    

    

2023

    

2022

    

2021

Net sales

$

666,435

$

646,137

$

583,277

Cost of sales

 

381,376

 

382,989

 

341,003

Gross profit

 

285,059

 

263,148

 

242,274

Operating expenses, net:

Research and development

 

112,853

 

103,565

 

88,680

Selling, general, and administrative

 

92,756

 

88,952

 

84,536

Amortization of intangible assets

 

8,481

 

10,018

 

12,280

Other operating expense (income), net

1,029

317

68

Total operating expenses, net

215,119

202,852

185,564

Operating income

 

69,940

 

60,296

 

56,710

Interest income

 

10,583

 

2,199

 

2,340

Interest expense

 

(11,770)

 

(11,510)

 

(28,360)

Other income (expense), net

(97,091)

(5,010)

Income (loss) before income taxes

 

(28,338)

 

50,985

 

25,680

Income tax expense (benefit)

 

2,030

 

(115,957)

 

(358)

Net income (loss)

$

(30,368)

$

166,942

$

26,038

Income (loss) per common share:

Basic

$

(0.56)

$

3.35

$

0.53

Diluted

$

(0.56)

$

2.71

$

0.49

Weighted average number of shares:

Basic

 

53,769

 

49,906

 

49,073

Diluted

 

53,769

 

65,607

 

53,643

See accompanying Notes to the Consolidated Financial Statements.

F-4


F-6


Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

Change in net unrealized gains or losses

 

(7

)

(6

)

(49

)

Reclassification adjustments for net (gains) losses included in net loss

 

 

18

 

 

Net unrealized gain (loss) on available-for-sale securities

 

(7

)

12

 

(49

)

Minimum pension liability:

 

 

 

 

 

 

 

Change in minimum pension liability

 

 

 

15

 

Reclassification adjustments for net (gains) losses included in net loss

 

 

866

 

 

Net changes related to minimum pension liability

 

 

866

 

15

 

Currency translation adjustments:

 

 

 

 

 

 

 

Change in currency translation adjustments

 

42

 

(19

)

(87

)

Reclassification adjustments for net (gains) losses included in net loss

 

 

(430

)

 

Net changes related to currency translation adjustments

 

42

 

(449

)

(87

)

 

 

 

 

 

 

 

 

Other comprehensive income (loss), net of tax

 

35

 

429

 

(121

)

 

 

 

 

 

 

 

 

Total comprehensive income (loss)

 

$

(44,758

)

$

(121,781

)

$

(32,099

)

For the year ended December 31,

    

    

2023

    

2022

    

2021

Net income (loss)

$

(30,368)

$

166,942

$

26,038

Other comprehensive income (loss), net of tax:

Available-for-sale securities:

Change in net unrealized gains or losses

 

691

 

(514)

 

(311)

Unrealized gain (loss) on available-for-sale securities

 

691

 

(514)

(311)

Currency translation adjustments:

Change in currency translation adjustments

 

(12)

 

(41)

 

(52)

Net changes related to currency translation adjustments

 

(12)

 

(41)

 

(52)

Total other comprehensive income (loss), net of tax

 

679

 

(555)

 

(363)

Total comprehensive income (loss)

$

(29,689)

$

166,387

$

25,675

See accompanying Notes to the Consolidated Financial Statements.

F-5


F-7


Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Stockholders’Stockholders' Equity

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Retained

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

Earnings

 

Other

 

 

 

 

 

Common Stock

 

Treasury Stock

 

Paid-in

 

(Accumulated

 

Comprehensive

 

 

 

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Deficit)

 

Income

 

Total

 

Balance at December 31, 2014

 

40,360

 

$

404

 

 

$

 

$

750,139

 

$

(13,080

)

$

1,469

 

$

738,932

 

Net loss

 

 

 

 

 

 

(31,978

)

 

(31,978

)

Other comprehensive loss, net of tax

 

 

 

 

 

 

 

(121

)

(121

)

Share-based compensation expense

 

 

 

 

 

17,986

 

 

 

17,986

 

Net issuance under employee stock plans

 

636

 

6

 

 

 

(988

)

 

 

(982

)

Purchases of common stock

 

 

 

469

 

(9,222

)

 

 

 

(9,222

)

Balance at December 31, 2015

 

40,996

 

410

 

469

 

(9,222

)

767,137

 

(45,058

)

1,348

 

714,615

 

Cumulative effect of change in accounting principle - adoption of ASU 2016-09

 

 

 

 

 

1,315

 

(1,315

)

 

 

Net loss

 

 

 

 

 

 

(122,210

)

 

(122,210

)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

429

 

429

 

Share-based compensation expense

 

 

 

 

 

15,741

 

 

 

15,741

 

Net issuance under employee stock plans

 

(281

)

(3

)

(1,072

)

19,948

 

(20,890

)

 

 

(945

)

Purchases of common stock

 

 

 

730

 

(13,035

)

 

 

 

(13,035

)

Balance at December 31, 2016

 

40,715

 

407

 

127

 

(2,309

)

763,303

 

(168,583

)

1,777

 

594,595

 

Net loss

 

 

 

 

 

 

(44,793

)

 

(44,793

)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

35

 

35

 

Share-based compensation expense

 

 

 

 

 

24,396

 

 

 

24,396

 

Net issuance under employee stock plans

 

313

 

3

 

(245

)

4,043

 

(9,795

)

 

 

(5,749

)

Stock issuance for business acquisition

 

7,201

 

72

 

 

 

 

 

228,800

 

 

 

 

 

228,872

 

Convertible Senior Notes, equity component

 

 

 

 

 

46,375

 

 

 

46,375

 

Purchases of common stock

 

 

 

203

 

(3,018

)

 

 

 

(3,018

)

Balance at December 31, 2017

 

48,229

 

$

482

 

85

 

$

(1,284

)

$

1,053,079

 

$

(213,376

)

$

1,812

 

$

840,713

 

    

    

    

    

    

Accumulated

    

Additional

Other

Common Stock

Paid-in

Accumulated

Comprehensive

Shares

Amount

Capital

Deficit

Income

Total

Balance at December 31, 2020

 

49,724

$

497

$

1,113,352

$

(707,321)

$

1,846

$

408,374

Net income (loss)

 

 

 

 

26,038

 

 

26,038

Other comprehensive income (loss), net of tax

 

 

 

 

 

(363)

 

(363)

Share-based compensation expense

 

15,249

 

 

 

15,249

Net issuance under employee stock plans

929

10

(5,600)

(5,590)

Extinguishment of equity component of repurchased/exchanged 2023 Notes

(6,080)

(6,080)

Balance at December 31, 2021

 

50,653

507

1,116,921

(681,283)

1,483

437,628

Cumulative effect of change in accounting principle - adoption of ASU 2020-06

(56,800)

12,540

(44,260)

Net income (loss)

 

166,942

 

166,942

Other comprehensive income (loss), net of tax

 

(555)

 

(555)

Share-based compensation expense

 

22,994

 

22,994

Net issuance under employee stock plans

1,007

10

(4,935)

(4,925)

Balance at December 31, 2022

 

51,660

517

1,078,180

(501,801)

928

577,824

Net income (loss)

 

(30,368)

 

(30,368)

Other comprehensive income (loss), net of tax

 

679

 

679

Share-based compensation expense

 

28,558

 

28,558

Net issuance under employee stock plans

244

2

(6,393)

(6,391)

Partial extinguishment of 2025 and 2027 Notes

4,460

45

102,095

102,140

Balance at December 31, 2023

 

56,364

$

564

$

1,202,440

$

(532,169)

$

1,607

$

672,442

See accompanying Notes to the Consolidated Financial Statements.

F-6


F-8


Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

Cash Flows from Operating Activities

 

 

 

 

 

 

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

50,095

 

32,650

 

39,850

 

Non-cash interest expense

 

10,446

 

 

 

Deferred income taxes

 

(33,875

)

940

 

2,648

 

Share-based compensation expense

 

24,396

 

15,741

 

17,986

 

Asset impairment

 

1,139

 

69,520

 

126

 

Provision for bad debts

 

99

 

171

 

43

 

Gain on sale of lab tools

 

 

 

(1,261

)

Gain on cumulative translation adjustment

 

 

(430

)

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

4,520

 

(8,667

)

10,715

 

Inventories and deferred cost of sales

 

6,336

 

(5,389

)

(12,312

)

Prepaid expenses and other current assets

 

(10,204

)

6,726

 

(39

)

Accounts payable and accrued expenses

 

12,197

 

(24,202

)

9,470

 

Customer deposits and deferred revenue

 

19,096

 

8,807

 

(20,738

)

Income taxes receivable and payable, net

 

775

 

547

 

759

 

Long-term income tax liability

 

(4,877

)

 

 

Other, net

 

(1,204

)

1,952

 

520

 

Net cash provided by (used in) operating activities

 

34,146

 

(23,844

)

15,789

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

Acquisitions of businesses, net of cash acquired

 

(401,828

)

 

(68

)

Capital expenditures

 

(24,272

)

(11,479

)

(13,887

)

Proceeds from the sale of investments

 

348,927

 

152,301

 

88,647

 

Payments for purchases of investments

 

(282,947

)

(103,394

)

(85,838

)

Proceeds from held for sale assets

 

2,284

 

9,512

 

3,068

 

Other

 

 

(230

)

1,000

 

Net cash provided by (used in) investing activities

 

(357,836

)

46,710

 

(7,078

)

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan

 

2,992

 

1,656

 

2,233

 

Restricted stock tax withholdings

 

(8,741

)

(2,601

)

(3,215

)

Purchases of common stock

 

(2,869

)

(13,349

)

(8,907

)

Proceeds from long-term debt borrowings

 

335,752

 

 

 

Principal payments on long-term debt

 

(1,194

)

(340

)

(314

)

Net cash provided by (used in) financing activities

 

325,940

 

(14,634

)

(10,203

)

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

42

 

(20

)

(87

)

Net increase (decrease) in cash and cash equivalents

 

2,292

 

8,212

 

(1,579

)

Cash and cash equivalents - beginning of period

 

277,444

 

269,232

 

270,811

 

Cash and cash equivalents - end of period

 

$

279,736

 

$

277,444

 

$

269,232

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

 

Interest paid

 

$

4,675

 

$

225

 

$

485

 

Income taxes paid

 

1,939

 

1,669

 

7,091

 

Non-cash operating and financing activities

 

 

 

 

 

 

 

Net transfer of inventory to property, plant and equipment

 

(97

)

1,827

 

 

For the year ended December 31,

    

2023

    

2022

    

2021

Cash Flows from Operating Activities

Net income (loss)

$

(30,368)

$

166,942

$

26,038

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Depreciation and amortization

 

24,966

 

25,645

 

26,058

Non-cash interest expense

1,118

962

13,819

Deferred income taxes

 

(2,211)

 

(118,040)

 

(651)

Share-based compensation expense

 

28,558

 

22,994

 

15,249

Loss on extinguishment of debt

97,091

4,029

Impairment of equity investments

980

Provision for bad debts

316

Change in contingent consideration

701

Changes in operating assets and liabilities:

Accounts receivable and contract assets

 

13,271

 

(12,826)

 

(26,664)

Inventories

 

(35,158)

 

(37,288)

 

(24,803)

Prepaid expenses and other current assets

 

(16,063)

 

7,668

 

7,621

Accounts payable and accrued expenses

 

(8,810)

 

(13,115)

 

20,225

Contract liabilities

 

(9,626)

 

64,087

 

(4,099)

Income taxes receivable and payable, net

 

(525)

 

557

 

947

Other, net

 

(1,586)

 

897

 

8,993

Net cash provided by (used in) operating activities

 

61,674

 

108,483

 

67,742

Cash Flows from Investing Activities

Capital expenditures

 

(27,930)

 

(24,604)

 

(40,643)

Acquisition of businesses, net of cash acquired

(30,373)

Proceeds from the sale of investments

 

182,853

 

59,738

 

330,702

Payments for purchases of investments

 

(177,880)

 

(104,014)

 

(247,256)

Proceeds from held for sale assets, net of costs to sell

 

 

 

1,725

Net cash provided by (used in) investing activities

(53,330)

(68,880)

44,528

Cash Flows from Financing Activities

Proceeds from issuance of 2029 Notes, net of issuance costs

223,202

Extinguishment of Convertible Notes

(218,991)

(115,604)

Debt issuance costs

(835)

Contingent consideration payment

(2,500)

Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan

 

4,618

 

3,698

 

3,402

Restricted stock tax withholdings

 

(11,009)

 

(8,248)

 

(8,992)

Net cash provided by (used in) financing activities

 

(4,680)

 

(4,550)

 

(122,029)

Effect of exchange rate changes on cash and cash equivalents

 

(16)

 

(53)

 

(52)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

3,648

 

35,000

 

(9,811)

Cash, cash equivalents, and restricted cash - beginning of period

 

155,472

 

120,472

 

130,283

Cash, cash equivalents, and restricted cash - end of period

$

159,120

$

155,472

$

120,472

Supplemental Disclosure of Cash Flow Information

Interest paid

$

11,781

$

10,139

$

12,551

Income taxes paid (refunds received)

5,095

1,434

(139)

Non-cash activities

Capital expenditures included in accounts payable and accrued expenses

4,388

2,285

9,096

Net transfer of inventory to property, plant and equipment

4,296

1,235

(63)

Right-of-use assets obtained in exchange for lease obligations

630

2,938

23,777

See accompanying Notes to the Consolidated Financial Statements.

F-7F-9



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements

Note 1 — Significant Accounting Policies

(a) Description of Business

Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” or the “Company”) operates in a single segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

(b) Basis of Presentation

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 20172023 the interim quarters ended on April 2, July 2, and October 1, and during 20162022 the interim quarters ended on April 3, July 3, and October 2. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements.

(c) Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) the best estimate ofstand-alone selling priceprices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) the fair value, less cost to sell, of assets held for sale; (vii) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (viii)(vii) the recoverability of long-lived assets; (ix)(viii) liabilities for product warranty and legal contingencies; (x)(ix) share-based compensation; (x) lease term and incremental borrowing rates used in determining operating lease assets and liabilities; (xi) income tax uncertainties. Actual results could differ from thoseuncertainties; (xii) purchase accounting estimates; and (xiii) contingent consideration estimates.

(d) Principles of Consolidation

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

(e) Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries that operate using local functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

F-8F-10



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(f) Revenue Recognition

The Company recognizes revenue when allRevenue is recognized upon the transfer of control of the following criteria have been met: persuasive evidencepromised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of an arrangement exists withvariable consideration and determines what portion of that, if any, has a customer; deliveryhigh probability of significant subsequent revenue reversal, and if so, that amount is excluded from the specified products has occurred or services have been rendered; prices are contractually fixed or determinable; and collectability is reasonably assured. Revenue is recorded including shipping and handling costs and excluding applicable taxes related to sales.

Contractstransaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the accounting units of the multiple-element arrangementsperformance obligations within a contract and to determine how the revenue should be allocated among the accounting units.performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single multiple-element arrangementcontract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria have been met in order to recognize revenue in the appropriate accounting period.

 

When there are separate units of accounting, the Company allocates revenue to each elementperformance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the followingprices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; or the best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. The Company uses BESP for the elements in its arrangements. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items.prices generally using an expected cost plus margin approach.

 

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majoritymany of thethese arrangements, a customer source inspection of the system is performed in the Company’s facility, or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery.delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below for certain contracts.date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferreddeferred. The Company recognizes such revenue and fully recognizedcosts upon obtaining objective evidence that the receipt of final customer acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

 

The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for the right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; it does not require significant changes to the features or capabilities of the equipment or involve constructing elaborate interfaces or connections subsequent to factory acceptance. The Company has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage the Company to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, the Company records the cost of the installation at the earlier of the time of revenue recognition for the system or when installation services are performed.

F-9



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

In certain cases, the Company’s products are soldcontracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. The amountRevenue recognized in advance of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount that has been billed that is not contingent upon acceptance provisions or ii)recorded as a contract asset on the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.Consolidated Balance Sheets.

 

The Company recognizes revenue related to maintenance and service contracts ratably over time based upon the applicablerespective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

 

F-11

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company may receive advanced payments on system transactions. The timing of the transfer of goods or services related to the advanced payments is either at the discretion of the customer or expected to be within one year from the advanced receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred even ifsince the related revenueexpected performance period is deferred in accordance with the above policy.one year or less.

 

The Company has elected to treat shipping and handling costs, including those costs incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location, as a fulfillment activity, and the Company includes such costs in “Cost of sales” in the Consolidated Statements of Operations as incurred. These costs are generally comprised of payments to third-party shippers. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

(g) Warranty Costs

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts forrecords the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a semiannualquarterly basis when the actual product performance or field expense differs from original estimates.

(h) Shipping and Handling Costs

Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

(i) Research and Development Costs

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

(j)(i) Advertising Expense

The cost of advertising is expensed as incurred and totaled $0.9$0.4 million, $0.8$0.3 million, and $0.9$0.3 million for the years ended December 31, 2017, 2016,2023, 2022, and 2015,2021, respectively.

(k)(j) Accounting for Share-BasedShare-based Compensation

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards, as well as purchase rights under the Employee Stock Purchase Plan. The Black-Scholes model includes assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information.

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company issuesgrants performance share units and awards (“PSUs” and “PSAs”). that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the probabilityconclusion of athe performance condition being metperiod is recognized in the period of the change in estimate. AtCompensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the performanceservice period the number of shares granted may vary from the original target based onupon the level of achievementattainment of the performance targets.or market conditions.

F-12

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 1(u), “Recently Adopted Accounting Standards,13, “Stock Plans,” for additional information concerning the Company’s early adoption of Accounting Standards Update (“ASU”) 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting.information.

(l)(k) Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date. A valuation allowance is provided for deferred tax assets if it is more likely than not that these items will not be realized, which is dependent upon the generation of future taxable income.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which makes broad and complex changes to the U.S. tax code. Certain income tax effects of the 2017 Tax Act are reflected in the Company’s financial results in accordance with Staff Accounting Bulletin No. 118 (“SAB 118”), which provides SEC staff guidance regarding the application of Accounting Standards Codification Topic 740 Income Taxes (“ASC 740”). See Note 17, “Income Taxes,” for further information on the financial statement impact of the 2017 Tax Act.

Because of the complexity of the new global intangible low-taxed income (“GILTI”) rule, the Company is continuing to evaluate this provision of the 2017 Tax Act and the application of ASC 740. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into the Company’s measurement of its deferred taxes (the “deferred method”). The Company’s selection of an accounting policy with respect to the new GILTI tax rules will depend, in part, on analyzing its global income to determine whether it

F-10



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

expects to have future U.S. inclusions in taxable income related to GILTI, and if so, what the impact will be. This assessment depends not only on the Company’s current structure and estimated future results of global operations, but also on its intent and ability to modify its structure and/or business. The Company is not yet able to reasonably estimate the effect of this provision of the 2017 Tax Act; therefore, the Company has not made any adjustments related to potential GILTI tax in its consolidated financial statements and has not made a policy election decision regarding whether to record deferred taxes on GILTI.

(m)(l) Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. TheHistorically, the Company has not experienced any material credit losses on its investments.

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. Finally, the Company also considers its current expectations of future economic conditions, when estimating its allowance for doubtful accounts. The allowance for doubtful accounts totaled $0.3$1.0 million and $0.7 million at December 31, 20172023 and 2016.2022 respectively.

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were insignificantimmaterial for the years ended December 31, 2017, 2016,2023, 2022, and 2015.2021.

(n)(m) Fair Value of Financial Instruments

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments.

F-13

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(o)(n) Cash, Cash Equivalents, and Short-TermShort-term Investments

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $12.5$97.8 million and $1.5$61.5 million of cash equivalents at December 31, 20172023 and 2016,2022, respectively.

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 77%29% and 54%18% of cash and cash equivalents were maintained outside the United States at December 31, 20172023 and 2016,2022, respectively.

MarketableShort-term investments consist of marketable debt securities, and are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income.”income” on the Consolidated Balance Sheets. These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

F-11



TableNon-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value and impairment charges are included in “Other income (expense), net” in the Consolidated Statements of ContentsOperations.

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(p)(o) Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. TheEach quarter the Company assesses the valuation and recoverability of all inventories, including manufacturing rawinventories: materials work-in-process,(raw materials, spare parts, and service inventory); work-in-process; finished goods, each quarter.goods; and evaluation inventory at customer facilities. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. EstimatesThe Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of net realizable value include, but are not limited to, management’s forecasts related tomaterials, and other qualitative factors. Unanticipated changes in demand for the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general market conditions, possible alternative uses, and ultimate realizationproducts may require a write down of excess inventory. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory, write-downs may be required andwhich would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Business Combinations,” for additional information.

(q)(p) Business Combinations

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Business Combinations,”Additionally, the Company estimates the fair value of contingent consideration included as part of the purchase price by assigning probabilities and discount factors to each of the various defined performance milestones, while using a Monte-Carlo simulation model to determine the most likely outcome for additional information.payments to be based on value of orders received.

F-14

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(r)(q) Goodwill and Indefinite-Lived IntangiblesIntangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise.

TheIn testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill.

The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method.

(s) Long-Lived(r) Long-lived Assets and Cost Method Investment

Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, covenants not-to-compete, and backlog and are initially recorded at fair value. Long-lived intangiblesintangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined.

F-12



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

Long-lived assets and cost method investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

F-15

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(s) Leases

The Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. The Company has options to renew or terminate certain leases. These options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less.

(t) Recently Adopted Accounting Standards

The Company adopted ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity on January 1, 2022, using the modified retrospective method for all financial instruments that were outstanding as of the adoption date. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models reduces non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes.

The adoption of ASU 2020-06 resulted in the following adjustments to the Consolidated Balance Sheets:

December 31, 2021

Adoption of
ASU 2020-06

January 1, 2022

 (in thousands)

Balance Sheet line item:

Long-term debt

$

229,438

$

44,260

$

273,698

Additional paid-in capital

1,116,921

 

(56,800)

 

1,060,121

Accumulated deficit

(681,283)

 

12,540

 

(668,743)

(u) Recent Accounting Pronouncements Not Yet Adopted

TheIn December 2023, the FASB issued ASU 2014-09, as amended: Revenue from Contracts with Customers,2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which has been codified as Accounting Standards Codification 606 (“ASC 606”). ASC 606 requires public entities to disclose consistent categories and greater disaggregation of information in the Company’s revenue recognitionrate reconciliation and for income taxes paid. It also includes certain other amendments to depictimprove the transfereffectiveness of promised goods or services to customers in an amount that reflects the consideration to which it expects to be entitled in exchangeincome tax disclosures. The guidance is effective for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606statements issued for reportingannual periods beginning after December 15, 2017. The most significant financial statement impacts of adopting ASC 606 will be the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance as well as the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, will generally be recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s current revenue recognition model for certain contracts that are subject to the billing retention constraint described above. The new performance obligation related to installation services under the new standard will generally be recognized as the installation services are performed, which is later than under the Company’s current revenue recognition model. Taken together, the Company does not believe these changes will have a material impact on the consolidated financial statements. The Company plans to adopt using the full retrospective method.

In January 2016, the FASB issued ASU 2016-01: Financial Instruments — Overall, which requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. For equity investments without readily observable market prices, entities have the option to either measure these investments at fair value every quarter, or measure at cost adjusted for changes in observable prices minus impairment. Changes in measurement under either alternative must be recognized in net income. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017; early adoption is permitted. The Company does not expect this ASU will have a material impact on the consolidated financial statements upon adoption, and will monitor its cost method investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

In February 2016, the FASB issued ASU 2016-02: Leases, which generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. In addition, interest on lease liabilities is to be recognized separately from the amortization of right-of-use assets in the Statement of Operations. Further, payments of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilities and variable lease payments are to be classified as operating activities in the Statement of Cash Flows. When the standard is adopted, the Company will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018,2024, with early applicationadoption permitted. The Company is currently in the process of evaluating the anticipated impact of adopting the ASUadoption on theits consolidated financial statements.statements.

F-13



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments, which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory, which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

The Company is also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

(u) Recently Adopted Accounting StandardsF-16

In January 2017, the FASB issued ASU 2017-04: Simplifying the Test for Goodwill Impairment, which eliminates the requirement to calculate the implied fair valueTable of goodwill when testing goodwill for impairment. Instead, if the carrying value of an entity’s reporting unit(s) exceeds fair value, then an impairment charge should be recorded equal to the difference. The Company has early adopted the ASU effective January 1, 2017, and it did not have a material impact on the consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accounting for share-based payments. The Company early adopted the ASU effective January 1, 2016. Beginning in 2016, excess tax benefits and deficiencies are recognized as income tax expense or benefit in the income statement in the reporting period incurred. The Company also made an accounting policy election to account for forfeitures when they occur. The ASU transition guidance requires that this election be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period in which the ASU is adopted. Accordingly, the Company recorded a $1.3 million charge to the opening accumulated deficit balance as of January 1, 2016, with a corresponding adjustment to additional paid-in capital, resulting in no impact to the opening balance of total stockholders’ equity. In addition, the Company recorded additional deferred tax assets with an equally offsetting valuation allowance of $2.4 million.

Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 2 — Income (Loss) Per Share

The Company considers unvested share-based awards that have non-forfeitable rights to dividends prior to vesting to be participating shares, which are treated as a separate class of security from the Company’s common shares for calculating per share data. Therefore, the Company applies the two-class method when calculating income (loss) per share. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. However, since the holders of the participating shares are not obligated to fund losses, participating shares are excluded from the calculation of loss per share.

The dilutive effect of the Convertible Senior Notes on income per share is calculated using the treasury stock method since the Company has both the current intent and ability to settle the principal amount of the Convertible Senior Notes in cash. See Note 12, “Debt,” for additional information on the Convertible Senior Notes.

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period under the two-class method.period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury

F-14



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

stock method. The dilutive effect of performance share units is included in diluted income per common share in the periods the performance targets have been achieved. achieved, or would have been achieved if the reporting date was the end of the contingency period. Upon the adoption of ASU 2020-06 on January 1, 2022, the Company includes the dilutive effect of shares issuable upon conversion of its Notes in the calculation of diluted income per share using the if-converted method. The Company has the option for the 2025 and 2027 Notes to settle the conversion value in any combination of cash or shares, and as such, the maximum number of shares issuable are included in the dilutive share count if the effect would be dilutive. The Company must settle the principal amount of the 2029 Notes in cash, and has the option to settle any excess of the conversion value over the principal amount in any combination of cash or shares. As such, the Company only includes the excess shares that may be issuable above the principal amount of the 2029 Notes in the dilutive share count, if the effect would be dilutive. Prior to the adoption of ASU 2020-06, based on the Company’s ability and intent to settle the principal amount of its convertible senior notes in cash, and the excess of the principal portion in shares of its common stock, the Company accounted for the conversion spread using the treasury stock method, and the shares issuable upon conversion of the Notes were not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount and if the effect would be dilutive.

The computations of basic and diluted income (loss) per share for the years ended December 31, 2017, 2016,2023, 2022, and 20152021 are as follows:

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

 

 

(in thousands, except per share amounts)

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

Diluted

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

44,174

 

39,340

 

39,742

 

Effect of potentially dilutive share-based awards

 

 

 

 

Diluted weighted average shares outstanding

 

44,174

 

39,340

 

39,742

 

 

 

 

 

 

 

 

 

Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses

 

72

 

312

 

1,017

 

 

 

 

 

 

 

 

 

Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive

 

239

 

107

 

146

 

 

 

 

 

 

 

 

 

Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive

 

1,744

 

1,896

 

2,111

 

 

 

 

 

 

 

 

 

Maximum potential shares to be issued for settlement of Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive

 

8,618

 

 

 

F-17

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

For the year ended December 31,

    

    

2023

    

2022

    

2021

(in thousands, except per share amounts)

Numerator:

Net income (loss)

$

(30,368)

$

166,942

$

26,038

Interest expense associated with convertible notes

10,832

Net income (loss) available to common shareholders

$

(30,368)

$

177,774

$

26,038

Denominator:

Basic weighted average shares outstanding

 

53,769

 

49,906

 

49,073

Effect of potentially dilutive share-based awards

 

734

1,090

Dilutive effect of convertible notes

 

 

14,967

 

3,480

Diluted weighted average shares outstanding

 

53,769

 

65,607

 

53,643

Net income per common share:

Basic

$

(0.56)

$

3.35

$

0.53

Diluted

$

(0.56)

$

2.71

$

0.49

Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses

6

Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive

850

Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive

212

815

456

Potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive

7,319

8,421

Note 3 — Fair Value Measurements

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

·                  Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

·                  Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

·                  Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or

F-15



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

estimation methodologies could have a significant effect on the estimated fair value amounts.

F-18

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The following table presents the Company’s assets that were measured at fair value on a recurring basis at December 31, 20172023 and 2016:2022:

    

Level 1

    

Level 2

    

Level 3

    

Total

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

(in thousands)

 

December 31, 2017

 

 

 

 

 

 

 

 

 

(in thousands)

December 31, 2023

Cash equivalents

 

 

 

 

 

 

 

 

 

Certificate of deposits and time deposits

$

74,262

$

$

$

74,262

Corporate debt

 

$

12,490

 

$

 

$

 

$

12,490

 

1,988

1,988

Total

 

$

12,490

 

$

 

$

 

$

12,490

 

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

33,895

 

$

 

$

 

$

33,895

 

Corporate debt

 

 

10,886

 

 

10,886

 

Commercial paper

 

 

2,999

 

 

2,999

 

Total

 

$

33,895

 

$

13,885

 

$

 

$

47,780

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

Corporate debt

 

$

 

$

1,501

 

$

 

$

1,501

 

Money market cash

21,587

21,587

Total

 

$

 

$

1,501

 

$

 

$

1,501

 

$

95,849

$

1,988

$

$

97,837

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

40,008

 

$

 

$

 

$

40,008

 

$

59,493

$

$

$

59,493

Government agency securities

 

 

10,012

 

 

10,012

 

41,818

41,818

Corporate debt

 

 

13,773

 

 

13,773

 

35,409

35,409

Commercial paper

 

 

2,994

 

 

2,994

 

9,944

9,944

Total

 

$

40,008

 

$

26,779

 

$

 

$

66,787

 

$

59,493

$

87,171

$

$

146,664

December 31, 2022

Cash equivalents

Certificate of deposits and time deposits

$

61,135

$

$

$

61,135

Money market cash

405

405

Total

$

61,540

$

$

$

61,540

Short-term investments

U.S. treasuries

$

62,849

$

$

$

62,849

Government agency securities

27,366

27,366

Corporate debt

41,591

41,591

Commercial paper

15,682

15,682

Total

$

62,849

$

84,639

$

$

147,488

The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets.markets, as well as certificates of deposits and time deposits that are classified as Level 1 due to their short-term nature. The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency.

F-19

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 4 — Investments

At December 31, 20172023 and 20162022 the amortized cost and fair value of marketable securities, which are included in “Short-term investments” on the Consolidated Balance Sheets, were as follows:

    

    

Gross

    

Gross

    

Amortized

Unrealized

Unrealized

Estimated

Cost

Gains

Losses

Fair Value

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Estimated

 

 

Cost

 

Gains

 

Losses

 

Fair Value

 

 

(in thousands)

 

December 31, 2017

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

33,914

 

$

 

$

(19

)

$

33,895

 

Corporate debt

 

10,894

 

 

(8

)

10,886

 

Commercial paper

 

2,999

 

 

 

2,999

 

Total

 

$

47,807

 

$

 

$

(27

)

$

47,780

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

(in thousands)

December 31, 2023

U.S. treasuries

 

$

40,013

 

$

 

$

(5

)

$

40,008

 

$

59,541

$

3

$

(51)

$

59,493

Government agency securities

 

10,020

 

 

(8

)

10,012

 

41,843

6

(31)

41,818

Corporate debt

 

13,780

 

 

(7

)

13,773

 

35,447

9

(47)

35,409

Commercial paper

 

2,994

 

 

 

2,994

 

9,944

9,944

Total

 

$

66,807

 

$

 

$

(20

)

$

66,787

 

$

146,775

$

18

$

(129)

$

146,664

December 31, 2022

U.S. treasuries

$

63,331

$

$

(482)

$

62,849

Government agency securities

27,464

(98)

27,366

Corporate debt

 

42,006

(415)

 

41,591

Commercial paper

15,682

15,682

Total

$

148,483

$

$

(995)

$

147,488

F-16



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Available-for-sale securities in a loss position at December 31, 20172023 and 20162022 were as follows:

Continuous Loss Position

Continuous Loss Position

for Less than 12 Months

for 12 Months or More

    

    

Gross

    

    

Gross

Estimated

Unrealized

Estimated

Unrealized

Fair Value

Losses

Fair Value

Losses

 

December 31, 2017

 

December 31, 2016

 

 

 

 

Gross

 

 

 

Gross

 

 

Estimated

 

Unrealized

 

Estimated

 

Unrealized

 

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

 

(in thousands)

 

(in thousands)

December 31, 2023

U.S. treasuries

 

$

33,895

 

$

(19

)

$

20,002

 

$

(5

)

$

43,118

$

(50)

$

$

Government agency securities

 

 

 

10,012

 

(8

)

34,885

(31)

Corporate debt

 

10,886

 

(8

)

13,773

 

(7

)

 

23,262

 

(33)

 

2,618

 

(15)

Total

 

$

44,781

 

$

(27

)

$

43,787

 

$

(20

)

$

101,265

$

(114)

$

2,618

$

(15)

December 31, 2022

U.S. treasuries

$

39,791

$

(84)

$

23,057

$

(398)

Government agency securities

22,528

(86)

4,838

(12)

Corporate debt

 

19,693

 

(138)

 

21,898

 

(277)

Total

$

82,012

$

(308)

$

49,793

$

(687)

F-20

Table of Contents

At December 31, 2017Veeco Instruments Inc. and 2016, there were no short-term investments that had been in a continuous loss position for more than 12 months.Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The contractual maturities of securities classified as available-for-sale at December 31, 20172023 were all due in one year or less. as follows:

December 31, 2023

Amortized

Estimated

Cost

Fair Value

(in thousands)

Due in one year or less

$

132,419

$

132,330

Due after one year through two years

14,356

 

14,334

Total

$

146,775

$

146,664

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were minimalThe realized gains or losses for the years ended December 31, 2017, 2016,2023, 2022, and 2015.2021 were immaterial.

Cost Method InvestmentOther Investments

The CompanyVeeco has an ownership interest of less than 20% in a non-marketable investment Kateeva, Inc. (“Kateeva”).in a separate entity, with a carrying value of $2.0 million at December 31, 2023 and 2022. The Company does not exert significant influence over Kateevathis entity. This equity investment does not have a readily observable market price, and therefore the Company has elected to measure this investment is carried at cost. The carrying value of the investment was $21.0 million at December 31, 2017 and 2016.cost, adjusted for changes in observable market prices minus impairment. The investment is included in “Other assets” on the Consolidated Balance Sheets. The investment is subject to a periodic impairment review; as there are no open-market valuations, the impairment analysis requiresreviews which require judgment. The analysis includesanalyses include assessments of Kateeva’sthe companies’ financial condition, the business outlookoutlooks for itstheir products and technology, itstechnologies, their projected results and cash flow,flows, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. Fair value ofDuring the investment is not estimated unless there areyear ended December 31, 2021, the Company identified events or changes in circumstances that could have a significant adverse effectimpairment indicators on the fair valueCompany’s investment, and recorded a non-cash impairment charge of $1.0 million. This impairment charge was included in “Other income (expense), net” in the investment. No such events or circumstances are present.Consolidated Statement of Operations.

Note 5 — Business CombinationsCombination

UltratechEpiluvac

On May 26, 2017,January 31, 2023, the Company completed itsacquired Epiluvac AB, a privately held manufacturer of chemical vapor deposition (CVD) epitaxy systems that enable silicon carbide (SiC) applications in the electric vehicle market. This acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspectionis expected to accelerate penetration into the emerging, high-growth SiC equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea.market. The results of Ultratech’sEpiluvac’s operations have been included in the consolidated financial statements since the date of acquisition.

Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. The acquisition date fair value of the consideration totaled $633.4$56.4 million, net of cash acquired, which consisted of the following:

    

Acquisition Date

(January 31, 2023)

(in thousands)

Cash paid, net of cash acquired

$

30,373

Contingent consideration

26,055

Acquisition date fair value

$

56,428

F-17


F-21


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Cash consideration, net of cash acquired of $229.4 million

 

$

404,489

 

Equity consideration (7.2 million shares issued)

 

228,644

 

Replacement equity awards attributable to pre-acquisition service

 

228

 

Acquisition date fair value

 

$

633,361

 

The purchase agreement included performance milestones that, if achieved, could trigger additional payments to the original selling shareholders. The contingent arrangements include payments up to $15.0 million based on the timely completion of certain defined milestones tied to strategic targets, and up to $20.0 million based on the percentage of orders received during the defined Earn-out period. The Earn-out period is four years after the closing date of the acquisition, or earlier if certain conditions are met.

Approximately $2.7

The Company estimated the fair value of the contingent consideration by assigning probabilities and discount factors to each of the various defined performance milestones, while using a Monte-Carlo simulation model to determine the most likely outcome for payments to be based on value of orders received. These fair value measurements are based on significant inputs not observable in the market and thus represent a Level 3 measurement as defined in ASC 820. The discount rate used was 5.54% for the strategic target and order value related contingent payments. The rate was determined based on the nature of the milestone, the risks and uncertainties involved and the time period until the milestone was measured. The determination of the various probabilities and discount factors is highly subjective, requires significant judgment and is influenced by a number of factors, including the adoption of SiC technology. The aggregate fair value of the contingent consideration arrangement at the acquisition date was $26.1 million. While the use of SiC is expected to grow in the near future, it is difficult to predict the rate at which SiC will be adopted by the market and thus would impact the sales of our equipment.

The Company updates its estimate of fair value of the contingent consideration each reporting period, utilizing the same methodologies described above. During the year ended December 31, 2023, the Company recognized approximately $0.7 million of additional contingent consideration, included within “Other operating expense (income) net” in the cash mergerConsolidated Statement of Operations. Additionally, during the year ended December 31, 2023, the Company paid $2.5 million to the selling shareholders in recognition of a performance milestone having been successfully completed. Total contingent consideration isliability as of December 31, 2023 was $24.2 million, of which $1.8 million was included in “Accrued expenses and other current liabilities” and $22.4 million was included within “Other liabilities” on the Consolidated Balance Sheets as of December 31, 2017 related to shareholder appraisal proceedings.Sheet.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

 

Acquisition Date

 

 

(May 26, 2017)

 

 

(in thousands)

 

Short-term investments

 

$

47,161

 

    

Acquisition Date

(January 31, 2023)

(in thousands)

Accounts receivable

 

45,465

 

$

247

Inventories

 

59,100

 

 

391

Deferred cost of sales

 

242

 

Prepaid expense and other current assets

 

7,217

 

 

381

Property, plant, and equipment

 

18,152

 

 

736

Intangible assets

 

346,940

 

28,540

Other assets

 

6,442

 

Total identifiable assets acquired

 

530,719

 

 

30,295

 

 

 

Accounts payable

 

24,291

 

Accrued expenses and other current liabilities

 

16,356

 

Customer deposits and deferred revenue

 

4,834

 

Accounts payable and accrued expenses

656

Contract liabilities

429

Deferred income taxes

 

32,478

 

5,723

Other liabilities

 

11,622

 

80

Total liabilities assumed

 

89,581

 

 

6,888

 

 

 

Net identifiable assets acquired

 

441,138

 

 

23,407

Goodwill

 

192,223

 

 

33,021

Net assets acquired

 

$

633,361

 

$

56,428

F-22

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company.Company, and therefore is also considered its fair value. Goodwill generated from the acquisition is primarily attributableattributed to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The classes of intangible assets acquired, and the estimated useful life of each class is presented in the table below:

Acquisition Date

(January 31, 2023)

    

Amount

    

Useful life

(in thousands)

Technology

$

28,020

 

15

years

Customer relationships

 

460

 

5

years

Backlog

60

1.5

years

Intangible assets acquired

$

28,540

F-18



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

Amount

 

Useful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

158,390

 

9 years

 

Customer relationships

 

116,710

 

12 years

 

Backlog

 

3,080

 

6 months

 

In-process research and development

 

43,340

 

*

 

Trademark and tradenames

 

25,420

 

7 years

 

Intangible assets acquired

 

$

346,940

 

 

 


*In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including:including cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and meet the criteria for recognition as IPR&D as of the date of the acquisition. In the future, the fair value of each project at the acquisition date will be either amortized or impaired depending on whether the projects are completed or abandoned. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflects the present value of the projected cash flows that are expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which is related to Ultratech’s lithography technologies and one-third of which is related to Ultratech’s laser annealing technologies.

For the year ended December 31, 2017,2023, the Company incurred approximately $1.1 million of acquisition related costs, included within “Selling, general, and administrative” in the Consolidated Statement of Operations. Epiluvac’s results of operations were approximately $17.8 million, including non-cash charges of $4.2 million relatedimmaterial to accelerated share-based compensation for employee terminations.

The amounts of net sales and income (loss) from operations before income taxes of Ultratech included in the Company’s Consolidated Statement of Operations for the year ended December 31, 2017 are2023. Additionally, the pro forma Consolidated Statement of Operations as follows:

 

 

Year ended 
December 31, 2017

 

 

 

(in thousands)

 

Net sales

 

$

65,530

 

Loss before income taxes

 

$

(62,762

)

Loss before income taxesif Epiluvac had been acquired as of UltratechJanuary 1, 2022 would not be materially different from the Company’s actual Consolidated Statement of Operations for the year ended December 31, 20172023 or 2022.

Note 6 — Inventories

Inventories are stated at the lower of $62.8 million includes acquisition costscost or net realizable value, with cost determined on a first-in, first-out basis. Inventories consist of $17.8 million, release of inventory fair value step-up related to purchase accounting of $9.6 million, amortization expense on intangible assets of $23.9 million, and restructuring charges of $3.3 million.the following:

December 31,

December 31,

    

2023

    

2022

(in thousands)

Materials

$

139,884

$

134,940

Work-in-process

 

71,278

 

68,765

Finished goods

 

6,183

 

1,513

Evaluation inventory

20,290

1,690

Total

$

237,635

$

206,908

The following table presents unaudited pro forma financial information as if the acquisition of Ultratech had occurred on January 1, 2016:

F-23

F-19



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands, except per share amounts)

 

Net sales

 

$

555,498

 

$

526,501

 

Loss before income taxes

 

(81,910

)

(218,023

)

Diluted earnings per share

 

$

(1.24

)

$

(4.67

)

Note 7 — Property, Plant, and Equipment

The pro-forma results were calculated by combining the audited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following:

(i)                                     Additional amortization expense related to identified intangible assets valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

(ii)                                  Additional depreciation expense for the property,Property, plant, and equipment, fair value adjustments that would have been incurred starting on January 1, 2016.net, consist of the following:

December 31,

December 31,

    

2023

    

2022

Average Useful Life

(in thousands)

Land

$

5,061

$

5,061

N/A

Building and improvements

 

61,679

 

64,198

10 – 40 years

Machinery and equipment (1)

 

181,180

 

155,533

3 – 10 years

Leasehold improvements

 

52,913

 

54,764

3 – 17 years

Gross property, plant, and equipment

 

300,833

 

279,556

Less: accumulated depreciation and amortization

 

182,374

 

172,275

Net property, plant, and equipment

$

118,459

$

107,281

(1)Machinery and equipment also includes software, furniture, and fixtures

(iii)          All acquisition related costs incurred byDepreciation expense was $16.5 million, $15.6 million, and $13.8 million for the Company as well as by Ultratech pre-acquisition have been removed from the yearyears ended December 31, 20172023, 2022, and included in the year ended December 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition.2021, respectively.

(iv)                              All amortization of inventory step-up has been removed from the year ended December 31, 2017 and recorded in the year ended December 31, 2016, as such costs would have been incurred as the corresponding inventory was sold.

(v)                                 Additional interest expense related to the Convertible Senior Notes (see Note 12, “Debt”) as if they had been issued on January 1, 2016.

(vi)                              Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

(vii)                           All shares issued in connection with the acquisition were considered outstanding as of January 1, 2016 for purposes of calculating diluted earnings per share.

Note 68 — Goodwill and Intangible Assets

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances duringfor the years indicated:year ending December 31, 2023:

 

 

Gross carrying

 

Accumulated

 

 

 

 

 

amount

 

impairment

 

Net amount

 

 

 

(in thousands)

 

Balance at December 31, 2015 and 2016

 

$

238,108

 

$

123,200

 

$

114,908

 

Acquisition

 

192,223

 

 

192,223

 

Balance at December 31, 2017

 

$

430,331

 

$

123,200

 

$

307,131

 

    

Gross carrying

    

Accumulated

    

amount

impairment

Net amount

    

(in thousands)

Balance at December 31, 2022

$

430,331

$

248,388

$

181,943

Acquisition

33,021

33,021

Balance at December 31, 2023

$

463,352

$

248,388

$

214,964

The Company performs its annual goodwill impairment test at the beginning of the fourth quarter each year. As the Company maintains a single goodwill reporting unit, it determines the fair value of its reporting unit based upon the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The annual test performed at the beginning of the fourth quarter of fiscal 20162023, 2022, and 20172021 did not result in any potential impairment as the fair value of the reporting unit was determined to exceed the carrying amount of the reporting unit.

F-20



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

As a result of a significant decline in the Company’s stock price during the fourth quarter, the Company determined it was appropriate to perform an interim goodwill impairment test as of the end of the fourth quarter. The Company determined the fair value of its reporting unit using both the adjusted market capitalization approach noted above, and a market approach, which was based on a review of comparable companies’ market-derived trailing twelve month revenue multiples. Both approaches indicated the fair value exceeded the carrying amount of the reporting unit and no impairment of goodwill existed at December 31, 2017. The valuation of goodwill will continue to be subject to changes in the Company’s market capitalization and observable market control premiums. This analysis is sensitive to changes in the Company’s stock price and absent other qualitative factors, the Company may be required to record goodwill impairment charges in future periods if the stock price declines and remains depressed for an extended period of time. 

F-24

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The components of purchased intangible assets were as follows:

December 31, 2023

December 31, 2022

Average

Accumulated

Accumulated

    

Remaining

    

Gross

    

Amortization

    

    

Gross

    

Amortization

    

Amortization

Carrying

and

Net

Carrying

and

Net

Period

Amount

Impairment

Amount

Amount

Impairment

Amount

 

 

 

December 31, 2017

 

December 31, 2016

 

 

Weighted

 

 

 

Accumulated

 

 

 

 

 

Accumulated

 

 

 

 

Average Remaining

 

Gross

 

Amortization

 

 

 

Gross

 

Amortization

 

 

 

 

Amortization

 

Carrying

 

and

 

Net

 

Carrying

 

and

 

Net

 

 

Period

 

Amount

 

Impairment

 

Amount

 

Amount

 

Impairment

 

Amount

 

 

(in years)

 

(in thousands)

 

(in years)

(in thousands)

Technology

 

8.0

 

$

307,588

 

$

133,121

 

$

174,467

 

$

149,198

 

$

113,904

 

$

35,294

 

11.9

$

355,928

$

321,923

$

34,005

$

327,908

$

316,918

$

10,990

Customer relationships

 

11.4

 

164,595

 

39,336

 

125,259

 

47,885

 

28,659

 

19,226

 

5.3

146,925

137,649

9,276

146,465

135,415

11,050

In-process R&D

 

 

43,340

 

 

43,340

 

 

 

 

Trademarks and tradenames

 

6.4

 

30,910

 

4,321

 

26,589

 

2,590

 

1,948

 

642

 

0.6

30,910

30,269

641

30,910

29,063

1,847

Indefinite-lived trademark

 

 

 

 

 

2,900

 

 

2,900

 

Other

 

2.0

 

3,686

 

3,498

 

188

 

2,026

 

1,710

 

316

 

0.6

 

3,746

 

3,723

 

23

 

3,686

 

3,686

 

Total

 

9.2

 

$

550,119

 

$

180,276

 

$

369,843

 

$

204,599

 

$

146,221

 

$

58,378

 

10.3

$

537,509

$

493,564

$

43,945

$

508,969

$

485,082

$

23,887

Other intangible assets primarily consist of patents, licenses, and backlog.

During 2016, the Company decided to reduce future investments in certain technologies and, as a result, recorded a non-cash impairment charge of $54.3 million for the related intangible purchased technology. The impairment charge was based on projected cash flows that required the use of unobservable inputs, and was recorded in “Asset impairment” in the Consolidated Statements of Operations.

Based on the intangible assets recorded at December 31, 2017,2023, and assuming no subsequent additions to or impairment of the underlying assets, the remaining estimated annual amortization expense, excluding in-process R&D, is expected to be as follows:

 

 

Amortization

 

 

 

(in thousands)

 

2018

 

$

54,128

 

2019

 

57,071

 

2020

 

54,382

 

2021

 

40,959

 

2022

 

26,009

 

Thereafter

 

93,954

 

Total

 

$

326,503

 

Amortization

    

(in thousands)

2024

$

6,983

2025

 

5,394

2026

 

4,517

2027

 

4,010

2028

 

4,050

Thereafter

18,991

Total

$

43,945

Note 7 — Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories consist of the following:

F-21



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Materials

 

$

59,919

 

$

46,457

 

Work-in-process

 

37,222

 

25,250

 

Finished goods

 

23,125

 

5,356

 

Total

 

$

120,266

 

$

77,063

 

Note 8 — Property, Plant, and Equipment and Assets Held for Sale

Property and equipment, net, consist of the following:

 

 

December 31,

 

Average

 

 

 

2017

 

2016

 

Useful Life

 

 

 

(in thousands)

 

 

 

Land

 

$

5,669

 

$

5,669

 

N/A

 

Building and improvements

 

54,449

 

50,814

 

10 – 40 years

 

Machinery and equipment(1)

 

126,829

 

99,370

 

3 – 10 years

 

Leasehold improvements

 

10,073

 

3,652

 

3 – 7 years

 

Gross property, plant, and equipment

 

197,020

 

159,505

 

 

 

Less: accumulated depreciation and amortization

 

111,962

 

98,859

 

 

 

Net property, plant, and equipment

 

$

85,058

 

$

60,646

 

 

 


(1) Machinery and equipment also includes software, furniture and fixtures

Depreciation expense was $14.6 million, $13.4 million, and $12.2 million for the years ended December 31, 2017, 2016, and 2015, respectively. During 2016, the Company decided to reduce future investments in certain technologies and, as a result, recorded an impairment charge of $3.3 million of property, plant, and equipment.

As part of the Company’s efforts to reduce costs, enhance efficiency, and streamline operations, the Company removed certain lab equipment that is no longer required and recorded a non-cash impairment charge of $6.2 million for the year ended December 31, 2016. Additionally, as part of that initiative, the Company listed its two facilities in South Korea for sale. When each facility was reclassified as held for sale, the Company determined that the carrying values of the buildings exceeded their fair market values, less cost to sell, and recorded net impairment charges of $4.5 million for the year ended December 31, 2016. Both facilities were sold before the end of 2016 at prices that approximated the revised carrying values.

Finally, during the year ended December 31, 2016, the Company recorded an impairment charge of approximately $1.2 million related to an owned property in St. Paul, Minnesota. The property was sold during 2017, resulting in an additional impairment charge of $0.7 million for the year ended December 31, 2017. There were no assets held for sale as of December 31, 2017 and 2016. All impairment charges were recorded in “Asset impairment” in the Consolidated Statements of Operations.

Note 9 — Accrued Expenses and Other Liabilities

The components of accrued expenses and other current liabilities were as follows:

December 31,

December 31,

    

2023

    

2022

(in thousands)

Payroll and related benefits

$

28,321

$

30,044

Warranty

8,864

8,601

Operating lease liabilities

4,025

3,333

Interest

1,149

2,853

Professional fees

1,834

2,102

Sales, use, and other taxes

 

1,825

 

2,027

Contingent consideration

1,814

Other

 

9,792

 

7,071

Total

$

57,624

$

56,031

F-22Contract Liabilities and Performance Obligations

Contract liabilities consist of unsatisfied performance obligations related to advanced payments received and billing in excess of revenue recognized. The contract liability balance as of December 31, 2022 was approximately $127.2 million, of which the Company recognized approximately $78.4 million into revenue during the year ended December 31, 2023.


F-25


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Payroll and related benefits

 

$

32,996

 

$

18,780

 

Warranty

 

6,532

 

4,217

 

Interest

 

4,430

 

 

Professional fees

 

3,942

 

1,827

 

Merger consideration payable

 

2,662

 

 

Installation

 

2,271

 

1,382

 

Sales, use, and other taxes

 

2,144

 

1,282

 

Restructuring liability

 

1,520

 

1,796

 

Other

 

3,842

 

3,917

 

Total

 

$

60,339

 

$

33,201

 

This reduction in contract liabilities was offset by new billings for products and services which were unsatisfied performance obligations to customers and revenue had not yet been recognized as of December 31, 2023.

As of December 31, 2023, the Company has approximately $195.1 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 92% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Customer deposits and deferred revenueOther liabilities

Customer deposits totaled $41.5 million and $22.2 millionOther Liabilities at December 31, 2017 and 2016, respectively,2023 was approximately $25.5 million, which are included in “Customer deposits and deferred revenue” in the Consolidated Balance Sheets.

Other liabilities

The Company maintains an executive non-qualified deferred compensation plan that was assumed from Ultratech that allows qualifying executives to defer cash compensation. Atcontingent consideration of $22.4 million. Additionally, at December 31, 2017, plan assets approximated $3.4 million representing the cash surrender value2023 and 2022, other liabilities included medical and dental benefits for former executives of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $4.7$1.9 million and is included within “Other liabilities” in the Consolidated Balance Sheets. Other liabilities also included$2.0 million, respectively; and asset retirement obligations of $3.3 million, medical and dental benefits of $2.2$0.9 million and acquisition related accruals of $0.4$0.7 million, at December 31, 2017. At December 31, 2016, other liabilities primarily consisted of a non-current income tax payable of $4.9 million.respectively.

Note 10 — Restructuring Charges

During 2016, the Company undertook restructuring activities as part of its initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technology development, which together impacted approximately 75 employees. These activities were substantially completed in 2017. In addition, during 2017, the Company began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs.

During 2015, charges of $4.7 million were recognized related to the closing of facilities in Ft. Collins, Colorado, Camarillo, California, and Hyeongok-ri, South Korea, as well as other cost reduction initiatives, which together impacted approximately 50 employees.

The following table shows the amounts incurred and paid for restructuring activities during the years ended December 31, 2017, 2016, and 2015 and the remaining accrued balance of restructuring costs at December 31, 2017, which is included in Accrued expenses and other current liabilities” in the Consolidated Balance Sheets:

F-23



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Personnel

 

 

 

 

 

 

 

Severance and

 

Facility

 

 

 

 

 

Related Costs

 

Closing Costs

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2014

 

$

1,428

 

$

 

$

1,428

 

Provision

 

3,513

 

1,166

 

4,679

 

Payments

 

(4,117

)

(1,166

)

(5,283

)

Balance at December 31, 2015

 

824

 

 

824

 

Provision

 

4,544

 

1,098

 

5,642

 

Changes in estimate

 

(2

)

 

(2

)

Payments

 

(3,570

)

(1,098

)

(4,668

)

Balance at December 31, 2016

 

1,796

 

 

1,796

 

Provision

 

4,714

 

5,257

 

9,971

 

Payments

 

(4,990

)

(5,257

)

(10,247

)

Balance - December 31, 2017

 

$

1,520

 

$

 

$

1,520

 

Included within restructuring expense in the Consolidated Statements of Operations for the year ended December 31, 2017 is approximately $1.9 million of non-cash charges related to accelerated share-based compensation for employee terminations.

Note 11 — Commitments and Contingencies

Warranty

Warranties are typically valid for one year from the date of system final acceptance, and the Company estimates the costs that may be incurred under the warranty. Estimated warranty costs are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and is affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs.

Changes in the Company’s product warranty reserves were as follows:

December 31,

    

2023

    

2022

    

2021

 

December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

Balance, beginning of the year

 

$

4,217

 

$

8,159

 

$

5,411

 

(in thousands)

Balance - beginning of the year

$

8,601

$

7,878

$

5,058

Warranties issued

 

5,817

 

3,916

 

7,873

 

 

6,479

 

8,304

 

7,102

Addition from Ultratech acquisition

 

1,889

 

 

 

Addition from Epiluvac acquisition

49

Consumption of reserves

 

(6,330

)

(6,433

)

(3,551

)

 

(7,029)

 

(7,527)

 

(5,784)

Changes in estimate

 

939

 

(1,425

)

(1,574

)

 

764

 

(54)

 

1,502

Balance, end of the year

 

$

6,532

 

$

4,217

 

$

8,159

 

Balance - end of the year

$

8,864

$

8,601

$

7,878

Minimum Lease Commitments

MinimumThe Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease commitments atterm of the Company’s operating leases as of December 31, 2017 for property2023 was 11 years, and equipment under operatingthe weighted average discount rate used in determining the present value of future lease agreements (exclusive of renewal options) are payable as follows:payments was 5.6%.

F-24F-26



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Operating

 

 

 

Leases

 

 

 

(in thousands)

 

Payments due by period:

 

 

 

2018

 

$

5,655

 

2019

 

5,533

 

2020

 

5,529

 

2021

 

2,307

 

2022

 

2,308

 

Thereafter

 

2,919

 

Total

 

$

24,251

 

The following table provides the maturities of lease liabilities at December 31, 2023:

Operating

    

Leases

(in thousands)

Payments due by period:

2024

$

3,692

2025

4,130

2026

4,087

2027

3,639

2028

3,422

Thereafter

30,824

Total future minimum lease payments

49,794

Less: Imputed interest

(14,240)

Total

$

35,554

Reported as of December 31, 2023

Accrued expenses and other current liabilities

$

4,025

Long-term operating lease liabilities

31,529

Total

$

35,554

Operating lease cost for the years ended December 31, 2023, 2022, and 2021 was $5.0 million, $7.4 million, and $6.6 million, respectively. Variable lease expense, which includes costs not included in the operating lease costs, for the years ended December 31, 2023, 2022, and 2021 was $1.1 million, $2.0 million, and $1.7 million, respectively. Additionally, the Company has an immaterial amount of short-term leases. Lease expense, which includes operating lease costs and variable lease costs, was $5.3$6.1 million, $2.5$9.4 million, and $2.3$8.4 million for the years ended December 31, 2017, 2016,2023, 2022, and 2015,2021, respectively. In addition, the Company is obligated under such leases for certain other expenses, including real estate taxes and insurance.

Legal Proceedings

On September 21, 2017, Blueblade Capital Opportunities LLC et al., on behalf Operating cash outflows from operating leases for the year ended December 31, 2023, 2022, and 2021 were $5.8 million, $7.5 million, and $6.6 million (excluding landlord reimbursements for leasehold improvements of purported beneficial owners of 440,100 shares of Ultratech common stock, filed an action against Ultratech$6.1 million in Delaware Court of Chancery requesting an appraisal of the value of their Ultratech stock pursuant to 8 Del. C. §262. The Company believes that the merger price, which was the product of arms-length negotiations, was fair and reasonable, and intends to contest the appraisal claim. Discovery2021 included within “Other, net” in the matter has commenced and a trial on the action is scheduled to begin in December 2018.Consolidated Statements of Cash Flows), respectively.

On April 12, 2017, the Company filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLC and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment. The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted the Company’s motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using the Company’s patented technology without the Company’s express authorization.Legal Proceedings

On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that the Company’s MOCVD products infringed a Chinese utility model patent relating to the synchronous movement engagement mechanism in a chemical vapor deposition reactor and seeking injunctive relief and monetary damages against Veeco Shanghai. On December 7, 2017, without providing notice to Veeco and without hearing Veeco’s position on alleged infringement, the Fujian High Court issued a preliminary injunction, applicable in China, that requires Veeco Shanghai to stop importing, making, selling, and offering to sell Veeco EPIK 700 model MOCVD systems and to stop importing, selling, and offering to sell wafer carriers used as supplies for the EPIK 700 MOCVD system.

On February 8, 2018, Veeco, AMEC, and SGL announced that they had mutually agreed to settle the pending litigation among the parties and to amicably resolve all pending disputes, including AMEC’s lawsuit against Veeco before the Fujian High Court in China and Veeco’s lawsuit against SGL before the U.S. District Court for the Eastern District of New York. As part of the settlement, all legal actions worldwide (in court, patent offices, and otherwise), between Veeco, AMEC, and SGL, and their affiliates, will be dismissed and/or otherwise withdrawn. As a result, all business processes, including sales, service, and importation, will be continued.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

F-25



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Concentrations of Credit Risk

The Company depends on purchases from its ten largest customers, which accounted for 67%65% and 73%63% of net accounts receivable at December 31, 20172023 and 2016,2022, respectively.

F-27

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Customers who accounted for more than 10% of net accounts receivable or net sales are as follows:

 

 

Accounts Receivable

 

Net Sales

 

 

 

Year ended December 31,

 

For the Year Ended December 31,

 

Customer

 

2017

 

2016

 

2017

 

2016

 

2015

 

Customer A

 

24

%

23

%

21

%

13

%

*

 

Customer B

 

*

 

17

%

*

 

*

 

*

 

Customer C

 

*

 

*

 

*

 

*

 

20

%

Customer D

 

*

 

*

 

*

 

*

 

12

%

Accounts Receivable

Net Sales 

 

December 31,

For the Year Ended December 31,

 

Customer

    

2023

    

2022

    

2023

    

2022

    

2021

 

Customer A

*

*

10

%

*

*

Customer B

10

%

*

*

*

10

%  

Customer C

11

%

*

*

*

*

Customer D

*

10

%

*

*

*

Customer E

 

*

*

*

*

15

%


*

*

Less than 10% of aggregate accounts receivable or net sales

The Company manufactures and sells its products to companies in different geographic locations. Refer to Note 18,16, “Segment Reporting and Geographic Information,” for additional information. In certain instances, the Company requires deposits from its customers for a portion of the sales price in advance of shipment and performs periodic credit evaluations on its customers. Where appropriate, the Company requires letters of credit on certain non-U.S. sales arrangements. Receivables generally are due within 30 to 90 days from the date of invoice. In some geographies, receivables may be payable up to 150 days from the date of the invoice.

Receivable Purchase Agreement

In December 2017, theThe Company entered into a Receivable Purchase Agreementreceivable purchase agreement with a financial institution to sell certain of its trade receivables from customers without recourse, up to $23.0$30.0 million at any point in time for a term of one year. Under the terms of the agreement, the Company may offer to sell certain eligible accounts receivable (the “Receivables”) to the financial institution (the “Purchaser”), which may accept such offer, and purchase the offered Receivables. The Purchaser will assume credit risk of the Receivables purchased; provided, however, the Company will service the Receivables, and as such servicer, collect and otherwise enforce the Receivables on behalf of the Purchaser.time. Pursuant to this agreement, the Company sold $15.0$32.7 million of Receivablesreceivables during the year ended December 31, 20172023, of which $19.9 million remained outstanding as of December 31, 2023 as defined in the receivable purchase agreement, and maintained $8.0$10.1 million was available under the agreement for additional sales of Receivables asreceivables. The Company sold $13.2 million of receivables during the year ended December 31, 2017.2022. The net sale of accounts receivable under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

Suppliers

The Company outsources certain functions to third parties, including the manufacture of someseveral of its MOCVD and Ultratech systems. While the Company primarily relies on one supplier for the manufacturing of these systems,its outsourcing partners to perform their contracted functions, the Company maintains a minimumsome level of internal manufacturing capability for these systems. In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The failure of the Company’s present outsourcing partners and suppliers to meet their contractual obligations under their supply arrangements and the Company’s inability to make alternative arrangements or resume the manufacture of these systems could have a material adverse effect on the Company’s revenues, profitability, cash flows, and relationships with its customers.

In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The Company’s inability to develop alternative sources, if necessary, could result in a prolonged interruption in supply or a significant increase in the price of one or more components, which could adversely affect the Company’s operating results.

F-26



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company had deposits with its suppliers of $7.6$19.4 million and $7.8$9.4 million at December 31, 20172023 and 2016,2022, respectively, that were included in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets.

Purchase Commitments

The Company had purchase commitments of $181.0$200.4 million at December 31, 2017, substantially all2023, the majority of which will come due within one year. Purchase commitments are primarily for inventory used in manufacturing products, as well as equipment and project materials used to support research and development activities, and are partially offset by existing deposits with suppliers.

F-28

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Bank Guarantees

The Company has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At December 31, 2017,2023, outstanding bank guarantees and letters of credit totaled $6.5$19.6 million and unused bank guarantees and letters of credit of $66.5 $13.0million were available to be drawn upon.

Note 1211 — Debt

Mortgage Payable

At December 31, 2016, the Company had a mortgage note payable associated with its property in St. Paul, Minnesota, which, during the third quarter of 2017 was fully extinguished in connection with the sale of the building. The carrying value of the property exceeded the carrying value of the mortgage note of $1.2 million at December 31, 2016. The annual interest rate on the note was 7.91%.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “Convertible Senior“2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior2023 Notes mature onhad a maturity date of January 15, 2023, (the “Maturity Date”), unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of notes issued.

Finally, on November 5, 2021, the Company entered into a privately negotiated note purchase agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to repurchase and retire approximately $111.5 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $105.5 million, for cash consideration of approximately $115.6 million, and approximately $1.0 million of accrued and unpaid interest. The Company accounted for the partial settlement of the 2023 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $4.0 million for the year ended December 31, 2021, which is included in “Other income (expense), net” in the Consolidated Statements of Operations, as well as a reduction of additional paid-in capital of $6.1 million for the repurchase of the conversion feature.

The Convertible Senior2023 notes that remained outstanding matured on January 15, 2023 and were paid in cash and settled by the Company at that time.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

F-29

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes due 2029 described below, the Company repurchased and retired approximately $106.0 million in aggregate principal amount of its outstanding 2025 Notes, with a carrying amount of $105.4 million, for approximately $106.0 million of cash and 0.7 million shares of the Company’s common stock. The Company accounted for the partial settlement of the 2025 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $16.5 million for the year ended December 31, 2023, which is included in “Other income (expense), net” in the Consolidated Statements of Operations.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes due 2029 described below, the Company repurchased and retired approximately $100.0 million in aggregate principal amount of its outstanding 2027 Notes, with a carrying amount of $98.5 million, for approximately $92.8 million of cash and 3.8 million shares of the Company’s common stock. The Company accounted for the partial settlement of the 2027 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $80.6 million for the year ended December 31, 2023, which is included in “Other income (expense), net” in the Consolidated Statements of Operations.

2029 Notes

On May 19, 2023, the Company completed a private offering of $230.0 million of 2.875% convertible senior notes due 2029 (the “2029 Notes”). The Company received net proceeds of approximately $223.2 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $198.8 million of net proceeds from the offering to fund the cash portion of the 2025 Notes and 2027 Notes extinguishments described above and retained the remainder for general corporate purposes. The 2029 Notes bear interest at a rate of 2.875% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2023. The 2029 Notes mature on June 1, 2029, unless earlier purchased by the Company, redeemed, or converted. The Company will settle any conversions of the 2029 Notes by paying cash up to the aggregate principal amount of the 2029 Notes to be converted, and paying or delivering either cash, shares of the Company’s stock, or a combination of cash and shares of common stock at the Company’s election, in respect of the remainder, if any, of the conversion obligation in excess of the aggregate principal amount of the 2029 Notes being converted.

The 2025 Notes, 2027 Notes, and 2029 Notes (collectively, the “Notes”) are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Convertible Senior Notes are convertible into cash, sharesat the option of the Company’s common stock, or a combination thereof, at the Company’s election,holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.9800rates are 41.6667, 71.5372, and 34.21852 shares of the Company’s common stock per $1,000 principal amount of Convertible Seniorthe 2025 Notes, 2027 Notes, and 2029 Notes, respectively, representing an initial effective conversion priceprices of $40.03$24.00, $13.98, and $29.22 per share of common stock.stock, respectively. The conversion raterates may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior events.

F-30

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee, but will not be adjusted for accrued but unpaid interest.to Consolidated Financial Statements (Continued)

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 20222024 with respect to the 2025 Notes, October 1, 2026 with respect to the 2027 Notes, and February 1, 2029, with respect to the 2029 Notes, only under the following circumstances:

F-27



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(i)                ��       
(i)During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii)During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii)If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv)Upon the occurrence of specified corporate events.

For the calendar quarter ended December 31, 2023, the last reported sales price of common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price on each applicable trading day;

(ii)                      During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of2027 Notes, and as such the product of2027 Notes are convertible by the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;holders until March 31, 2024.

(iii)                   If the Company calls any or all of the Convertible Senior Notes for redemptionHolders may convert their notes at any time, prior toregardless of the close of businessforegoing circumstances, on the scheduled trading day immediately preceding the redemption date; or

(iv)                  Upon the occurrence of specified corporate events.

On or after October 15, 2022,2024 with respect to the 2025 Notes, October 1, 2026 with respect to the 2027 Notes, and February 1, 2029 with respect to the 2029 Notes, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardlessrespective maturity date.

Accounting for the Notes after the adoption of ASU 2020-06

The Company adopted ASU 2020-06 on January 1, 2022 as further described in Note 1, “Basis of Presentation”. Following the adoption of ASU 2020-06, the Notes are recorded as a single unit within liabilities in the consolidated balance sheets as the conversion features within the Notes are not derivatives that require bifurcation and the Notes do not involve a substantial premium. Transaction costs of $9.2 million, $1.9 million, $3.1 million, and $6.8 million incurred in connection with the issuance of the foregoing circumstances.2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes, respectively, were recorded as direct deductions from the related debt liabilities and recognized as non-cash interest expense using the effective interest method over the expected terms of the Notes.

UponAccounting for the Notes prior to the adoption of ASU 2020-06

With respect to the 2023 Notes, 2025 Notes, and 2027 Notes, upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option,options, prior to the adoption of ASU 2020-06, the Company segregated the liability component of the instrumentinstruments from the equity component.components. The liability component wascomponents were measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt componentcomponents required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt.debt, or 7.0%, 8.0%, and 9.1% with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively. The excess of the aggregate face valuevalues of the Convertible Senior Notes over the estimated fair valuevalues of the liability componentcomponents of $72.5 million, was$21.0 million, and $34.2 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recognized as a debt discountdiscounts and recorded as

F-31

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

an increase to additional paid-in capital and willwere to be amortized over the expected lifelives of the Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount isdiscounts were recognized as non-cash interest expense.

The transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the Convertible Senior2023 Notes, 2025 Notes, and 2027 Notes, respectively, were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component arewere being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected termterms of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million, $0.3 million, and $0.8 million, for the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, reduced the value of the equity componentcomponents recognized in stockholders’stockholders' equity.

The carrying valuevalues of the Convertible Senior Notes isare as follows:

 

 

December 31,

 

 

 

2017

 

 

 

(in thousands)

 

Principal amount

 

$

345,000

 

Unamortized debt discount

 

(63,022

)

Unamortized transaction costs

 

(6,348

)

Net carrying value

 

$

275,630

 

December 31, 2023

December 31, 2022

  

Principal Amount

  

Unamortized
transaction costs

  

Net carrying value

  

Principal Amount

  

Unamortized
debt discount/
transaction costs

  

Net carrying value

(in thousands)

2023 Notes

$

$

$

$

20,173

$

(4)

$

20,169

2025 Notes

 

26,500

 

(102)

 

26,398

 

132,500

 

(990)

 

131,510

2027 Notes

25,000

(313)

24,687

125,000

(2,019)

122,981

2029 Notes

230,000

(6,144)

223,856

Net carrying value

$

281,500

$

(6,559)

$

274,941

$

277,673

$

(3,013)

$

274,660

Total interest expense related to the Convertible Senior Notes is as follows:

For the year ended December 31,

    

2023

2022

2021

 

(in thousands)

Cash Interest Expense

 

  

  

Coupon interest expense - 2023 Notes

$

23

$

545

$

3,138

Coupon interest expense - 2025 Notes

2,360

4,637

4,637

Coupon interest expense - 2027 Notes

2,385

4,688

4,688

Coupon interest expense - 2029 Notes

4,078

Non-cash Interest Expense

 

 

 

Amortization of debt discount/transaction costs- 2023 Notes

 

4

 

97

 

4,932

Amortization of debt discount/transaction costs- 2025 Notes

240

457

4,795

Amortization of debt discount/transaction costs- 2027 Notes

220

408

4,092

Amortization of debt discount/transaction costs- 2029 Notes

654

Total Interest Expense

$

9,964

$

10,832

$

26,282

F-28



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

For the year ended
December 31,

 

 

 

2017

 

 

 

(in thousands)

 

Cash Interest Expense

 

 

 

Coupon interest expense

 

$

8,901

 

Non-Cash Interest Expense

 

 

 

Amortization of debt discount

 

9,490

 

Amortization of transaction costs

 

956

 

Total Interest Expense

 

$

19,347

 

The Company determined the Convertible Senior2025 Notes is a, 2027 Notes, and 2029 Notes are Level 2 liabilityliabilities in the fair value hierarchy and had estimated its fair value as $300.7 millionvalues at December 31, 2017.2023 of $36.5 million, $57.6 million, and $298.0 million, respectively.

NoteCapped Call Transactions

In connection with the offering of the 2027 Notes, on May 13, — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rate changes could affect2020, the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company entered into monthly forward derivative contractsprivately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price

F-32

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the intentcapped call counterparties, are not part of mitigatingthe terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of this risk.the net proceeds from the offering of the 2027 Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

Revolving Credit Facility

On December 16, 2021, the Company entered into a loan and security agreement providing for a senior secured revolving credit facility in an aggregate principal amount of $150 million (the “Credit Facility”), including a $15 million letter of credit sublimit. The Credit Facility is guaranteed by the Company’s direct material U.S. subsidiaries, subject to customary exceptions. Borrowings under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company, subject to customary exceptions. The Credit Facility has a term of five years, maturing on December 16, 2026, or earlier if certain liquidity measures are not met prior to the 2025 Notes maturing. Subject to certain conditions and the receipt of commitments from the lenders, the Loan and Security Agreement allows for revolving commitments under the Credit Facility to be increased by up to $75 million. The existing lenders under the Credit Facility are entitled, but not obligated, to provide such incremental commitments.

Borrowings will bear interest at a floating rate which can be, at the Company’s option, either (a) an alternate base rate plus an applicable rate ranging from 0.50% to 1.25% or (b) a SOFR rate (with a floor of 0.00%) for the specified interest period plus an applicable rate ranging from 1.50% to 2.25%, in each case, depending on the Company’s Secured Net Leverage Ratio (as defined in the Loan and Security Agreement). The Company only used derivativewill pay an unused commitment fee ranging from 0.25% to 0.35% based on unused capacity under the Credit Facility and the Company’s Secured Net Leverage Ratio. The Company may use the proceeds of borrowings under the Credit Facility to pay transaction fees and expenses, provide for its working capital needs and reimburse drawings under letters of credit and for other general corporate purposes.

The Loan and Security Agreement contains customary affirmative covenants for transactions of this type, including, among others, the provision of financial instrumentsand other information to the administrative agent, notice to the administrative agent upon the occurrence of certain material events, preservation of existence, maintenance of properties and insurance, compliance with laws, including environmental laws, the provision of additional guarantees, and an affiliate transactions covenant, subject to certain exceptions. The Loan and Security Agreement contains customary negative covenants, including, among others, restrictions on the ability to merge and consolidate with other companies, incur indebtedness, refinance our existing convertible notes, grant liens or security interests on assets, make investments, acquisitions, loans, or advances, pay dividends, and sell or otherwise transfer assets.

F-33

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Loan and Security Agreement contains financial maintenance covenants that require the Borrower to maintain an Interest Coverage Ratio (as defined in the contextLoan and Security Agreement) of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts were recorded as “Other, net”less than 3.00 to 1.00, a Total Net Leverage Ratio (as defined in the Company’s Consolidated StatementsLoan and Security Agreement) of Operations.not more than 4.50 to 1.00, and a Secured Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 2.50 to 1.00, in each case, tested at the end of each fiscal quarter commencing with the fiscal quarter ending March 31, 2023. The Company executed derivative transactions with highly rated financial institutionsLoan and Security Agreement also provides for a number of customary events of default, including, among others: payment defaults to mitigate counterparty risk.the lenders; voluntary and involuntary bankruptcy proceedings; covenant defaults; material inaccuracies of representations and warranties; certain change of control events; material money judgments; and other customary events of default. The occurrence of an event of default could result in the acceleration of obligations and the termination of lending commitments under the Loan and Security Agreement.

A summaryNo amounts were outstanding under the Credit Facility as of the foreign exchange derivatives outstanding on December 31, 2017 is as follows:

 

 

Fair Value

 

Maturity Dates

 

Notional Amount

 

 

 

(in thousands)

 

Foreign currency exchange forwards

 

$

 

January 2018

 

$

622

 

The Company did not have any outstanding derivative contracts at2023 or December 31, 2016.2022.

The following table shows the gains and (losses) from currency exchange derivatives during the years ended December 31, 2017, 2016, and 2015, which are included in “Other, net” in the Consolidated Statements of Operations:

 

 

Year ended December 31,

 

 

 

2017

 

2016

 

2015

 

 

 

(in thousands)

 

Foreign currency exchange forwards

 

$

(6

)

$

219

 

$

 

Note 1412 — Stockholders’ Equity

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

Unrealized

Gains (Losses)

Foreign

on Available

Currency

for Sale 

    

Translation

    

Securities

    

Total

(in thousands)

Balance - December 31, 2020

$

1,866

$

(20)

$

1,846

Other comprehensive income (loss)

(52)

(311)

(363)

Balance - December 31, 2021

1,814

(331)

1,483

Other comprehensive income (loss)

(41)

(514)

(555)

Balance - December 31, 2022

$

1,773

$

(845)

$

928

Other comprehensive income (loss)

 

(12)

 

691

 

679

Balance - December 31, 2023

$

1,761

$

(154)

$

1,607

F-29



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

 

 

 

 

Unrealized

 

 

 

 

 

Foreign Currency

 

Minimum Pension

 

Gains (Losses) on
Available for Sale

 

 

 

 

 

Translation

 

Liability

 

Securities

 

Total

 

 

 

(in thousands)

 

Balance - December 31, 2014

 

$

2,333

 

$

(881

)

$

17

 

$

1,469

 

Other comprehensive income (loss)

 

(87

)

15

 

(49

)

(121

)

Balance - December 31, 2015

 

2,246

 

(866

)

(32

)

1,348

 

Other comprehensive income (loss), before reclassifications

 

(19

)

 

(6

)

(25

)

Amounts reclassified from AOCI

 

(430

)

866

 

18

 

454

 

Other comprehensive income (loss)

 

(449

)

866

 

12

 

429

 

Balance - December 31, 2016

 

1,797

 

 

(20

)

1,777

 

Other comprehensive income (loss)

 

42

 

 

(7

)

35

 

Balance - December 31, 2017

 

$

1,839

 

$

 

$

(27

)

$

1,812

 

The Company did not allocate additional tax expense (benefit) to other comprehensive income (loss) for allthe years presentedended December 31, 2021, as the Company iswas in a full valuation allowance position such that a deferred tax asset related to amounts recognized in other comprehensive income iswas not regarded as realizable on a more-likely-than-not basis.

During 2016, The Company allocated an immaterial amount of additional tax benefit to other comprehensive income (loss) for the year ended December 31, 2022, as the Company finalized the processis no longer in a full valuation allowance position. The Company allocated an immaterial amount of additional tax expense to terminate a defined benefit plan. As a result, the Company reclassified the minimum pension liability of $0.9 million, net of a tax benefit of $0.4 million, from “Accumulated other comprehensive income” inincome (loss) for the Consolidated Balance Sheets to “Other, net” in the Consolidated Statements of Operations. Additionally the Company completed its plan to liquidate one of its subsidiaries in Korea. As a result of this liquidation, a cumulative translation gain of $0.4 million was reclassified from “Accumulated other comprehensive income” to “Other, net” in the Consolidated Statements of Operations.year ended December 31, 2023.

Preferred Stock

The Board of Directors has authority under the Company’s Certificate of Incorporation to issue shares of preferred stock, par value $0.01, with voting and economic rights to be determined by the Board of Directors. As of December 31, 2017,2023, no preferred shares have been issued.

Treasury StockF-34

The share repurchase program authorized by our Board of Directors in October 2015 expired on October 28, 2017. On December 11, 2017, our Board of Directors authorized a new program to repurchase up to $100 million of our common stock to be completed through December 11, 2019. At December 31, 2017, $3.0 million of the $100 million had been utilized, of which approximately $0.1 million is included in “Accrued expenses and other current liabilities” on the Consolidated Balance Sheets as of December 31, 2017. Repurchases are expected to be made from time to time in the open market or in privately negotiated transactions in accordance with applicable federal securities laws.

The Company records treasury stock purchases under the cost method using the first-in, first-out (“FIFO”) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and if additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is charged to accumulated deficit.

F-30



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 1513 — Stock Plans

Share-based incentive awards are provided to employees under the terms of the Company’s equity incentive compensation plans (the “Plans”), which are administered by the Compensation Committee of the Board of Directors. The 2019 Plan originated as the 2010 Stock Incentive Plan and was originally approved by the Company’s shareholders.shareholders in May 2010. This Plan was subsequently amended, as approved by shareholders, in 2013, 2016, 2019 (at which time the Plan was renamed the 2019 Stock Incentive Plan), and 2022 (as amended to date, the “2019 Plan”). The Company’s employees, non-employee directors, and consultants are eligible to receive awards under the 2010 Stock Incentive2019 Plan, (as amended to date, the “2010 Plan”), which can include non-qualified stock options, incentive stock options, restricted share awards (“RSAs”), restricted share units (“RSUs”), performance share awards (“PSAs”), performance share units (“PSUs”),RSAs, RSUs, PSAs, PSUs, share appreciation rights, dividend equivalent rights, or any combination thereof. The Company settles awards under the Plans with newly issued shares or with shares held in treasury.

In 2013, the Board of Directors granted equity awards to certain employees under the Company’s 2013 Inducement Stock Incentive Plan (the “Inducement Plan”). The Company issued 124,500 stock option shares and 87,000 RSUs under this plan. Stock options under this plan vest over a three year period and have a 10-year term, and RSUs under this plan vest over a two or four year period. At December 31, 2013, the Inducement Plan was merged into the 2010 Plan and is considered an inactive plan with no further shares available for grant. At December 31, 2017 there are 2,000 option shares and no RSUs outstanding under the Inducement Plan.

The Company is authorized to issue up to 10.617.8 million shares under the 2010 Plan, including additional shares authorized under plan amendments approved by shareholders in 2016 and 2013.2019 Plan. Option awards are granted with an exercise price equal to the closing price of the Company’s common stock on the trading day prior to the date of grant; option awards generally vest over a three year period and have a seven or ten year term. RSAs and RSUs generally vest over one to five years. Certain option and share awards provide for accelerated vesting if there is a change in control, as defined in the 20102019 Plan. At December 31, 2017,2023, there are 1.4 millionis an immaterial amount of option shares and 0.61.7 million RSUs and PSUs outstanding under the 20102019 Plan.

During 2016 the Company’s Board of Directors approved the 2016 Employee Stock Purchase Plan (“ESPP”). The Company is authorized to issue up to 750,0002.25 million shares under the ESPP.approved 2016 employee stock purchase plan (“ESPP”), including additional shares authorized under plan amendments approved by shareholders in 2019 and 2021. Under the ESPP, substantially all employees in the U.S. may purchase the Company’s common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of the Company’s common stock at the beginning or end of each six-month Offer Period,offer period, as defined in the ESPP, and subject to certain limits. The ESPP was approved by the Company’s shareholders.

During 2017, in connection with the acquisition of Ultratech, the Company assumed certain restricted stock units (the “Assumed RSUs”) available and outstanding under the Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan, as amended (the “Ultratech Plan”). The Assumed RSUs remain subject to the terms set forth in the award agreement governing the award and the Ultratech Plan, except that the Assumed RSUs relate to shares of Company common stock and the number of restricted stock units was adjusted pursuant to the terms of the acquisition to reflect the difference in the value of a share of Company common stock and a share of Ultratech common stock prior to closing the acquisition. The Assumed RSUs were converted into 338,144 restricted stock units of the Company, and generally vest over 50 months. After the acquisition and notwithstanding any other provisions of the Ultratech Plan, no further grants will be made under the Ultratech Plan, and the Company is solely maintaining the Ultratech Plan with respect to the Assumed RSUs. At December 31, 2017, there are 0.1 million RSUs outstanding under the assumed Ultratech Plan.

Shares Reserved for Future Issuance

At December 31, 2017,2023, the Company has 5.74.5 million shares reserved to cover exercises of outstanding stock options, vesting of RSUs, and additional grants under the 20102019 Plan.At December 31, 2017,2023, the Company has 0.50.4 million shares reserved to cover future issuances under the ESPP Plan.

F-31



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Share-Based Compensation

The Company recognized share-based compensation in the following line items in the Consolidated Statements of Operations for the periods indicated:

For the year ended December 31,

    

2023

    

2022

    

2021

 

For the year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

(in thousands)

Cost of sales

 

$

2,505

 

$

1,956

 

$

2,495

 

 

$

4,913

 

$

4,551

 

$

2,373

Research and development

 

2,957

 

3,324

 

4,031

 

8,994

6,682

3,850

Selling, general, and administrative

 

12,851

 

10,433

 

11,474

 

14,651

11,761

9,026

Restructuring

 

1,880

 

 

 

Acquisition costs

 

4,203

 

 

 

Total

 

$

24,396

 

$

15,713

 

$

18,000

 

$

28,558

$

22,994

$

15,249

The Company did not realize any tax benefits associated with share-based compensation for the yearsyear ended December 31, 2017, 2016, and 2015,2021 due to the full valuation allowance on its U.S. deferred tax assets. See Note 17,15, “Income Taxes” for additional information. The Company recognized a tax benefit of approximately $3.9 million and $4.5 million associated with share-based compensation for the years ended December 31, 2023 and 2022, respectively. The Company capitalized an insignificantimmaterial amount of share-based compensation into inventory for the years ended December 31, 2017, 2016,2023, 2022, and 2015.2021.

F-35

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Unrecognized share-based compensation costs at December 31, 20172023 are summarized below:

    

Unrecognized

    

Weighted

Share-Based

Average Period

Compensation

Expected to be

Costs

Recognized

 

Unrecognized

 

Weighted

 

 

Share-Based

 

Average Period

 

 

Compensation

 

Expected to be

 

 

Costs

 

Recognized

 

 

(in thousands)

 

(in years)

 

Stock option awards

 

$

 12

 

0.3

 

(in thousands)

(in years)

Restricted stock units

 

6,157

 

2.8

 

$

19,428

2.1

Restricted stock awards

 

21,656

 

2.6

 

 

9,967

1.2

Performance share units

 

4,685

 

2.1

 

 

7,875

1.8

Total unrecognized share-based compensation cost

 

$

32,510

 

2.7

 

 

$

37,270

1.8

Stock Option Awards

Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2017, options outstanding that have vested and are expected to vest are as follows:

 

 

 

 

 

 

Weighted

 

 

 

 

 

Number

 

Weighted

 

Average

 

Aggregate

 

 

 

of

 

Average

 

Remaining

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Contractual Life

 

Value

 

 

 

(in thousands)

 

 

 

(in years)

 

(in thousands)

 

Vested

 

1,389

 

$34.99

 

3.9

 

 

Expected to vest

 

5

 

30.18

 

4.2

 

 

Total

 

1,394

 

$34.97

 

3.9

 

 

F-32



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The aggregate intrinsic value represents the difference between the option exercise price and $14.85, the closing price of the Company’s common stock on December 29, 2017, the last trading day of the Company’s fiscal year as reported on the NASDAQ Stock Market.

Additional information with respect to stock option activity:

 

 

Number of
Shares

 

Weighted
Average
Exercise Price

 

 

 

(in thousands)

 

 

 

Balance - December 31, 2014

 

2,391

 

$

31.65

 

Granted

 

17

 

30.22

 

Exercised

 

(192

)

12.95

 

Expired or forfeited

 

(152

)

38.15

 

Balance - December 31, 2015

 

2,064

 

32.91

 

Granted

 

 

 

Exercised

 

(194

)

12.18

 

Expired or forfeited

 

(294

)

34.44

 

Balance - December 31, 2016

 

1,576

 

35.18

 

Granted

 

 

 

Exercised

 

(18

)

30.03

 

Expired or forfeited

 

(164

)

37.47

 

Balance - December 31, 2017

 

1,394

 

$

34.97

 

The following table summarizes the equity activity related to stock options:

Weighted 

Number of

Average

    

Shares

    

Exercise Price

(in thousands)

Balance - December 31, 2020

730

$

35.26

Exercised

(2)

 

23.36

Expired

(285)

40.16

Balance - December 31, 2021

443

32.15

Expired

(266)

32.95

Balance - December 31, 2022

177

30.94

Exercised

(2)

30.47

Expired

(165)

30.53

Balance - December 31, 2023

10

$

37.42

At December 31, 2023, stock option information at December 31, 2017:

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Aggregate

 

Average

 

Weighted

 

 

 

Aggregate

 

Average

 

Weighted

 

Range of

 

 

 

Intrinsic

 

Remaining

 

Average

 

 

 

Intrinsic

 

Remaining

 

Average

 

Exercise Prices

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

$20.00 – $30.00

 

25

 

$

 

5.0

 

$

28.13

 

23

 

$

 

5.0

 

$

28.03

 

$30.01 – $40.00

 

1,197

 

 

4.0

 

32.84

 

1,194

 

 

4.0

 

32.84

 

$40.01 – $50.00

 

39

 

 

1.3

 

48.05

 

39

 

 

1.3

 

48.05

 

$50.01 – $60.00

 

133

 

 

3.3

 

51.70

 

133

 

 

3.3

 

51.70

 

 

 

1,394

 

 

3.9

 

$

34.97

 

1,389

 

$

 

3.9

 

$

34.99

 

The fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model.

Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive equity awards. No options were granted in 2017 or 2016. Theshares outstanding had a weighted average estimated valuesremaining contractual life of employee stock option grants as well as the weighted average assumptions that were used in calculating such values during fiscal year 2015 was based on estimates at the date of grant as follows:0.5 years.

F-33



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Year ended December 31,

 

 

 

2015

 

Weighted average fair value

 

$

10.58

 

Dividend yield

 

0

%

Expected volatility factor(1)

 

44

%

Risk-free interest rate(2)

 

1.18

%

Expected life (in years)(3)

 

3.9

 


(1)         Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term of the options and the implied volatility derived from the market prices of the Company’s traded options.

(2)         The risk-free rate for periods within the contractual term of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant.

(3)         The expected life is the number of years the Company estimates that options will be outstanding prior to exercise. The Company’s computation of expected life was determined using a lattice-based model incorporating historical post vest exercise and employee termination behavior.

The following table summarizes information on options exercised for the periods indicated:

Year ended December 31,

    

2023

    

2022

    

2021

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

(in thousands)

Cash received from options exercised

 

$

431

 

$

494

 

$

2,233

 

$

56

$

$

37

Intrinsic value of options exercised

 

$

51

 

$

1,165

 

$

2,089

 

$

56

$

$

6

RSAs, RSUs, PSAs, PSUs

RSAs are stock awards issued to employees and directors that are subject to specified restrictions and a risk of forfeiture. RSUs are stock awards issued to employees that entitle the holder to receive shares of common stock as the awards vest. PSAs and PSUs are awards that result in a payment to a grantee inan issuance of shares of common stock to employees if certain performance goals and vesting criteriaor market conditions are achieved. TheseAll of these awards typically vest over one to fivefour years and vesting is subject to the grantee’semployee's continued service with the Company and, in the case of performance awards, meeting thecertain performance condition.or market conditions. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant.grant, or, in the case of performance awards with market conditions, fair value is determined using a Monte Carlo simulation.

F-36

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The following table summarizes the equity activity of non-vested restricted shares and performance shares:

    

    

Weighted

Average

Number of

Grant Date

Shares

Fair Value

(in thousands)

Balance - December 31, 2020

 

2,040

$

12.73

Granted

 

1,031

24.26

Performance award adjustments

159

18.38

Vested

 

(1,014)

15.50

Forfeited

(133)

15.08

Balance - December 31, 2021

2,083

17.33

Granted

1,253

29.12

Performance award adjustments

85

14.03

Vested

(844)

15.00

Forfeited

(81)

20.18

Balance - December 31, 2022

2,496

23.83

Granted

1,282

23.83

Performance award adjustments

183

10.59

Vested

(1,364)

17.47

Forfeited

(133)

29.29

Balance - December 31, 2023

2,464

$

26.19

F-34



TableThe total fair value of Contents

Veeco Instruments Inc.shares that vested during the years ended December 31, 2023, 2022, and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Number of
Shares

 

Weighted
Average
Grant Date
Fair Value

 

 

 

(in thousands)

 

 

 

Balance - December 31, 2014

 

1,237

 

$

34.27

 

Granted

 

672

 

30.33

 

Vested

 

(389

)

35.65

 

Forfeited

 

(122

)

34.46

 

Balance - December 31, 2015

 

1,398

 

31.97

 

Granted

 

1,166

 

17.59

 

Vested

 

(349

)

32.73

 

Forfeited

 

(266

)

27.31

 

Balance - December 31, 2016

 

1,949

 

23.85

 

Granted

 

674

 

29.22

 

Performance award adjustments

 

(25

)

20.95

 

Assumed from Ultratech

 

338

 

31.75

 

Vested

 

(831

)

27.67

 

Forfeited

 

(225

)

26.29

 

Balance - December 31, 2017

 

1,880

 

$

25.41

 

2021 was $30.3 million, $22.1 million, and $22.8 million, respectively. For performance awards, the final number of shares earned will vary depending on the achievement of the actual results relative to the performance targets.or market conditions. Each performance award is included in the table above at the grant date target share amount until the end of the performance period (ifif not previously forfeited). forfeited.

The total fair value of shares that vestedperformance awards with market conditions is estimated on the date of grant using a Monte Carlo simulation. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive these awards. The weighted average fair value and the assumptions used in calculating such values during fiscal years 2023, 2022, and 2021 for performance awards with market conditions were based on estimates at the years ended December 31, 2017, 2016,date of grant as follows:

Year ended December 31,

2023

    

2022

    

2021

Weighted average fair value

$

32.25

$

45.28

$

27.81

Dividend yield

0

%  

0

%  

0

%  

Expected volatility factor(1)

54

%  

58

%  

63

%  

Risk-free interest rate(2)

3.84

%  

2.13

%  

0.34

%  

Expected life (in years)(3)

3.0

 

3.0

 

3.0

(1)Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.
(2)The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.
(3)The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise.

F-37

Table of Contents

Veeco Instruments Inc. and 2015 was $22.3 million, $7.5 million, and $9.6 million, respectively.Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Employee Stock Purchase Plan

For the years ended December 31, 20172023, 2022, and 2016,2021 the Company received cash proceeds of $2.6$4.6 million, $3.7 million, and $1.2$3.4 million, and issued shares of 163,000258,153, 208,140, and 83,000,196,024, respectively, under the ESPP Plan. The weighted average estimated values of employee purchase rights as well as the weighted average assumptions that were used in calculating such values during fiscal years 20172023, 2022, and 20162021 were based on estimates at the date of grant as follows:

 

Year ended December 31,

 

 

2017

 

2016

 

Year ended December 31,

 

2023

    

2022

    

2021

 

Weighted average fair value

 

$

7.09

 

$

4.45

 

$

5.77

$

6.00

$

5.90

Dividend yield

 

0

%

0

%

0

%  

0

%  

0

%

Expected volatility factor(1)

 

36

%

43

%

Risk-free interest rate(2)

 

0.99

%

0.35

%

Expected life (in years)(3)

 

0.5

 

0.5

 

Expected volatility factor(1)

42

%  

43

%  

52

%

Risk-free interest rate(2)

5.03

%  

1.73

%  

0.07

%

Expected life (in years)(3)

0.5

 

0.5

 

0.5

(1)Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.
(2)The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.
(3)The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise.


(1)         Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term of the options and the implied volatility derived from the market prices of the Company’s traded options.

(2)         The risk-free rate for periods within the contractual term of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant.

(3)         The expected life is the number of years the Company estimates that options will be outstanding prior to exercise. The Company’s computation of expected life was determined using a lattice-based model incorporating historical post vest exercise and employee termination behavior.

F-35



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 1614 — Retirement Plans

The Company maintains a defined contribution plan for the benefit of its U.S. employees. The plan is intended to be tax qualified and contains a qualified cash or deferred arrangement as described under Section 401(k) of the Internal Revenue Code. Eligible participants may elect to contribute a percentage of their base compensation, and the Company may make matching contributions, generally equal to fifty cents for every dollar employees contribute, up to the lesser of three percent of the employee’s eligible compensation, or three percent of the maximum the employee is permitted to contribute under thenas limited by current Internal Revenue Code limitations.regulations. Generally, the plan calls for vesting in the Company contributions over the initial five years of a participant’s employment. In addition, the Company assumed Ultratech’s 401(k) plan as a result of the merger, and Ultratech’s plan was merged into the Company’s existing plan effective January 1, 2018. The Company recognized costsprovided employer contributions associated with these plansthis plan of approximately $2.7$3.4 million, $2.6$3.0 million, and $2.5$2.6 million for the years ended December 31, 2017, 2016,2023, 2022, and 2015,2021, respectively.

During 2016, the Company finalized the process to terminate a defined benefit plan it had acquired in the year 2000. The plan had been frozen as of September 30, 1991, and no further benefits had been accrued by participants since that date. In connection with the termination, responsibility for the payment of benefits under the plan was transferred to an insurance company. As a result, the Company reclassified the minimum pension liability of $0.9 million, net of a tax benefit of $0.4 million, from “Accumulated other comprehensive income” in the Consolidated Balance Sheets to “Other, net” in the Consolidated Statements of Operations.

Note 1715 — Income Taxes

The amounts of income (loss) before income taxes attributable to domestic and foreign operations were as follows:

Year ended December 31,

    

2023

    

2022

    

2021

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

(in thousands)

Domestic

 

$

(96,809

)

$

(123,021

)

$

(53,553

)

$

(33,383)

$

47,368

$

23,561

Foreign

 

15,909

 

3,577

 

30,907

 

 

5,045

 

3,617

 

2,119

Total

 

$

(80,900

)

$

(119,444

)

$

(22,646

)

$

(28,338)

$

50,985

$

25,680

F-38

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Significant components of the expense (benefit) for income taxes consisted of the following:

Year ended December 31,

    

2023

    

2022

    

2021

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

(in thousands)

Current:

 

 

 

 

 

 

 

Federal

 

$

 

$

 

$

139

 

$

3,299

$

$

Foreign

 

(2,246

)

1,937

 

6,952

 

 

1,136

 

1,506

 

183

State and local

 

15

 

(111

)

(407

)

 

(194)

 

577

 

110

Total current expense (benefit) for income taxes

 

(2,231

)

1,826

 

6,684

 

 

4,241

 

2,083

 

293

Deferred:

 

 

 

 

 

 

 

Federal

 

(34,786

)

1,459

 

2,104

 

 

(3,026)

 

(96,811)

 

119

Foreign

 

1,652

 

(646

)

516

 

 

512

 

(484)

 

(507)

State and local

 

(742

)

127

 

28

 

 

303

 

(20,745)

 

(263)

Total deferred expense (benefit) for income taxes

 

(33,876

)

940

 

2,648

 

 

(2,211)

 

(118,040)

 

(651)

Total expense (benefit) for income taxes

 

$

(36,107

)

$

2,766

 

$

9,332

 

$

2,030

$

(115,957)

$

(358)

F-36



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The income tax expense (benefit) was reconciled to the tax expense computed at the U.S. federal statutory tax rate as follows:

Year ended December 31,

    

2023

    

2022

    

2021

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

(in thousands)

Income tax expense (benefit) at U.S. statutory rates

 

$

(28,315

)

$

(41,806

)

$

(7,926

)

$

(5,951)

$

10,706

$

5,393

State taxes, net of U.S. federal impact

 

(2,523

)

(1,963

)

(1,607

)

 

1,073

 

1,101

 

(607)

Effect of international operations

 

9,355

 

8,849

 

(7,659

)

 

(7,668)

 

(11,149)

 

609

Research and development tax credit

 

620

 

(801

)

(1,628

)

 

(7,287)

 

(6,470)

 

(3,964)

Net change in valuation allowance

 

1,342

 

50,520

 

23,655

 

 

662

 

(104,972)

 

(2,389)

Change in accrual for unrecognized tax benefits

 

(4,772

)

(1,700

)

4,876

 

 

(369)

 

3,349

 

398

Subsidiary liquidation

 

 

(12,435

)

 

Share-based compensation

 

99

 

2,133

 

 

2,084

606

1,208

Effect of 2017 Tax Act

 

(11,344

)

 

 

Worthless stock deduction

 

 

 

(2,069

)

Change in entity tax status

 

 

 

904

 

Extinguishment of debt

19,289

(1,090)

Adoption of new accounting standard

(9,295)

Other

 

(569

)

(31

)

786

 

 

197

 

167

 

84

Total expense (benefit) for income taxes

 

$

(36,107

)

$

2,766

 

$

9,332

 

$

2,030

$

(115,957)

$

(358)

The 2017 income tax benefit of $36.1 million includes a $24.2 million income tax benefit related to domestic losses incurred during the year ended December 31, 2017, as the deferred tax liability created by the issuance of the Convertible Senior Notes and recorded as a component of APIC is treated as a source of income in fiscal 2017. Additionally, on December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”). The 2017 Tax Act makes broad and complex changes to the U.S. tax code that affects the Company’s 2017 financial results, including, but not limited to, a one-time transition tax on certain foreign earnings. The 2017 Tax Act also establishes new tax laws that will affect the Company’s financial results after 2017, including a reduction in the U.S. federal corporate income tax rate from 35 percent to 21 percent; current U.S. taxation of global intangible low tax income (“GILTI”) of non-U.S. operations; additional limitations on the deductibility of executive compensation; and limitations on the deductibility of interest.F-39

The Company recognized the income tax effects of the 2017 Tax Act in its 2017 financial statements in accordance with SAB 118, which provides SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. As such, the Company’s financial results reflect the income tax effects of the 2017 Tax Act, including provisional amounts for specific income tax effects of the 2017 Tax Act for which the accounting under ASC 740 is incomplete but for which a reasonable estimate could be determined. The Company will complete its analysis and finalize the amounts within the measurement period as provided by SAB 118.

The Company is still in the process of evaluating the impacts of the 2017 Tax Act and considers the amounts recorded to be provisional, except for the impact of the change in tax rate on its deferred tax assets and liabilities as of December 31, 2017, for which the accounting is complete.

The most significant impacts of the 2017 Tax Act on the Company’s federal income taxes are as follows:

Reduction of the U.S. Corporate Income Tax Rate

The Company measures deferred tax assets and liabilities using enacted tax rates that will apply in the years in which the temporary differences are expected to be recovered or paid. Accordingly, the Company’s deferred tax assets and liabilities were re-measured as of December 22, 2017 to reflect the reduction in the U.S. corporate income tax rate from 35 percent to 21 percent. The Company recorded an income tax benefit of $4.8 million, as the net deferred tax assets were reduced by $25.6 million, with a corresponding valuation allowance reduction of $30.4 million.

One-Time Transition Tax on Foreign Earnings

As of December 31, 2017, the Company had $155.8 million of accumulated undistributed earnings generated by its non-U.S. subsidiaries, of which approximately $140.2 million was subject to the one-time transition tax on foreign earnings. The determination of the transition tax requires further analysis regarding the amount and composition of the Company’s historical foreign earnings, which is expected to be completed in the second half of 2018. The Company is expecting to

F-37



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

fully offset the U.S. tax liability with certain current year and carryforward tax attributes. As the Company maintains a full valuation allowance against its U.S. deferred tax assets, the Company did not record an income tax expense related to the transition tax.

Valuation Allowance

The 2017 Tax Act modified the net operating loss (“NOL”) provisions to provide for an indefinite carryforward of NOLs arising in tax years beginning after December 31, 2017. The 2017 Tax Act also limits the amount of NOL deductions that can be used in any one year to 80 percent of the taxpayer’s taxable income, effective with respect to NOLs arising in tax years beginning after December 31, 2017. The Company recognized an income tax benefit of $6.5 million for the year ended December 31, 2017 related to a reduction in the Company’s valuation allowance as a result of the Company scheduling out the reversals of its net deferred tax assets which resulted in tax amortization on indefinite-lived intangible assets becoming available to offset existing deferred tax assets that are now expected to have an indefinite life.

Deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes. The tax effects of the temporary differences were as follows:

December 31,

    

2023

    

2022

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Deferred tax assets:

 

 

 

 

 

Inventory valuation

 

$

8,007

 

$

6,681

 

 

$

12,682

$

11,931

Net operating losses

 

73,458

 

54,527

 

5,841

 

5,647

Credit carry forwards

 

34,966

 

24,598

 

49,086

59,988

Warranty and installation accruals

 

1,690

 

1,757

 

1,766

 

1,862

Share-based compensation

 

7,385

 

12,624

 

4,637

 

5,267

Contract liabilities

19,785

24,504

Operating leases

8,034

8,349

Research and experimental ("R&E") capitalization

34,504

19,071

Other

 

1,966

 

6,778

 

4,885

 

6,553

Total deferred tax assets

 

127,472

 

106,965

 

141,220

 

143,172

Valuation allowance

 

(100,684

)

(106,793

)

(11,745)

 

(11,083)

Net deferred tax assets

 

26,788

 

172

 

129,475

 

132,089

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Purchased intangible assets

 

45,807

 

11,071

 

14,166

 

8,724

Undistributed earnings

 

 

186

 

Convertible Senior Notes

 

13,534

 

 

(39)

Operating leases

5,548

5,994

Depreciation

 

1,339

 

69

 

(1,588)

 

2,346

Total deferred tax liabilities

 

60,680

 

11,326

 

18,126

 

17,025

Net deferred taxes

 

$

(33,892

)

$

(11,154

)

 

$

111,349

$

115,064

The Company is no longerdoes not permanently reinvesting futurereinvest its earnings from certain foreign jurisdictions and has recorded an expenseaccrued for foreign tax withholdings of $6.2$1.0 million on its unremitted earnings as of December 31, 2017.2023.

During the year ended December 31, 2023, income tax expense of $2.0 million was primarily comprised of 1) a $16.2 million income tax expense on pre-tax income from operations; 2) a $2.0 million income tax expense for share based compensation, partially offset by 3) a $7.5 million tax benefit related to Foreign-Derived Intangible Income; 4) a $7.7 million tax benefit associated with research and development tax credits; and 5) a $1.0 million tax benefit associated with the loss on extinguishment of convertible notes under Section 249 of the Internal Revenue Code of 1986, as amended (Section 249).

At December 31, 2017, the Company had U.S. federal NOL carryforwards of approximately $301.6 million that will expire between 2024 and 2037, if not utilized. In connection with the Ultratech acquisition, $119.0 million of historical NOL carryforwards were acquired, which are subject to an annual limitation. The Company has $3.5 million of capital loss carryforwards that expire in 2021. At December 31, 2017,2023, the Company had U.S. federal research and development credits of $16.7$34.9 million that will expire between 20182030 and 2037. The Ultratech acquisition resulted in2043. Additionally, the carryover of $10.9 million of research and development credit carryforwards, which are subject to an annual limitation. The Company also has state and local NOL carryforwards of approximately

F-38



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

$127.4 $56.8 million (a net deferred tax asset of $7.6$4.0 million, net of federal tax benefits and before the valuation allowance) that will expire between 20182024 and 2036.2042. Finally, the Company has state credits of $27.1$33.6 million, some of which are indefinite and others that will expire between 20182024 and 2030.2038.

F-40

Table of Contents

Veeco Instruments Inc. and Subsidiaries

The Company makes assessmentsNotes to estimate if sufficient taxable income will be generated in the future to use existing deferred tax assets. As of December 31, 2017, the Company continued to have a cumulative three year loss with respect to its U.S. operations. As such, the Company has recorded a valuation allowance against its U.S. deferred tax assets. During 2017, the Company’s valuation allowance decreased by approximately $6.1 million, primarily related to re-measurement due to the reduction in the U.S. federal corporate income tax rate from 35 percent to 21 percent, utilization of certain carryforward tax attributes used for the mandatory repatriation tax partially offset by an increase in the valuation allowance related to the Ultratech business combination.Consolidated Financial Statements (Continued)

A roll-forward of the Company’s uncertain tax positions for all U.S. federal, state, and foreign tax jurisdictions was as follows:

December 31,

    

2023

    

2022

    

2021

 

December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

(in thousands)

Balance at beginning of year

 

$

7,452

 

$

9,152

 

$

4,276

 

$

16,110

$

12,761

$

12,363

Additions for tax positions related to current year

 

511

 

1,038

 

5,596

 

 

2,596

 

4,180

 

2,642

Additions for tax positions related to prior years

 

3

 

233

 

143

 

 

83

 

 

50

Reductions for tax positions related to prior years

 

(4,877

)

(2,826

)

 

 

(3,048)

 

(731)

 

(1,196)

Reductions due to the lapse of the statute of limitations

 

(122

)

(39

)

(642

)

Settlements

 

(287

)

(106

)

(221

)

 

 

(100)

 

(1,098)

Additions for business combination

 

5,589

 

 

 

Balance at end of year

 

$

8,269

 

$

7,452

 

$

9,152

 

$

15,741

$

16,110

$

12,761

If the amount of unrecognized tax benefits at December 31, 20172023 were recognized, the Company’s income tax provision would decrease by $0.6$13.9 million. The gross amount of interest and penalties accrued in income tax payable in the Consolidated Balance Sheets was approximately $0.3$0.6 million and $0.5 million at both December 31, 20172023 and 2016.2022, respectively.

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction, and various state, local, and foreign jurisdictions. All material consolidated federal income tax matters have been concluded for years through 20142017 subject to subsequent utilization of NOLs generated in such years. All material state and local income tax matters have been reviewed through 2012. The majority of the Company’s foreign jurisdictions have been reviewed through 2015. The Company’s major foreign jurisdictions’ statutes of limitation remain open with respect to the tax years 2016 through 2022 for Germany, 2017 through 2022 for China, 20152022 for Taiwan, and 2020 through 20172022 for Germany and Singapore, and 2016 through 2017 for Taiwan. Income tax matters for Ultratech pre-acquisition periods have been reviewed through 2000 for federal, 1997 for major states and 2003 for foreign jurisdictions.Singapore. The Company does not anticipate that its uncertain tax position will change significantly within the next twelve months subject to the completion of the ongoing tax audits and any resultant settlement.

Note 1816 — Segment Reporting and Geographic Information

The Company operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices. The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results.

Sales by marketend-market is as follows:

For the year ended December 31,

    

    

2023

    

2022

    

2021

(in thousands)

Sales by end-market

Semiconductor

$

412,724

$

369,369

$

247,051

Compound Semiconductor

87,258

121,194

106,972

Data Storage

 

88,473

 

87,544

 

168,760

Scientific & Other

 

77,980

 

68,030

 

60,494

Total

$

666,435

$

646,137

$

583,277

F-39



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

 

 

(in thousands)

 

Sales by end-market

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

253,785

 

$

144,675

 

$

291,133

 

Advanced Packaging, MEMS & RF Filters

 

69,353

 

68,304

 

61,935

 

Scientific & Industrial

 

120,788

 

111,198

 

118,132

 

Front-End Semiconductor

 

40,830

 

8,274

 

5,838

 

Total

 

$

484,756

 

$

332,451

 

$

477,038

 

The Company’s significant operations outside the United States include sales and service offices in China, Europe, and Rest of World.APAC. For geographic reporting, sales are attributed to the location in which the customer facility is located.

F-41

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Sales and long-lived tangible assets by geographic region are as follows:

 

 

Net Sales to Unaffiliated Customers

 

Long-lived Tangible Assets

 

 

 

2017

 

2016

 

2015

 

2017

 

2016

 

2015

 

 

 

(in thousands)

 

United States

 

$

94,936

 

$

85,637

 

$

86,627

 

$

81,046

 

$

60,012

 

$

64,951

 

China

 

107,844

 

85,834

 

242,442

 

64

 

219

 

422

 

EMEA(1)

 

76,636

 

83,410

 

64,019

 

231

 

93

 

96

 

Rest of World

 

205,340

 

77,570

 

83,950

 

3,717

 

322

 

14,121

 

Total

 

$

484,756

 

$

332,451

 

$

477,038

 

$

85,058

 

$

60,646

 

$

79,590

 

Net Sales to Unaffiliated Customers

Long-lived Tangible Assets

    

2023

    

2022

    

2021

    

2023

    

2022

    

2021

(in thousands)

United States

$

162,790

$

197,433

$

217,209

$

117,594

$

106,550

$

99,220

EMEA(1)

 

76,697

 

87,837

 

55,129

 

219

 

60

 

94

China

217,942

123,703

105,998

182

70

67

Rest of APAC

208,693

235,735

204,633

464

601

362

Rest of World

 

313

 

1,429

 

308

 

 

 

Total

$

666,435

$

646,137

$

583,277

$

118,459

$

107,281

$

99,743


(1) 

(1)EMEA consists of Europe, the Middle East, and Africa

Note 19 — Selected Quarterly Financial Information (unaudited)

The following table presents selected unaudited financial data for each fiscal quarter of 2017 and 2016. Although unaudited, this information has been prepared on a basis consistent with the Company’s audited Consolidated Financial Statements and, in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments) that are considered necessary for a fair presentation of this information in accordance with GAAP. Such quarterly results are not necessarily indicative of future results of operations.

 

 

Fiscal 2017

 

Fiscal 2016

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Q1

 

Q2

 

Q3

 

Q4

 

 

 

(in thousands, except per share amounts)

 

Net sales

 

$

94,386

 

$

115,066

 

$

131,872

 

$

143,432

 

$

78,011

 

$

75,348

 

$

85,482

 

$

93,609

 

Gross profit

 

34,200

 

38,720

 

53,061

 

58,337

 

31,956

 

31,439

 

33,455

 

36,008

 

Net income (loss)

 

1,095

 

(18,388

)

(21,884

)

(5,616

)

(15,533

)

(32,082

)

(69,598

)

(4,998

)

Basic income (loss) per common share

 

0.03

 

(0.43

)

(0.47

)

(0.12

)

(0.40

)

(0.82

)

(1.78

)

(0.13

)

Diluted income (loss) per common share

 

0.03

 

(0.43

)

(0.47

)

(0.12

)

(0.40

)

(0.82

)

(1.78

)

(0.13

)

Acquisition of Ultratech

During the second quarter of 2017, the Company acquired Ultratech. The results of operations of Ultratech have been included in the consolidated financial statements since the date of acquisition. Refer to Note 5, “Business Combinations,” for additional information.

Impairment Charge

During the third quarter of 2016, the Company decided to reduce future investments in certain technologies and, as a result, recorded a charge for impairment of $54.3 million for the related intangible purchased technology. The impairment charge was based on projected cash flows that required the use of unobservable inputs. Refer to Note 6, “Goodwill and Intangible Assets,” for additional information.

F-40


F-42


Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Schedule II — Valuation and Qualifying Accounts

 

 

 

Additions

 

 

 

 

 

 

 

 

Charged

 

 

 

 

 

 

 

 

Balance at

 

(Credited)

 

Charged to

 

 

 

Balance at

 

 

Beginning

 

to Costs and

 

Other

 

 

 

End of

 

Additions

Charged

    

Balance at

    

(Credited)

    

Charged to

    

    

Balance at

Beginning

 to Costs and

Other

End of

Deducted from asset accounts:

 

of Period

 

Expenses

 

Accounts

 

Deductions

 

Period

 

of Period

Expenses

Accounts

Deductions

Period

 

(in thousands)

 

Year ended December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

Year ended December 31, 2023

Allowance for doubtful accounts

 

$

286

 

$

99

 

$

 

$

(115

)

$

270

 

$

736

$

316

$

$

(66)

$

986

Valuation allowance in net deferred tax assets

 

106,793

 

(51,410

)

45,301

 

 

100,684

 

 

11,083

 

662

 

 

 

11,745

 

$

107,079

 

$

(51,311

)

$

45,301

 

$

(115

)

$

100,954

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

$

11,819

$

978

$

$

(66)

$

12,731

Year ended December 31, 2022

Allowance for doubtful accounts

 

$

206

 

$

171

 

$

 

$

(91

)

$

286

 

$

736

$

$

$

$

736

Valuation allowance in net deferred tax assets

 

56,273

 

50,520

 

 

 

106,793

 

 

116,054

 

(104,971)

 

 

 

11,083

 

$

56,479

 

$

50,691

 

$

 

$

(91

)

$

107,079

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2015

 

 

 

 

 

 

 

 

 

 

 

$

116,790

$

(104,971)

$

$

$

11,819

Year ended December 31, 2021

Allowance for doubtful accounts

 

$

731

 

$

43

 

$

 

$

(568

)

$

206

 

$

736

$

$

$

$

736

Valuation allowance in net deferred tax assets

 

34,909

 

23,655

 

(2,291

)

 

56,273

 

 

118,443

 

 

 

(2,389)

 

116,054

 

$

35,640

 

$

23,698

 

$

(2,291

)

$

(568

)

$

56,479

 

$

119,179

$

$

$

(2,389)

$

116,790

S-1


S-1